Identification

Name
Paclitaxel
Accession Number
DB01229  (APRD00259, DB05261, DB05927, DB05526, DB05281)
Type
Small Molecule
Groups
Approved, Vet approved
Description

Paclitaxel is a chemotherapeutic agent marketed under the brand name Taxol among others. Used as a treatment for various cancers, paclitaxel is a mitotic inhibitor that was first isolated in 1971 from the bark of the Pacific yew tree which contains endophytic fungi that synthesize paclitaxel. It is available as an intravenous solution for injection and the newer formulation contains albumin-bound paclitaxel marketed under the brand name Abraxane.

Structure
Thumb
Synonyms
  • 5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
  • Paclitaxel
  • Taxol A
External IDs
ABI-007 / BMS 181339-01 / BMS-181339-01 / DHP 107 / MBT 0206 / MBT-0206 / NK 105 / NSC-125973 / QW-8184 / S-8184
Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
AbraxaneInjection, powder, for suspension5 mg/mlIntravenousCelgene Europe Limited2008-01-11Not applicableEu
AbraxaneInjection, powder, for suspension5 mg/mlIntravenousCelgene Europe Limited2008-01-11Not applicableEu
AbraxaneInjection, powder, lyophilized, for suspension100 mg/20mLIntravenousAbraxis BioScience, LLC2005-02-10Not applicableUs
Abraxane for Injectable SuspensionPowder, for suspensionIntravenousCelgene2006-08-31Not applicableCanada
PaclitaxelInjection6 mg/1mLIntravenousWG Critical Care, LLC2013-07-11Not applicableUs
PaclitaxelInjection6 mg/1mLIntravenousWG Critical Care, LLC2013-07-11Not applicableUs
PaclitaxelInjection6 mg/1mLIntravenousWG Critical Care, LLC2013-07-11Not applicableUs
PaclitaxelLiquid6 mgIntravenousIvax Pharmaceuticals IncorporatedNot applicableNot applicableCanada
Paclitaxel for InjectionSolutionIntravenousTEVA Canada LimitedNot applicableNot applicableCanada
Paclitaxel for InjectionSolutionIntravenousBiolyse Pharma Corporation2001-10-31Not applicableCanada
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Aj-paclitaxelSolutionIntravenousAgila Jamp Canada IncNot applicableNot applicableCanada
Apo-paclitaxel InjectableSolutionIntravenousApotex Corporation2005-02-07Not applicableCanada
OnxolInjection, solution, concentrate6 mg/1mLIntravenousIVAX Pharmaceuticals Inc2002-01-252010-07-31Us
PaclitaxelInjection, solution6 mg/1mLIntravenousSagent Pharmaceuticals2011-09-272017-06-30Us
PaclitaxelInjection, solution100 mg/16.7mLIntravenousAlvogen Inc.2017-12-272020-01-01Us
PaclitaxelInjection, solution6 mg/1mLIntravenousBedford Pharmaceuticals2001-08-232013-07-31Us
PaclitaxelInjection, solution6 mg/1mLIntravenousHospira, Inc.2004-03-01Not applicableUs
PaclitaxelInjection, solution6 mg/1mLIntravenousBedford Pharmaceuticals2006-12-012013-04-30Us
PaclitaxelInjection, solution30 mg/5mLIntravenousAlvogen Inc.2017-12-272020-08-01Us
PaclitaxelInjection, solution6 mg/1mLIntravenousFresenius Kabi USA, LLC2009-03-20Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
International/Other Brands
Paxceed
Categories
UNII
P88XT4IS4D
CAS number
33069-62-4
Weight
Average: 853.9061
Monoisotopic: 853.330955345
Chemical Formula
C47H51NO14
InChI Key
RCINICONZNJXQF-MZXODVADSA-N
InChI
InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1
IUPAC Name
(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-2-yl benzoate
SMILES
[H][C@]12[C@H](OC(=O)C3=CC=CC=C3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)C4=CC=CC=C4)C4=CC=CC=C4)C(C)=C([C@@H](OC(C)=O)C(=O)[C@]1(C)[C@@H](O)C[C@H]1OC[C@@]21OC(C)=O)C3(C)C

Pharmacology

Indication

Used in the treatment of Kaposi's sarcoma and cancer of the lung, ovarian, and breast. Abraxane® is specfically indicated for the treatment of metastatic breast cancer and locally advanced or metastatic non-small cell lung cancer.

Associated Conditions
Pharmacodynamics

Paclitaxel is a taxoid antineoplastic agent indicated as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast cancer. Paclitaxel is a novel antimicrotubule agent that promotes the assembly of microtubules from tubulin dimers and stabilizes microtubules by preventing depolymerization. This stability results in the inhibition of the normal dynamic reorganization of the microtubule network that is essential for vital interphase and mitotic cellular functions. In addition, paclitaxel induces abnormal arrays or "bundles" of microtubules throughout the cell cycle and multiple asters of microtubules during mitosis.

Mechanism of action

Paclitaxel interferes with the normal function of microtubule growth. Whereas drugs like colchicine cause the depolymerization of microtubules in vivo, paclitaxel arrests their function by having the opposite effect; it hyper-stabilizes their structure. This destroys the cell's ability to use its cytoskeleton in a flexible manner. Specifically, paclitaxel binds to the β subunit of tubulin. Tubulin is the "building block" of mictotubules, and the binding of paclitaxel locks these building blocks in place. The resulting microtubule/paclitaxel complex does not have the ability to disassemble. This adversely affects cell function because the shortening and lengthening of microtubules (termed dynamic instability) is necessary for their function as a transportation highway for the cell. Chromosomes, for example, rely upon this property of microtubules during mitosis. Further research has indicated that paclitaxel induces programmed cell death (apoptosis) in cancer cells by binding to an apoptosis stopping protein called Bcl-2 (B-cell leukemia 2) and thus arresting its function.

TargetActionsOrganism
ATubulin beta-1 chain
inhibitor
Humans
AApoptosis regulator Bcl-2
inhibitor
Humans
AMicrotubule-associated protein 4Not AvailableHumans
AMicrotubule-associated protein 2Not AvailableHumans
AMicrotubule-associated protein tauNot AvailableHumans
UNuclear receptor subfamily 1 group I member 2
inducer
Humans
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption

When a 24 hour infusion of 135 mg/m^2 is given to ovarian cancer patients, the maximum plasma concentration (Cmax) is 195 ng/mL, while the AUC is 6300 ng•h/mL.

Volume of distribution
  • 227 to 688 L/m^2 [apparent volume of distribution at steady-state, 24 hour infusion]
Protein binding

89%-98% bound to plasma protein. The presence of cimetidine, ranitidine, dexamethasone, or diphenhydramine did not affect protein binding of paclitaxel.

Metabolism

Hepatic. In vitro studies with human liver microsomes and tissue slices showed that paclitaxel was metabolized primarily to 6a-hydrox-ypaclitaxel by the cytochrome P450 isozyme CYP2C8; and to two minor metabolites, 3’-p-hydroxypaclitaxel and 6a, 3’-p-dihydroxypaclitaxel, by CYP3A4.

Route of elimination

In 5 patients administered a 225 or 250 mg/m2 dose of radiolabeled paclitaxel as a 3-hour infusion, a mean of 71% of the radioactivity was excreted in the feces in 120 hours, and 14% was recovered in the urine.

Half life

When a 24 hour infusion of 135 mg/m^2 is given to ovarian cancer patients, the elimination half=life is 52.7 hours.

Clearance
  • 21.7 L/h/m2 [Dose 135 mg/m2, infusion duration 24 h]
  • 23.8 L/h/m2 [Dose 175 mg/m2, infusion duration 24 h]
  • 7 L/h/m2 [Dose 135 mg/m2, infusion duration 3 h]
  • 12.2 L/h/m2 [Dose 175 mg/m2, infusion duration 3 h]
Toxicity

Rat (ipr) LD50=32530 µg/kg. Symptoms of overdose include bone marrow suppression, peripheral neurotoxicity, and mucositis. Overdoses in pediatric patients may be associated with acute ethanol toxicity.

Affected organisms
  • Humans and other mammals
Pathways
PathwayCategory
Paclitaxel Action PathwayDrug action
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
(R)-warfarinThe therapeutic efficacy of (R)-warfarin can be increased when used in combination with Paclitaxel.
(S)-WarfarinThe therapeutic efficacy of (S)-Warfarin can be increased when used in combination with Paclitaxel.
2-MethoxyethanolThe risk or severity of adverse effects can be increased when Paclitaxel is combined with 2-Methoxyethanol.
4-hydroxycoumarinThe therapeutic efficacy of 4-hydroxycoumarin can be increased when used in combination with Paclitaxel.
6-Deoxyerythronolide BThe metabolism of Paclitaxel can be decreased when combined with 6-Deoxyerythronolide B.
7-ethyl-10-hydroxycamptothecinThe metabolism of Paclitaxel can be decreased when combined with 7-ethyl-10-hydroxycamptothecin.
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Paclitaxel.
9-(N-methyl-L-isoleucine)-cyclosporin AThe risk or severity of adverse effects can be increased when Paclitaxel is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
9-aminocamptothecinThe metabolism of Paclitaxel can be decreased when combined with 9-aminocamptothecin.
AbataceptThe metabolism of Paclitaxel can be increased when combined with Abatacept.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
  • Avoid echinacea. Co-administration may decrease the effectiveness of immunosuppressants, and echinacea may induce CYP3A4 increasing paclitaxel metabolism.
  • Exercise caution with grapefruit products. Grapefruit inhibits CYP3A4 metabolism, which may increase the serum concentration of paclitaxel.
  • Exercise caution with St. John's Wort. This herb induces the CYP3A4 metabolism of paclitaxel and may reduce its serum concentration.

References

Synthesis Reference

Hendricus B. A. de Bont, Ruben G. G. Leenders, Johan W. Scheeren, Hidde J. Haisma, Dick de Vos, "Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy." U.S. Patent US5760072, issued September, 1989.

US5760072
General References
  1. Wall ME, Wani MC: Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res. 1995 Feb 15;55(4):753-60. [PubMed:7850785]
  2. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT: Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971 May 5;93(9):2325-7. [PubMed:5553076]
  3. Fuchs DA, Johnson RK: Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat Rep. 1978 Aug;62(8):1219-22. [PubMed:688258]
  4. Saville MW, Lietzau J, Pluda JM, Feuerstein I, Odom J, Wilson WH, Humphrey RW, Feigal E, Steinberg SM, Broder S, et al.: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet. 1995 Jul 1;346(8966):26-8. [PubMed:7603142]
  5. Authors unspecified: ABI 007. Drugs R D. 2004;5(3):155-9. [PubMed:15139776]
  6. Gaitanis A, Staal S: Liposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use. Methods Mol Biol. 2010;624:385-92. doi: 10.1007/978-1-60761-609-2_26. [PubMed:20217610]
External Links
Human Metabolome Database
HMDB0015360
KEGG Drug
D00491
KEGG Compound
C07394
PubChem Compound
36314
PubChem Substance
46506910
ChemSpider
10368587
BindingDB
50001839
RxNav
56946
ChEBI
45863
ChEMBL
CHEMBL428647
ZINC
ZINC000096006020
Therapeutic Targets Database
DNC001411
PharmGKB
PA450761
Guide to Pharmacology
GtP Drug Page
PDBe Ligand
TA1
RxList
RxList Drug Page
Drugs.com
Drugs.com Drug Page
Wikipedia
Paclitaxel
ATC Codes
L01CD01 — Paclitaxel
AHFS Codes
  • 10:00.00 — Antineoplastic Agents
PDB Entries
1jff / 2hxf / 2hxh / 2p4n / 2wbe / 3dco / 3edl / 3iz0 / 3j6g / 3j6p
show 54 more
FDA label
Download (220 KB)
MSDS
Download (74 KB)

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
0Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas1
0CompletedTreatmentBreast Cancer1
0Not Yet RecruitingTreatmentMalignant Neoplasm of Pancreas1
0Not Yet RecruitingTreatmentSquamous Cell Carcinoma (SCC)1
0RecruitingTreatmentAnatomic Stage III Breast Cancer AJCC v8 / Anatomic Stage IIIA Breast Cancer AJCC v8 / Anatomic Stage IIIB Breast Cancer AJCC v8 / Anatomic Stage IIIC Breast Cancer AJCC v8 / Anatomic Stage IV Breast Cancer AJCC v8 / Locally Advanced Breast Carcinoma / Metastatic Triple-Negative Breast Carcinoma / Prognostic Stage III Breast Cancer AJCC v8 / Prognostic Stage IIIA Breast Cancer AJCC v8 / Prognostic Stage IIIB Breast Cancer AJCC v8 / Prognostic Stage IIIC Breast Cancer AJCC v8 / Prognostic Stage IV Breast Cancer AJCC v81
0RecruitingTreatmentBorderline Pancreatic Inoperable Cancer / Locally Advanced Pancreatic Cancer / Malignant Neoplasm of Pancreas1
0RecruitingTreatmentCancer, Anaplastic Thyroid1
0RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC)1
0RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)2
0TerminatedTreatmentAdenocarcinoma of the Pancreas1
0TerminatedTreatmentStage I Non-Small Cell Lung Cancer / Stage II Non-Small Cell Lung Cancer1
0Unknown StatusTreatmentPancreatic Adenocarcinoma Locally Advanced / Pancreatic Adenocarcinoma Metastatic / Pancreatic Adenocarcinoma Resectable1
1Active Not RecruitingDiagnosticMetastatic Breast Cancer / Neoplasms, Breast / Rb+ Breast Cancer1
1Active Not RecruitingOtherNeoplasms, Advanced Solid2
1Active Not RecruitingOtherPancreatic Cancer Metastatic1
1Active Not RecruitingTreatmentAdenocarcinoma of the Cervix / Adenosquamous carcinoma of the cervix / Cervical Squamous Cell Carcinoma / Cervical Squamous Cell Carcinoma, Not Otherwise Specified / Stage IB Cervical Cancer / Stage IB Cervical Cancer AJCC v6 and v7 / Stage IIA Cervical Cancer / Stage IIA Cervical Cancer AJCC v7 / Stage IIB Cervical Cancer / Stage IIB Cervical Cancer AJCC v6 and v7 / Stage IIIA Cervical Cancer / Stage IIIA Cervical Cancer AJCC v6 and v7 / Stage IIIB Cervical Cancer / Stage IIIB Cervical Cancer AJCC v6 and v7 / Stage IVA Cervical Cancer / Stage IVA Cervical Cancer AJCC v6 and v71
1Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas / Borderline Resectable Pancreatic Adenocarcinoma / Locally Advanced Pancreatic Adenocarcinoma / Malignant Neoplasm of Pancreas / Stage II Pancreatic Cancer AJCC v6 and v7 / Stage IIA Pancreatic Cancer AJCC v6 and v7 / Stage IIB Pancreatic Cancer AJCC v6 and v7 / Stage III Pancreatic Cancer AJCC v6 and v71
1Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas / Head and Neck Squamous Cell Carcinoma (HNSCC) / Non-Resectable Cholangiocarcinoma / Pancreatic Adenocarcinoma Metastatic / Recurrent Gallbladder Carcinoma / Recurrent Non-Small Cell Lung Carcinoma / Stage III Pancreatic Cancer / Stage IIIA Gallbladder Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIB Gallbladder Cancer / Stage IIIb Non-small Cell Lung Cancer / Stage IV Gallbladder Cancer / Stage IV Non-Small Cell Lung Cancer / Stage IV Pancreatic Cancer / Unresectable Gallbladder Carcinoma / Unresectable Pancreatic Cancer1
1Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas / Locally Advanced Solid Tumors / Metastatic Solid Tumors1
1Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas / Pancreatic Adenocarcinoma Metastatic / Stage III Pancreatic Cancer AJCC v6 and v7 / Stage IV Pancreatic Cancer / Stage IV Pancreatic Cancer AJCC v6 and v7 / Unresectable Pancreatic Carcinoma1
1Active Not RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Gastric Adenocarcinoma / Gastroesophageal Cancer (GC) / Neoplasms, Esophageal / Squamous Cell Carcinoma (SCC)1
1Active Not RecruitingTreatmentAdult Solid Neoplasm1
1Active Not RecruitingTreatmentAdvanced Breast Cancer2
1Active Not RecruitingTreatmentAdvanced Breast Carcinoma / Metastatic Breast Carcinoma / Stage III Breast Cancer AJCC V7 / Stage IIIA Breast Cancer AJCC v7 / Stage IIIB Breast Cancer AJCC v7 / Stage IIIC Breast Cancer AJCC v7 / Stage IV Breast Cancer AJCC v6 and v7 / Triple-Negative Breast Carcinoma1
1Active Not RecruitingTreatmentAdvanced Malignant Solid Neoplasm / Metastatic Malignant Solid Neoplasm / Unresectable Malignant Solid Neoplasm1
1Active Not RecruitingTreatmentAdvanced Ovarian Cancer / Carboplatin / Paclitaxel / Triple Negative Metastatic Breast Cancer1
1Active Not RecruitingTreatmentAdvanced Solid Tumors1
1Active Not RecruitingTreatmentAdvanced Stage Solid Tumors1
1Active Not RecruitingTreatmentBreast Cancer2
1Active Not RecruitingTreatmentBreast Cancer / Carcinoma, Colorectal / Carcinoma, Pancreatic / Melanoma / Non-Small Cell Lung Carcinoma (NSCLC) / Ovarian Cancer / Prostate Cancer / Renal Cell Adenocarcinoma / Tumors, Solid1
1Active Not RecruitingTreatmentCancer, Advanced3
1Active Not RecruitingTreatmentCancer, Advanced / Metastatic Cancers / Metastatic Non-Small Cell Lung Cancer / Neoplasms / Non Small Cell Lung Cancer Metastatic / Non Small Cell Lung Cancer Stage IIIB / Non-Small Cell Lung Cancer Stage IIIB / Non-Small Cell Lung Carcinoma (NSCLC) / Tumors, Solid1
1Active Not RecruitingTreatmentCarcinoma of Unknown Primary / Carcinoma, Breast / Endometrial Carcinoma / Esophageal Carcinoma / Hepatic Failure / Lung, Carcinoma / Malignant Head and Neck Neoplasm / Malignant Testicular Neoplasm / Melanoma / Metastatic Malignant Neoplasm / Ovarian Carcinoma / Renal Failure / Transitional Cell Carcinoma / Unresectable Malignant Neoplasm1
1Active Not RecruitingTreatmentCarcinoma, Breast / Metastatic Breast Cancer1
1Active Not RecruitingTreatmentCarcinoma, Squamous Cell of Head and Neck / Non-Small Cell Lung Carcinoma (NSCLC) / Small Cell Lung Cancer (SCLC)1
1Active Not RecruitingTreatmentDiseases of Oesophagus Stomach and Duodenum1
1Active Not RecruitingTreatmentEndometrial Adenocarcinomas / Endometrial Adenosquamous Carcinoma / Endometrial Clear Cell Adenocarcinoma / Endometrial Mucinous Adenocarcinoma / Endometrial Serous Adenocarcinoma / Endometrial Squamous Cell Carcinoma / Endometrial Transitional Cell Carcinoma / Endometrial Undifferentiated Carcinoma / Endometrioid Adenocarcinoma / Recurrent Uterine Corpus Carcinoma / Stage III Uterine Corpus Cancer / Stage III Uterine Corpus Cancer AJCC v7 / Stage IIIA Uterine Corpus Cancer / Stage IIIA Uterine Corpus Cancer AJCC v7 / Stage IIIB Uterine Corpus Cancer / Stage IIIB Uterine Corpus Cancer AJCC v7 / Stage IIIC Uterine Corpus Cancer / Stage IIIC Uterine Corpus Cancer AJCC v7 / Stage IV Uterine Corpus Cancer / Stage IV Uterine Corpus Cancer AJCC v7 / Stage IVA Uterine Corpus Cancer / Stage IVA Uterine Corpus Cancer AJCC v7 / Stage IVB Uterine Corpus Cancer / Stage IVB Uterine Corpus Cancer AJCC v7 / Uterine Carcinosarcoma1
1Active Not RecruitingTreatmentEndometrial Cancer / Endometrial Carcinoma / Neoplasms, Endometrial1
1Active Not RecruitingTreatmentEsophageal Cancers / Gastro-esophageal Cancer / Malignant Neoplasm of Stomach1
1Active Not RecruitingTreatmentFallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Cancer1
1Active Not RecruitingTreatmentFallopian Tube Cancer / No Prior Chemotherapy / Ovarian Cancer / Primary Peritoneal Cancer1
1Active Not RecruitingTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer1
1Active Not RecruitingTreatmentFallopian Tube Carcinoma / Fallopian Tube Carcinosarcoma / Fallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Mucinous Adenocarcinoma / Fallopian Tube Serous Neoplasm / Fallopian Tube Transitional Cell Carcinoma / Fallopian Tube Undifferentiated Carcinoma / Ovarian Brenner Tumor / Ovarian Carcinoma / Ovarian Carcinosarcoma / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Adenocarcinoma / Ovarian Seromucinous Tumor / Ovarian Serous Adenocarcinoma / Ovarian Transitional Cell Carcinoma / Ovarian Undifferentiated Carcinoma / Primary Peritoneal Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Stage IIA Fallopian Tube Cancer AJCC v6 and v7 / Stage IIA Ovarian Cancer AJCC V6 and v7 / Stage IIB Fallopian Tube Cancer AJCC v6 and v7 / Stage IIB Ovarian Cancer AJCC v6 and v7 / Stage IIC Fallopian Tube Cancer AJCC v6 and v7 / Stage IIC Ovarian Cancer AJCC v6 and v7 / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIA Primary Peritoneal Cancer AJCC v7 / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIB Primary Peritoneal Cancer AJCC v7 / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IIIC Primary Peritoneal Cancer AJCC v7 / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer AJCC v6 and v7 / Stage IV Primary Peritoneal Cancer AJCC v71
1Active Not RecruitingTreatmentFallopian Tube Carcinoma / Primary Peritoneal Carcinoma / Recurrent Endometrial Cancer / Recurrent Ovarian Cancer1
1Active Not RecruitingTreatmentGastroesophageal Cancer (GC)1
1Active Not RecruitingTreatmentHepatocellular,Carcinoma / Malignant Neoplasm of Pancreas1
1Active Not RecruitingTreatmentMalignancies1
1Active Not RecruitingTreatmentMalignant Neoplasm of Pancreas2
1Active Not RecruitingTreatmentMalignant Neoplasm of Pancreas / Pancreatic Ductal Adenocarcinoma1
1Active Not RecruitingTreatmentMalignant Neoplasm of Pancreas / Resectable Pancreatic Carcinoma / Stage I Pancreatic Cancer AJCC v6 and v7 / Stage IA Pancreatic Cancer AJCC v6 and v7 / Stage IB Pancreatic Cancer AJCC v6 and v7 / Stage II Pancreatic Cancer AJCC v6 and v7 / Stage IIA Pancreatic Cancer AJCC v6 and v7 / Stage IIB Pancreatic Cancer AJCC v6 and v71
1Active Not RecruitingTreatmentMesothelioma1
1Active Not RecruitingTreatmentMetastatic Breast Cancer1
1Active Not RecruitingTreatmentMetastatic Breast Cancer / Recurrent Breast Cancer1
1Active Not RecruitingTreatmentMetastatic Non-Small Cell Lung Cancer1
1Active Not RecruitingTreatmentNeoplasms1
1Active Not RecruitingTreatmentNeoplasms, Gynecologic1
1Active Not RecruitingTreatmentNeoplasms / Non-Small Cell Lung Carcinoma (NSCLC)1
1Active Not RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)3
1Active Not RecruitingTreatmentPancreatic Adenocarcinoma Metastatic1
1Active Not RecruitingTreatmentPancreatic Cancer Metastatic1
1Active Not RecruitingTreatmentPancreatic Cancer Stage III / Pancreatic Cancer Stage IV1
1Active Not RecruitingTreatmentRecurrent Lung Non-Small Cell Carcinoma / Stage III Lung Non-Small Cell Cancer AJCC v7 / Stage IIIA Lung Non-Small Cell Cancer AJCC v7 / Stage IIIB Lung Non-Small Cell Cancer AJCC v71
1Active Not RecruitingTreatmentStage II Non-Small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
1Active Not RecruitingTreatmentStage IIA Non-small Cell Lung Cancer / Stage IIB Non-small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
1Active Not RecruitingTreatmentStage IIIb Non-small Cell Lung Cancer / Stage IIIB Non-Small Cell Lung Cancer AJCC v7 / Stage IV Non-Small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer AJCC v71
1Active Not RecruitingTreatmentTumors, Solid4
1CompletedNot AvailableBone Diseases / Neoplasms1
1CompletedNot AvailableHead and Neck Carcinoma / Lung Cancers / Neurologic toxicity / Ovarian Cancer1
1CompletedNot AvailableMalignancies1
1CompletedBasic ScienceLung Cancers / Non-Small Cell Lung Carcinoma (NSCLC)1
1CompletedOtherAdvanced Solid Tumors, Neoplasms, Advanced Solid1
1CompletedOtherSolid Malignancies1
1CompletedOtherTumors, Solid1
1CompletedSupportive CareUnspecified Adult Solid Tumor, Protocol Specific1
1CompletedTreatmentAdenocarcinoma of the Pancreas / Adult Solid Neoplasm / Advanced Malignant Solid Neoplasm / ALK positive / Pancreatic Adenocarcinoma Metastatic / Solid Neoplasms / Stage III Pancreatic Cancer / Stage IV Pancreatic Cancer1
1CompletedTreatmentAbdominal wall neoplasm1
1CompletedTreatmentAbdominal wall neoplasm / Carcinoma NOS1
1CompletedTreatmentAbdominal wall neoplasm / Carcinoma, Squamous Cell of Head and Neck / Esophageal Squamous Cell Carcinoma (ESCC) / Esophagogastric Junction Neoplasms / Fallopian Tube Neoplasms / Neoplasms, Ovarian / Pancreatic Ductal Carcinoma / Small Cell Lung Cancer (SCLC) / Stomach Neoplasms / Triple Negative Breast Neoplasms1
1CompletedTreatmentAbdominal wall neoplasm / Fallopian Tube Neoplasms / Neoplasms, Ovarian / Non-Small Cell Lung Carcinoma (NSCLC) / Pancreatic Ductal Carcinoma / Transitional Cell Carcinoma / Tumor Virus Infections / Urinary Bladder Neoplasms1
1CompletedTreatmentAdenocarcinoma of the Cervix / Adenosquamous carcinoma of the cervix / Cervical Squamous Cell Carcinoma / Cervical Squamous Cell Carcinoma, Not Otherwise Specified / Recurrent Cervical Carcinoma / Stage IVB Cervical Cancer / Stage IVB Cervical Cancer AJCC v6 and v71
1CompletedTreatmentAdenocarcinoma of the Pancreas3
1CompletedTreatmentAdenocarcinoma of the Pancreas / Pancreatic Adenocarcinoma Metastatic1
1CompletedTreatmentAdenocarcinomas1
1CompletedTreatmentAdenocarcinomas of the Gastroesophageal Junction / Esophageal Cancers / Malignant Neoplasm of the Cervical Esophagus / Malignant Neoplasm of the Thoracic Esophagus / Stage IIA Esophageal Cancer AJCC v7 / Stage IIB Esophageal Cancer AJCC v7 / Stage IIIA Esophageal Cancer AJCC v7 / Stage IIIB Esophageal Cancer AJCC v7 / Stage IIIC Esophageal Cancer AJCC v71
1CompletedTreatmentAdenocarcinomas / Malignant Neoplasm of Pancreas / Neoplasms, Pancreatic1
1CompletedTreatmentAdenocarcinomas / Neoplasms, Pancreatic1
1CompletedTreatmentAdenocarcinomas / Non-Small Cell Lung Carcinoma (NSCLC)1
1CompletedTreatmentAdult Grade III Lymphomatoid Granulomatosis / Adult Nasal Type Extranodal NK/T-Cell Lymphoma / Contiguous Stage II Adult Burkitt Lymphoma / Contiguous Stage II Adult Diffuse Large Cell Lymphoma / Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma / Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma / Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma / Contiguous Stage II Adult Lymphoblastic Lymphoma / Contiguous Stage II Grade 1 Follicular Lymphoma / Contiguous Stage II Grade 2 Follicular Lymphoma / Contiguous Stage II Grade 3 Follicular Lymphoma / Contiguous Stage II Mantle Cell Lymphoma / Contiguous Stage II Marginal Zone Lymphoma / Contiguous Stage II Small Lymphocytic Lymphoma / Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue / Nodal marginal zone B-cell lymphomas / Noncontiguous Stage II Adult Burkitt Lymphoma / Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma / Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma / Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma / Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma / Noncontiguous Stage II Adult Lymphoblastic Lymphoma / Noncontiguous Stage II Grade 1 Follicular Lymphoma / Noncontiguous Stage II Grade 2 Follicular Lymphoma / Noncontiguous Stage II Grade 3 Follicular Lymphoma / Noncontiguous Stage II Mantle Cell Lymphoma / Noncontiguous Stage II Marginal Zone Lymphoma / Noncontiguous Stage II Small Lymphocytic Lymphoma / Peripheral T-Cell Lymphoma (PTCL) / Recurrent Adult Burkitt Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Recurrent Adult Diffuse Mixed Cell Lymphoma / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Recurrent Adult Immunoblastic Large Cell Lymphoma / Recurrent Adult Lymphoblastic Lymphoma / Recurrent Grade 1 Follicular Lymphoma / Recurrent Grade 2 Follicular Lymphoma / Recurrent Grade 3 Follicular Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Marginal Zone Lymphoma / Recurrent Small Lymphocytic Lymphoma / Splenic Marginal Zone Lymphoma / Stage I Adult Burkitt Lymphoma / Stage I Adult Diffuse Large Cell Lymphoma / Stage I Adult Diffuse Mixed Cell Lymphoma / Stage I Adult Diffuse Small Cleaved Cell Lymphoma / Stage I Adult Immunoblastic Large Cell Lymphoma / Stage I Adult Lymphoblastic Lymphoma / Stage I Grade 1 Follicular Lymphoma / Stage I Grade 2 Follicular Lymphoma / Stage I Grade 3 Follicular Lymphoma / Stage I Mantle Cell Lymphoma / Stage I Marginal Zone Lymphoma / Stage I Small Lymphocytic Lymphoma / Stage III Adult Burkitt Lymphoma / Stage III Adult Diffuse Large Cell Lymphoma / Stage III Adult Diffuse Mixed Cell Lymphoma / Stage III Adult Diffuse Small Cleaved Cell Lymphoma / Stage III Adult Immunoblastic Large Cell Lymphoma / Stage III Adult Lymphoblastic Lymphoma / Stage III Grade 1 Follicular Lymphoma / Stage III Grade 2 Follicular Lymphoma / Stage III Grade 3 Follicular Lymphoma / Stage III Mantle Cell Lymphoma / Stage III Marginal Zone Lymphoma / Stage III Small Lymphocytic Lymphoma / Stage IV Adult Burkitt Lymphoma / Stage IV Adult Diffuse Large Cell Lymphoma / Stage IV Adult Diffuse Mixed Cell Lymphoma / Stage IV Adult Diffuse Small Cleaved Cell Lymphoma / Stage IV Adult Immunoblastic Large Cell Lymphoma / Stage IV Adult Lymphoblastic Lymphoma / Stage IV Grade 1 Follicular Lymphoma / Stage IV Grade 2 Follicular Lymphoma / Stage IV Grade 3 Follicular Lymphoma / Stage IV Mantle Cell Lymphoma / Stage IV Marginal Zone Lymphoma / Stage IV Small Lymphocytic Lymphoma / Unspecified Adult Solid Tumor, Protocol Specific / Waldenström's Macroglobulinemia (WM)1
1CompletedTreatmentAdult Solid Neoplasm / Estrogen Receptor Negative / Estrogen Receptor Positive / HER2/Neu Negative / Male Breast Carcinoma / Progesterone Receptor Negative / Recurrent Breast Carcinoma / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer / Triple-Negative Breast Carcinoma1
1CompletedTreatmentAdult Solid Neoplasm / Estrogen Receptor Negative / HER2/Neu Negative / Male Breast Carcinoma / Progesterone Receptor Negative / Recurrent Breast Carcinoma / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer / Triple-Negative Breast Carcinoma1
1CompletedTreatmentAdult Solid Neoplasm / Brca1 Mutation Carrier / Brca2 Mutation Carrier / Hereditary Breast and Ovarian Cancer Syndrome1
1CompletedTreatmentAdult Solid Neoplasm / Recurrent Breast Carcinoma / Stage IV Breast Cancer1
1CompletedTreatmentAdvanced Adult Primary Liver Cancer / Advanced Gastric Cancer / Bone Metastases / Cancer, Anaplastic Thyroid / Carcinoma of the Appendix / Distal Urethral Cancer / Fallopian Tube Cancer / Gastrinoma / Glucagonoma / Hepatic Metastases / Inflammatory Breast Cancer (IBC) / Insulinoma / Localized Unresectable Adult Primary Liver Cancer / Lung Cancer Metastatic / Male Breast Cancer / Malignant Pericardial Effusion / Malignant Pleural Effusions / Metastases to skin / Metastatic Bladder Cancer / Metastatic Colon Cancer / Metastatic Gastrointestinal Carcinoid Tumor / Metastatic Parathyroid Cancer / Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter / Newly Diagnosed Carcinoma of Unknown Primary / Non-Small Cell Lung Cancer Recurrent / Occult Non-small Cell Lung Cancer / Pancreatic Polypeptide Tumor / Primary Peritoneal Cavity Cancer / Proximal Urethral Cancer / Pulmonary Carcinoid Tumor / Recurrent Adenoid Cystic Carcinoma of the Oral Cavity / Recurrent Adrenocortical Carcinoma / Recurrent Adult Primary Liver Cancer / Recurrent Anal Cancer / Recurrent Bladder Cancer / Recurrent Breast Cancer / Recurrent Carcinoma of Unknown Primary / Recurrent Cervical Cancer / Recurrent Colon Cancer / Recurrent Endometrial Carcinoma / Recurrent Esophageal Cancer / Recurrent Extrahepatic Bile Duct Cancer / Recurrent Gallbladder Cancer / Recurrent Gastric Cancer / Recurrent Gastrointestinal Carcinoid Tumor / Recurrent Islet Cell Carcinoma / Recurrent Malignant Testicular Germ Cell Tumor / Recurrent Mucoepidermoid Carcinoma of the Oral Cavity / Recurrent Ovarian Epithelial Cancer / Recurrent Pancreatic Cancer / Recurrent Parathyroid Cancer / Recurrent Prostate Cancer / Recurrent Rectal Cancer / Recurrent Salivary Gland Cancer / Recurrent Small Intestine Cancer / Recurrent Squamous Cell Carcinoma of the Larynx / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Recurrent Squamous Cell Carcinoma of the Oropharynx / Recurrent Thyroid Cancer / Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter / Recurrent Urethral Cancer / Recurrent Vaginal Cancer / Recurrent Vulvar Cancer / Renal Cell Cancer, Recurrent / Small Intestine Adenocarcinoma / Somatostatinoma / Stage III Adenoid Cystic Carcinoma of the Oral Cavity / Stage III Adrenocortical Carcinoma / Stage III Bladder Cancer / Stage III Cervical Cancer / Stage III Colon Cancer / Stage III Endometrial Carcinoma / Stage III Esophageal Cancer / Stage III Follicular Thyroid Cancer / Stage III Gastric Cancer / Stage III Malignant Testicular Germ Cell Tumor / Stage III Mucoepidermoid Carcinoma of the Oral Cavity / Stage III Ovarian Epithelial Cancer / Stage III Pancreatic Cancer / Stage III Papillary Thyroid Cancer / Stage III Prostate Cancer / Stage III Rectal Cancer / Stage III Renal Cell Cancer / Stage III Salivary Gland Cancer / Stage III Squamous Cell Carcinoma of the Larynx / Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage III Squamous Cell Carcinoma of the Nasopharynx / Stage III Squamous Cell Carcinoma of the Oropharynx / Stage III Vaginal Cancer / Stage III Vulvar Cancer / Stage IIIA Anal Cancer / Stage IIIA Breast Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIB Anal Cancer / Stage IIIB Breast Cancer / Stage IIIb Non-small Cell Lung Cancer / Stage IV Adenoid Cystic Carcinoma of the Oral Cavity / Stage IV Adrenocortical Carcinoma / Stage IV Anal Cancer / Stage IV Breast Cancer / Stage IV Endometrial Carcinoma / Stage IV Esophageal Cancer / Stage IV Follicular Thyroid Cancer / Stage IV Mucoepidermoid Carcinoma of the Oral Cavity / Stage IV Non-Small Cell Lung Cancer / Stage IV Ovarian Epithelial Cancer / Stage IV Pancreatic Cancer / Stage IV Papillary Thyroid Cancer / Stage IV Prostate Cancer / Stage IV Rectal Cancer / Stage IV Renal Cell Cancer / Stage IV Salivary Gland Cancer / Stage IV Squamous Cell Carcinoma of the Larynx / Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Stage IV Squamous Cell Carcinoma of the Oropharynx / Stage IVA Cervical Cancer / Stage IVA Vaginal Cancer / Stage IVB Cervical Cancer / Stage IVB Vaginal Cancer / Stage IVB Vulvar Cancer / Thyroid Gland Medullary Carcinoma / Unresectable Extrahepatic Bile Duct Cancer / Unresectable Gallbladder Cancer / Urethral Cancer Associated With Invasive Bladder Cancer / WDHA Syndrome1
1CompletedTreatmentAdvanced Cancers3
1CompletedTreatmentAdvanced Cancers / Liver Cancer / Tumors, Solid1
1CompletedTreatmentAdvanced Malignancies / Cancer, Advanced1
1CompletedTreatmentAdvanced Malignant Solid Tumors1
1CompletedTreatmentAdvanced Melanoma1
1CompletedTreatmentAdvanced Nonhematologic Malignancies1
1CompletedTreatmentAdvanced Pancreatic Cancer2
1CompletedTreatmentAdvanced Solid Malignancies / Malignancies, Hematologic1
1CompletedTreatmentAdvanced Solid Tumors5
1CompletedTreatmentAdvanced Solid Tumors / Impaired kidney function / Kidney Diseases1
1CompletedTreatmentAdvanced Solid Tumors / Malignancies / Tumors1
1CompletedTreatmentAdvanced Solid Tumors / Metastatic Solid Tumors1
1CompletedTreatmentAdvanced Solid Tumors / Neoplasms1
1CompletedTreatmentAdvanced Solid Tumours2
1CompletedTreatmentBrain and Central Nervous System Tumors / Breast Cancer / Cancer, Bladder / Esophageal Cancers / Extragonadal Germ Cell Tumor / Lung Cancers / Malignant Neoplasm of Stomach / Ovarian Cancer / Prostate Cancer1
1CompletedTreatmentBrain and Central Nervous System Tumors / Breast Cancer / Lung Cancers / Malignant Lymphomas / Malignant Melanoma of Skin / Melanoma (Skin) / Ovarian Cancer / Renal Cancers / Small Intestine Cancer / Unspecified Adult Solid Tumor, Protocol Specific1
1CompletedTreatmentBreast Cancer13
1CompletedTreatmentBreast Cancer - Female / Malignant Neoplasm of Female Breast / Unspecified Adult Solid Tumor - Protocol Specific1
1CompletedTreatmentBreast Cancer, Non-small Lung Cancer1
1CompletedTreatmentBreast Cancer / Colorectal Cancers / Esophagogastric Cancer / Malignant Neoplasm of Pancreas / Non-Small Cell Lung Carcinoma (NSCLC)1
1CompletedTreatmentBreast Cancer / Colorectal Cancers / Head and Neck Carcinoma / Lung Cancers / Malignant Melanoma of Skin / Malignant Neoplasm of Pancreas / Melanoma (Skin) / Ovarian Cancer / Prostate Cancer / Unspecified Adult Solid Tumor, Protocol Specific1
1CompletedTreatmentBreast Cancer / Endometrial Cancer / Head and Neck (HNSCC) / Non-Small Cell Lung Carcinoma (NSCLC) / Ovarian Cancer / Small Cell Lung Cancer (SCLC)1
1CompletedTreatmentBreast Cancer / Gynecological Cancers / Head and Neck Carcinoma / Non-Small Cell Lung Carcinoma (NSCLC) / Non-squamous Cell Lung Cancer / Ovarian Cancer / Small Cell Lung Cancer (SCLC)1
1CompletedTreatmentBreast Cancer / Locally Recurrent and Metastatic Breast Cancer / Malignancies / Metastases / Metastatic Cancers / Neoplasms, Breast / Oncology / Tumors / Tumors, Breast / Tumors, Solid1
1CompletedTreatmentBreast Cancer / Lung Cancers / Malignant Neoplasm of Colon / Malignant Neoplasm of Stomach / Ovarian Cancer / Tumors, Solid1
1CompletedTreatmentBreast Cancer / Malignancies / Malignant Lymphomas / Ovarian Cancer / Renal Cell Adenocarcinoma1
1CompletedTreatmentBreast Cancer / Metastatic Breast Cancer, Locally Advanced Breast Cancer1
1CompletedTreatmentBreast Cancer / Metastatic Breast Cancer / Triple Negative Breast Cancer (TNBC)1
1CompletedTreatmentBreast Cancer / Metastatic Cancers1
1CompletedTreatmentBreast Cancer / Metastatic Cancers / Neoplasms1
1CompletedTreatmentBreast Cancer / Tumors, Solid1
1CompletedTreatmentBrenner Tumor / Fallopian Tube Cancer / Ovarian Carcinosarcoma / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mixed Epithelial Carcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Serous Cystadenocarcinoma / Ovarian Undifferentiated Adenocarcinoma / Primary Peritoneal Cavity Cancer / Stage II Ovarian Epithelial Cancer / Stage III Ovarian Epithelial Cancer / Stage IV Ovarian Epithelial Cancer1
1CompletedTreatmentBrenner Tumor / Fallopian Tube Cancer / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mixed Epithelial Carcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Serous Cystadenocarcinoma / Ovarian Undifferentiated Adenocarcinoma / Primary Peritoneal Cavity Cancer / Stage II Ovarian Epithelial Cancer / Stage III Ovarian Epithelial Cancer / Stage IV Ovarian Epithelial Cancer1
1CompletedTreatmentBrenner Tumor / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mixed Epithelial Carcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Serous Cystadenocarcinoma / Ovarian Undifferentiated Adenocarcinoma / Stage III Ovarian Epithelial Cancer / Stage IV Ovarian Epithelial Cancer1
1CompletedTreatmentCancer Ovaries / Cancer Peritoneal / Fallopian Tube Cancer1
1CompletedTreatmentCancer, Advanced3
1CompletedTreatmentCancer, Bladder / Cervical Cancers / Endometrial Cancer / Vaginal Cancers1
1CompletedTreatmentCancer, Bladder / Transitional Cell Cancer of the Renal Pelvis and Ureter2
1CompletedTreatmentCarcinoma NOS / Fallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer1
1CompletedTreatmentCarcinoma NOS / Neoplasms Metastasis1
1CompletedTreatmentCarcinoma, Small Cell1
1CompletedTreatmentCervical Cancers1
1CompletedTreatmentChemotherapeutic Agent Toxicity / Endometrial Adenocarcinomas / Fallopian Tube Carcinoma / Gastrointestinal Complications / Malignant Ovarian Mixed Epithelial Tumor / Neurotoxicity Syndrome / Ovarian Brenner Tumor / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Serous Cystadenocarcinoma / Primary Peritoneal Carcinoma / Stage II Ovarian Cancer / Stage III Ovarian Cancer / Stage IV Ovarian Cancer / Undifferentiated Ovarian Carcinoma1
1CompletedTreatmentChronic Lung Diseases / Malignancies1
1CompletedTreatmentColorectal Cancers / Esophageal Cancers / Gastrointestinal Stromal Tumors (GISTs) / Malignant Neoplasm of Pancreas / Malignant Neoplasm of Stomach / Rectal Carcinoma1
1CompletedTreatmentColorectal Cancers / Lung Cancers / Unspecified Adult Solid Tumor, Protocol Specific1
1CompletedTreatmentEndometrial Adenosquamous Carcinoma / Endometrial Clear Cell Adenocarcinoma / Endometrial Mixed Adenocarcinoma / Endometrial Serous Adenocarcinoma / Endometrial Squamous Cell Carcinoma / Endometrial Undifferentiated Carcinoma / Recurrent Uterine Corpus Carcinoma / Stage IIIA Uterine Corpus Cancer / Stage IIIC Uterine Corpus Cancer / Stage IVA Uterine Corpus Cancer / Stage IVB Uterine Corpus Cancer1
1CompletedTreatmentEndometrial Cancer1
1CompletedTreatmentEndometrial Cancer / Ovarian Cancer1
1CompletedTreatmentEndometrial Carcinoma / Malignancies / Non-Small Cell Lung Carcinoma (NSCLC) / Ovarian Carcinoma1
1CompletedTreatmentEndometrial Clear Cell Adenocarcinoma / Endometrial Serous Adenocarcinoma / Stage III Uterine Corpus Cancer / Stage IV Uterine Corpus Cancer1
1CompletedTreatmentEsophageal Cancers2
1CompletedTreatmentEsophageal Squamous Cell Carcinoma (ESCC)1
1CompletedTreatmentEsophagus Disorders / Squamous Carcinoma of Esophagus1
1CompletedTreatmentFallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Cancer1
1CompletedTreatmentFallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Epithelial Cancer1
1CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Peritoneal Cavity Cancer2
1CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer1
1CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cavity Cancer1
1CompletedTreatmentFallopian Tube Carcinoma / Infectious Disorder / Neutropenia / Ovarian Carcinosarcoma / Primary Peritoneal Carcinoma / Stage III Ovarian Cancer / Stage IV Ovarian Cancer1
1CompletedTreatmentFumarate Hydratase (FH)-Deficient Tumors / Mesothelioma / Non-Small Cell Lung Carcinoma (NSCLC) / Renal Cell Adenocarcinoma / Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST) / Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal Stromal Tumors / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC) / Tumors Harboring Amplifications in the cMyc Gene / Tumors Harboring Isocitrate Dehydrogenase-1 (IDH1) and IDH2 Mutations / Tumors, Solid1
1CompletedTreatmentGenital Neoplasms, Female1
1CompletedTreatmentHER-2 Gene Amplification1
1CompletedTreatmentHER2 Negative Breast Cancer / HER2-Negative Breast Cancer / Human Epidermal Growth Factor 2 Negative Carcinoma of Breast / Male Breast Cancer / Recurrent Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
1CompletedTreatmentHER2 Positive Breast Cancers / Male Breast Cancer / Recurrent Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
1CompletedTreatmentHER2 Positive Breast Cancers / Metastatic Breast Cancer1
1CompletedTreatmentHead and Neck Carcinoma4
1CompletedTreatmentHead and Neck Carcinoma / Squamous Cell Cancer1
1CompletedTreatmentLeukemias / Malignant Lymphomas / Unspecified Adult Solid Tumor, Protocol Specific1
1CompletedTreatmentLiver Metastasis / Melanoma1
1CompletedTreatmentLocally Advanced Non-Small Cell Lung Cancer / Non-Small Cell Lung Carcinoma (NSCLC)1
1CompletedTreatmentLocally Advanced, Metastatic Solid Tumors1
1CompletedTreatmentLocally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer / Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer / Primary Peritoneal Cancer or Endometrial Cancer1
1CompletedTreatmentLocally Recurrent and Metastatic Breast Cancer1
1CompletedTreatmentLung Cancers8
1CompletedTreatmentLung Cancers / Metastatic Cancers1
1CompletedTreatmentMale Breast Cancer / Non-Small Cell Lung Cancer Recurrent / Recurrent Breast Cancer / Recurrent Endometrial Carcinoma / Recurrent Gastric Cancer / Recurrent Ovarian Epithelial Cancer / Refractory Small cell lung cancer1
1CompletedTreatmentMale Breast Cancer / Recurrent Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
1CompletedTreatmentMalignancies5
1CompletedTreatmentMalignancies / Neoplasms1
1CompletedTreatmentMalignant Diseases1
1CompletedTreatmentMalignant Lymphomas / Small Intestine Cancer / Unspecified Adult Solid Tumor, Protocol Specific1
1CompletedTreatmentMalignant Lymphomas / Unspecified Adult Solid Tumor, Protocol Specific1
1CompletedTreatmentMalignant Neoplasm of Pancreas6
1CompletedTreatmentMalignant Neoplasm of Pancreas / Stage IV Pancreatic Cancer2
1CompletedTreatmentMalignant Ovarian Mixed Epithelial Tumor / Ovarian Brenner Tumor / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Serous Cystadenocarcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Undifferentiated Ovarian Carcinoma1
1CompletedTreatmentMalignant Peritoneal Neoplasm1
1CompletedTreatmentMelanoma1
1CompletedTreatmentMetastatic Breast Cancer6
1CompletedTreatmentMetastatic Pancreas Adenocarcinoma1
1CompletedTreatmentMetastatic Pancreatic Ductal Adenocarcinoma1
1CompletedTreatmentMetastatic or Advanced Non-Small Cell Lung Cancer (NSCLC) / Non-Small Cell Lung Carcinoma (NSCLC)1
1CompletedTreatmentMetastatic or Locally Advanced Solid Tumors1
1CompletedTreatmentNeoplasm Metastases / Neoplasms1
1CompletedTreatmentNeoplasms13
1CompletedTreatmentNeoplasms, Breast2
1CompletedTreatmentNeoplasms, Breast Neoplasms, Head and Neck Neoplasms1
1CompletedTreatmentNeoplasms, Breast / Neoplasms, Pancreatic1
1CompletedTreatmentNeoplasms, Breast / Solid Tumor Cancers1
1CompletedTreatmentNeoplasms, Head and Neck / Squamous Cell Carcinoma (SCC)1
1CompletedTreatmentNeoplasms, Ovarian2
1CompletedTreatmentNon Small Cell Lung Carcinoma (NSCLC) / Non-Small Cell Lung Carcinoma (NSCLC)1
1CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)14
1CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Ovarian Epithelial Cancer1
1CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Small Cell Lung Cancer (SCLC) / Tumors, Solid1
1CompletedTreatmentNon-Squamous Non-Small Cell Lung Cancer1
1CompletedTreatmentNon-hematologic Malignancies1
1CompletedTreatmentOncology, Medical1
1CompletedTreatmentOvarian Cancer3
1CompletedTreatmentOvarian Cancer / Peritoneal Cavity Cancer / Unspecified Adult Solid Tumor, Protocol Specific1
1CompletedTreatmentOvarian Cancer / Primary Peritoneal Cavity Cancer3
1CompletedTreatmentOvarian Cancer / Tumors, Solid1
1CompletedTreatmentOvarian Epithelial Cancer1
1CompletedTreatmentOvarian Sarcoma / Ovarian Stromal Cancer / Recurrent Endometrial Carcinoma / Recurrent Ovarian Epithelial Cancer / Recurrent Ovarian Germ Cell Tumor / Stage III Endometrial Carcinoma / Stage III Ovarian Epithelial Cancer / Stage III Ovarian Germ Cell Tumor / Stage IV Endometrial Carcinoma / Stage IV Ovarian Epithelial Cancer / Stage IV Ovarian Germ Cell Tumor / Unspecified Adult Solid Tumor, Protocol Specific1
1CompletedTreatmentPancreatic Cancer Metastatic1
1CompletedTreatmentProstate Cancer2
1CompletedTreatmentRecurrent Ovarian Cancer1
1CompletedTreatmentSmall Cell Lung Cancer (SCLC)1
1CompletedTreatmentSolid Cancers3
1CompletedTreatmentSquamous Cell Carcinoma of the Head and Neck (SCCHN)1
1CompletedTreatmentStage IIIA Non-Small Cell Lung Cancer1
1CompletedTreatmentTriple Negative Breast Neoplasms1
1CompletedTreatmentTumors1
1CompletedTreatmentTumors, Solid8
1CompletedTreatmentUnspecified Adult Solid Tumor, Protocol Specific22
1Enrolling by InvitationOtherOncology1
1Not Yet RecruitingTreatmentAdvanced Esophageal Adenocarcinoma / Advanced Gastroesophageal Junction Adenocarcinoma / Clinical Stage II Esophageal Adenocarcinoma AJCC v8 / Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 / Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 / Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage III Esophageal Adenocarcinoma AJCC v8 / Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Unresectable Gastroesophageal Junction Adenocarcinoma1
1Not Yet RecruitingTreatmentBreast Cancer1
1Not Yet RecruitingTreatmentCarcinoma, Ovarian Epithelial / Endometrial Cancer / Fallopian Tube Neoplasms / Malignant Peritoneal Neoplasm / Solid Tumor, Adult / Tumors, Solid1
1Not Yet RecruitingTreatmentFallopian Tube Cancer / Ovarian Epithelial Cancer / Primary Peritoneal Carcinoma1
1Not Yet RecruitingTreatmentMalignant Neoplasm of Stomach1
1Not Yet RecruitingTreatmentMetastatic Breast Cancer1
1Not Yet RecruitingTreatmentOvarian Cancer1
1Not Yet RecruitingTreatmentPeritoneal Carcinomatosis1
1Not Yet RecruitingTreatmentStage III Pancreatic Cancer AJCC v8 / Stage IV Pancreatic Cancer AJCC v8 / Unresectable Pancreatic Carcinoma1
1Not Yet RecruitingTreatmentTumors, Solid1
1RecruitingDiagnosticEsophageal Cancers1
1RecruitingTreatmentAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Acute Lymphoblastic Leukaemia Recurrent / Acute, recurrent Myeloid Leukemia / Anatomic Stage IV Breast Cancer AJCC v8 / Anemia / Ann Arbor Stage III Hodgkin Lymphoma / Ann Arbor Stage III Non-Hodgkin Lymphoma / Ann Arbor Stage IIIA Hodgkin Lymphoma / Ann Arbor Stage IIIB Hodgkin Lymphoma / Ann Arbor Stage IV Hodgkin Lymphoma / Ann Arbor Stage IV Non-Hodgkin Lymphoma / Ann Arbor Stage IVA Hodgkin Lymphoma / Ann Arbor Stage IVB Hodgkin Lymphoma / Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative / Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Castration-Resistant Prostate Carcinoma / Chronic Lymphocytic Leukemia (CLL) - Refractory / Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Chronic, recurrent Lymphocytic Leukemia / Hematopoietic and Lymphoid Cell Neoplasm / Locally Advanced Pancreatic Adenocarcinoma / Metastatic Breast Carcinoma / Metastatic Malignant Solid Neoplasm / Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis / Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable / Pancreatic Adenocarcinoma Metastatic / Primary Myelofibrosis / Prognostic Stage IV Breast Cancer AJCC v8 / Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Recurrent Hematologic Malignancy / Recurrent Hodgkin Lymphoma / Recurrent Myelodysplastic Syndrome / Recurrent Myelodysplastic/Myeloproliferative Neoplasm / Recurrent Myeloproliferative Neoplasm / Recurrent Non-Hodgkin Lymphoma / Recurrent Plasma Cell Myeloma / Recurrent Small Lymphocytic Lymphoma / Refractory Acute Lymphoblastic Leukemia / Refractory Acute Myelogenous Leukemia (AML) / Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive / Refractory Chronic Myelomonocytic Leukemia / Refractory Hematologic Malignancy / Refractory Hodgkin Lymphoma / Refractory Malignant Solid Neoplasm / Refractory Myelodysplastic Syndrome / Refractory Myelodysplastic/Myeloproliferative Neoplasm / Refractory Non-Hodgkin's lymphoma / Refractory Plasma Cell Myeloma / Refractory Primary Myelofibrosis / Refractory Small Lymphocytic Lymphoma / Stage II Pancreatic Cancer AJCC v8 / Stage IIA Pancreatic Cancer AJCC v8 / Stage IIB Pancreatic Cancer AJCC v8 / Stage III Pancreatic Cancer AJCC v8 / Stage IV Pancreatic Cancer AJCC v8 / Stage IV Prostate Cancer AJCC v8 / Stage IVA Prostate Cancer AJCC v8 / Stage IVB Prostate Cancer AJCC v8 / Unresectable Pancreatic Adenocarcinoma1
1RecruitingTreatmentAdenocarcinoma of the Pancreas2
1RecruitingTreatmentAdenocarcinoma of the Pancreas / Carcinoma NOS / Carcinoma, Non-Small Cell / Diffuse Large B-Cell Lymphoma (DLBCL) / Follicular Lymphoma (FL) / Hodgkins Disease (HD) / Lymphoma, B-Cell / Malignancies / Malignancies, Hematologic / Malignant Lymphomas / Melanoma / Metastatic Non-Small Cell Lung Cancer / Neoplasms / Neoplasms Metastasis / Neoplasms, Head and Neck / Neoplasms, Squamous Cell / Non-Hodgkin's Lymphoma (NHL) / Non-Small Cell Lung Carcinoma (NSCLC) / Squamous Cell Cancer / Squamous Cell Carcinoma (SCC) / Squamous Cell Carcinoma of the Head and Neck (SCCHN) / Squamous Cell Neoplasm1
1RecruitingTreatmentAdenosquamous carcinoma of the cervix / Cervical Adenosarcoma / Cervical Carcinosarcoma / Cervical Squamous Cell Carcinoma, Not Otherwise Specified / Endometrial Clear Cell Adenocarcinoma / Endometrial Endometrioid Adenocarcinoma / Endometrial Mixed Adenocarcinoma / Endometrial Mucinous Adenocarcinoma / Endometrial Squamous Cell Carcinoma / Endometrial Transitional Cell Carcinoma / Endometrial Undifferentiated Carcinoma / Fallopian Tube Adenocarcinoma / Fallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Mucinous Adenocarcinoma / Fallopian Tube Serous Adenocarcinoma / Fallopian Tube Transitional Cell Carcinoma / Malignant Ovarian Epithelial Tumor / Malignant Peritoneal Neoplasm / Ovarian Carcinosarcoma / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Adenocarcinoma / Ovarian Serous Adenocarcinoma / Ovarian Transitional Cell Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Melanoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Stage IV Skin Melanoma / Undifferentiated Fallopian Tube Carcinoma / Undifferentiated Ovarian Carcinoma / Uterine Corpus Carcinosarcoma1
1RecruitingTreatmentAdvanced Gastric Cancer1
1RecruitingTreatmentAdvanced Malignant Neoplasm / Recurrent Malignant Neoplasm / Refractory Malignant Neoplasm1
1RecruitingTreatmentAdvanced Malignant Solid Neoplasm / Anatomic Stage III Breast Cancer AJCC v8 / Anatomic Stage IIIA Breast Cancer AJCC v8 / Anatomic Stage IIIB Breast Cancer AJCC v8 / Anatomic Stage IIIC Breast Cancer AJCC v8 / Estrogen Receptor Positive / HER2/Neu Negative / Metastatic Malignant Solid Neoplasm / Prognostic Stage III Breast Cancer AJCC v8 / Prognostic Stage IIIA Breast Cancer AJCC v8 / Prognostic Stage IIIB Breast Cancer AJCC v8 / Prognostic Stage IIIC Breast Cancer AJCC v8 / Recurrent Breast Carcinoma / TP53 wt Allele / Unresectable Malignant Solid Neoplasm1
1RecruitingTreatmentAdvanced Malignant Solid Neoplasm / KRAS Gene Mutation / Ovarian Carcinoma / Refractory Malignant Solid Neoplasm / Refractory Ovarian Carcinoma1
1RecruitingTreatmentAdvanced Malignant Solid Neoplasm / Refractory Malignant Solid Neoplasm1
1RecruitingTreatmentAdvanced Nonhaematologic Malignancies1
1RecruitingTreatmentAdvanced Ovarian Cancer / Breast Cancer Stage IIIB / Breast Cancer Stage IIIc / Carcinoma Breast Stage IV / Ovarian Cancer Stage IIIB / Ovarian Cancer Stage IIIC / Pancreas Cancer, Stage III / Pancreas Cancer, Stage IV / Peritoneal Carcinomatosis / Stomach Cancer Stage III / Stomach Cancer Stage IV With Metastases1
1RecruitingTreatmentAdvanced Solid Tumors1
1RecruitingTreatmentAdvanced Solid Tumors Cancer1
1RecruitingTreatmentAdvanced Solid Tumors / Advanced Solid Tumors Cancer1
1RecruitingTreatmentAdvanced Solid Tumors / Head and Neck Squamous Cell Carcinoma (HNSCC) / Malignancies / Metastatic Solid Tumors / Non-Small Cell Lung Carcinoma (NSCLC) / Non-small-cell-lung-cancer (NSCLC) / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)1
1RecruitingTreatmentAdvanced Solid Tumors / Malignant Lymphomas1
1RecruitingTreatmentAdvanced/Metastatic Tumors1
1RecruitingTreatmentAggressive Non-Hodgkin Lymphoma / B-Cell Non-Hodgkin Lymphomas(NHL) / CD20 Positive / Recurrent B-Cell Non-Hodgkin Lymphoma / Recurrent Small Lymphocytic Lymphoma / Refractory B-Cell Non-Hodgkin Lymphoma / Refractory Small Lymphocytic Lymphoma / Small Lymphocytic Lymphoma1
1RecruitingTreatmentAnatomic Stage 0 Breast Cancer AJCC v8 / Anatomic Stage I Breast Cancer AJCC v8 / Anatomic Stage IA Breast Cancer AJCC v8 / Anatomic Stage IB Breast Cancer AJCC v8 / Anatomic Stage II Breast Cancer AJCC v8 / Anatomic Stage IIA Breast Cancer AJCC v8 / Anatomic Stage IIB Breast Cancer AJCC v8 / Early-Stage Breast Carcinoma / Estrogen Receptor Negative / HER2/Neu Negative / Progesterone Receptor Negative / Prognostic Stage 0 Breast Cancer AJCC v8 / Prognostic Stage I Breast Cancer AJCC v8 / Prognostic Stage IA Breast Cancer AJCC v8 / Prognostic Stage IB Breast Cancer AJCC v8 / Prognostic Stage II Breast Cancer AJCC v8 / Prognostic Stage IIA Breast Cancer AJCC v8 / Prognostic Stage IIB Breast Cancer AJCC v8 / Triple-Negative Breast Carcinoma1
1RecruitingTreatmentAnatomic Stage I Breast Cancer AJCC v8 / Anatomic Stage IA Breast Cancer AJCC v8 / Anatomic Stage IB Breast Cancer AJCC v8 / Anatomic Stage II Breast Cancer AJCC v8 / Anatomic Stage IIA Breast Cancer AJCC v8 / Anatomic Stage IIB Breast Cancer AJCC v8 / Anatomic Stage III Breast Cancer AJCC v8 / Anatomic Stage IIIA Breast Cancer AJCC v8 / Anatomic Stage IIIB Breast Cancer AJCC v8 / Anatomic Stage IIIC Breast Cancer AJCC v8 / Prognostic Stage I Breast Cancer AJCC v8 / Prognostic Stage IA Breast Cancer AJCC v8 / Prognostic Stage IB Breast Cancer AJCC v8 / Prognostic Stage II Breast Cancer AJCC v8 / Prognostic Stage IIA Breast Cancer AJCC v8 / Prognostic Stage IIB Breast Cancer AJCC v8 / Prognostic Stage III Breast Cancer AJCC v8 / Prognostic Stage IIIA Breast Cancer AJCC v8 / Prognostic Stage IIIB Breast Cancer AJCC v8 / Prognostic Stage IIIC Breast Cancer AJCC v81
1RecruitingTreatmentAnatomic Stage III Breast Cancer AJCC v8 / Anatomic Stage IIIA Breast Cancer AJCC v8 / Anatomic Stage IIIB Breast Cancer AJCC v8 / Anatomic Stage IIIC Breast Cancer AJCC v8 / Anatomic Stage IV Breast Cancer AJCC v8 / Estrogen Receptor Positive / HER2/Neu Negative / Invasive Breast Carcinoma / Prognostic Stage III Breast Cancer AJCC v8 / Prognostic Stage IIIA Breast Cancer AJCC v8 / Prognostic Stage IIIB Breast Cancer AJCC v8 / Prognostic Stage IIIC Breast Cancer AJCC v8 / Prognostic Stage IV Breast Cancer AJCC v8 / Recurrent Breast Carcinoma1
1RecruitingTreatmentAngiosarcoma of Skin1
1RecruitingTreatmentBiliary Cancers / Gastric Cancer in Situ / Malignant Neoplasm of Pancreas1
1RecruitingTreatmentBreast Adenocarcinoma / Breast Cancer / Human Epidermal Growth Factor 2 Negative Carcinoma of Breast / Recurrent Breast Carcinoma / Stage IV Breast Cancer1
1RecruitingTreatmentBreast Cancer5
1RecruitingTreatmentCancer of the Esophagus / Esophageal Cancers / Esophagus Cancer1
1RecruitingTreatmentCancer, Advanced / Colorectal Cancers / Metastatic Melanoma / Metastatic Non-Small Cell Lung Cancer / Metastatic Pancreatic Ductal Adenocarcinoma1
1RecruitingTreatmentCancer, Advanced / Lung Cancers / Metastatic Lung Cancer / Non-Small Cell Lung Carcinoma (NSCLC) / Non-Squamous Non-Small Cell Neoplasm of Lung / Squamous Cell Carcinoma of Lung1
1RecruitingTreatmentCancer, Advanced / Metastatic Cancers / NonHodgkin Lymphoma / Tumors, Solid1
1RecruitingTreatmentCancer, Bladder / Cholangiocarcinomas / Malignant Neoplasm of Colon / Malignant Neoplasm of Stomach / Melanoma / Ovarian Cancer / Palpable Subcutaneous Malignant Lesions / Renal Cell Adenocarcinoma / Tumors, Solid1
1RecruitingTreatmentClinical Stage IV Gastric Cancer AJCC v8 / Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IVA Gastric Cancer AJCC v8 / Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IVB Gastric Cancer AJCC v8 / Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Metastatic Gastric Adenocarcinoma / Metastatic Gastroesophageal Junction Adenocarcinoma / Pathologic Stage IV Gastric Cancer AJCC v8 / Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Peritoneal Carcinomatosis / Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8 / Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v81
1RecruitingTreatmentColorectal Cancers / Gastroesophageal Cancer (GC) / Renal Cell Adenocarcinoma1
1RecruitingTreatmentEndometrial Cancer / Ovarian Cancer1
1RecruitingTreatmentEsophageal Cancers / Gastroesophageal Cancer (GC) / Malignant Neoplasm of Stomach1
1RecruitingTreatmentEsophageal Cancers / Lung Cancers1
1RecruitingTreatmentEsophagogastric Adenocarcinoma1
1RecruitingTreatmentEstrogen Receptor Negative / HER2/Neu Negative / Progesterone Receptor Negative / Recurrent Breast Carcinoma / Stage IV Breast Cancer / Triple-Negative Breast Carcinoma1
1RecruitingTreatmentFIGO Stage IVA Ovarian Cancer / FIGO Stage IVB Ovarian Cancer / Platinum-Resistant Ovarian Carcinoma / Recurrent Fallopian Tube Cancer / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Cancer / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Cancer / Recurrent Primary Peritoneal Carcinoma / Recurrent Uterine Corpus Cancer / Recurrent Uterine Corpus Carcinoma / Stage III Fallopian Tube Cancer AJCC v7 / Stage III Ovarian Cancer AJCC v6 and v7 / Stage III Primary Peritoneal Cancer AJCC v7 / Stage III Uterine Corpus Cancer AJCC v7 / Stage IIIA Fallopian Tube Cancer / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIA Primary Peritoneal Cancer AJCC v7 / Stage IIIA Primary Peritoneal Cavity Cancer / Stage IIIA Uterine Corpus Cancer / Stage IIIA Uterine Corpus Cancer AJCC v7 / Stage IIIB Fallopian Tube Cancer / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIB Primary Peritoneal Cancer AJCC v7 / Stage IIIB Primary Peritoneal Cavity Cancer / Stage IIIB Uterine Corpus Cancer / Stage IIIB Uterine Corpus Cancer AJCC v7 / Stage IIIC Fallopian Tube Cancer / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IIIC Primary Peritoneal Cancer AJCC v7 / Stage IIIC Primary Peritoneal Cavity Cancer / Stage IIIC Uterine Corpus Cancer / Stage IIIC Uterine Corpus Cancer AJCC v7 / Stage IV Fallopian Tube Cancer / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer / Stage IV Ovarian Cancer AJCC v6 and v7 / Stage IV Primary Peritoneal Cancer AJCC v7 / Stage IV Primary Peritoneal Cavity Cancer / Stage IV Uterine Corpus Cancer AJCC v7 / Stage IVA Uterine Corpus Cancer / Stage IVA Uterine Corpus Cancer AJCC v7 / Stage IVB Uterine Corpus Cancer / Stage IVB Uterine Corpus Cancer AJCC v71
1RecruitingTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer1
1RecruitingTreatmentFallopian Tubes / High Grade Serous Ovarian / Primary Peritoneal Cancer1
1RecruitingTreatmentGastric Adenocarcinoma1
1RecruitingTreatmentHER2-expressing Cancers1
1RecruitingTreatmentMalignancies2
1RecruitingTreatmentMalignancies / Tumors, Solid1
1RecruitingTreatmentMalignant Lymphomas / Tumors, Solid1
1RecruitingTreatmentMalignant Neoplasm of Breast / Malignant Neoplasms of Bone and Articular Cartilage / Malignant Neoplasms of Digestive Organs / Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System / Malignant Neoplasms of Female Genital Organs / Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites / Malignant Neoplasms of Independent (Primary) Multiple Sites / Malignant Neoplasms of Lip Oral Cavity and Pharynx / Malignant Neoplasms of Male Genital Organs / Malignant Neoplasms of Mesothelial and Soft Tissue / Malignant Neoplasms of Respiratory and Intrathoracic Organs / Malignant Neoplasms of Thyroid and Other Endocrine Glands / Malignant Neoplasms of Urinary Tract / Malignant Neoplasms Stated as Primary Lymphoid Haematopoietic / Recurrent Malignant Solid Neoplasm / Refractory Malignant Solid Neoplasm1
1RecruitingTreatmentMalignant Neoplasm of Pancreas1
1RecruitingTreatmentMalignant Neoplasm of Pancreas / Pancreatic Cancer Metastatic1
1RecruitingTreatmentMetastatic Breast Cancer2
1RecruitingTreatmentMetastatic Breast Cancer / Tumors, Solid1
1RecruitingTreatmentNeoplasms1
1RecruitingTreatmentNeoplasms, Breast1
1RecruitingTreatmentOvarian Cancer3
1RecruitingTreatmentOvarian Cancer / TNBC - Triple-Negative Breast Cancer1
1RecruitingTreatmentOvarian Carcinosarcoma1
1RecruitingTreatmentPancreatic Cancer Metastatic / Pancreatic Cancer Stage IV / Stage IV Pancreatic Cancer1
1RecruitingTreatmentRecurrent Salivary Gland Cancer / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Recurrent Squamous Cell Carcinoma of the Larynx / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Recurrent Squamous Cell Carcinoma of the Oropharynx / Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Recurrent Verrucous Carcinoma of the Larynx / Recurrent Verrucous Carcinoma of the Oral Cavity / Salivary Gland Squamous Cell Carcinoma / Tongue Cancer1
1RecruitingTreatmentRecurrent and Metastatic Gastric Cancer1
1RecruitingTreatmentRefractory Cancer1
1RecruitingTreatmentSolid Tumor, Adult2
1RecruitingTreatmentTumors, Solid5
1SuspendedOtherMalignant Neoplasm of Pancreas1
1SuspendedTreatmentBorderline Resectable Pancreatic Cancer Treated With Chemoradiotherapy / Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy1
1SuspendedTreatmentMalignancies1
1TerminatedOtherNon-hematologic Malignancies / Pharmacokinetics of ASP98531
1TerminatedTreatmentAbdominal wall neoplasm / Fallopian Tube Neoplasms / Neoplasms, Ovarian1
1TerminatedTreatmentAdenocarcinoma of the Lung / Bronchoalveolar Cell Lung Cancer / Large Cell Lung Cancer / Squamous Cell Carcinoma of Lung / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
1TerminatedTreatmentAdenocarcinoma of the Lung / Bronchoalveolar Cell Lung Cancer / Large Cell Lung Cancer / Stage II Non-Small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
1TerminatedTreatmentAdenocarcinoma of the Pancreas / Malignant Neoplasm of Pancreas1
1TerminatedTreatmentAdvanced Aggressive Non-Hodgkin's Lymphoma / Advanced Hodgkin's Lymphoma / Advanced Indolent Non-Hodgkin's Lymphoma / Advanced Pancreatic Adenocarcinoma / Advanced Solid Tumors / Advanced Triple-Negative Breast Cancer / Advanced Urothelial Carcinoma / Breast Cancer / Cancer, Advanced / Lymphoma, Hodgkins / Malignant Neoplasm of Pancreas / Metastatic Cancers / Non-Hodgkin's Lymphoma (NHL) / Tumors, Solid / UC (Ureter and Urethera)1
1TerminatedTreatmentAdvanced Gastric Cancer / Human Immunodeficiency Virus (HIV) Infections / Non-Small Cell Lung Cancer Recurrent / Recurrent Anal Cancer / Recurrent Breast Cancer / Recurrent Esophageal Cancer / Recurrent Gastric Cancer / Recurrent Metastatic Squamous Neck Cancer With Occult Primary / Recurrent Ovarian Epithelial Cancer / Recurrent Salivary Gland Cancer / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Recurrent Squamous Cell Carcinoma of the Larynx / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Recurrent Squamous Cell Carcinoma of the Oropharynx / Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Recurrent Verrucous Carcinoma of the Larynx / Recurrent Verrucous Carcinoma of the Oral Cavity / Salivary Gland Squamous Cell Carcinoma / Stage IV Anal Cancer / Stage IV Breast Cancer / Stage IV Esophageal Cancer / Stage IV Non-Small Cell Lung Cancer / Stage IV Ovarian Epithelial Cancer / Stage IV Salivary Gland Cancer / Stage IV Squamous Cell Carcinoma of the Hypopharynx / Stage IV Squamous Cell Carcinoma of the Larynx / Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Stage IV Squamous Cell Carcinoma of the Oropharynx / Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IV Verrucous Carcinoma of the Larynx / Stage IV Verrucous Carcinoma of the Oral Cavity / Unspecified Adult Solid Tumor, Protocol Specific1
1TerminatedTreatmentAdvanced Solid Cancers1
1TerminatedTreatmentAdvanced Solid Tumors2
1TerminatedTreatmentAdvanced Solid Tumors / Ovarian Cancer / Small Cell Lung Cancer (SCLC)1
1TerminatedTreatmentAdvanced and Metastatic Gastric or Gastroesophageal Adenocarcinoma / Neoplasms, Advanced or Metastatic1
1TerminatedTreatmentBRCA-mutated Solid Tumor / Triple Negative Metastatic Breast Cancer1
1TerminatedTreatmentBenign Neoplasm of Pancreas / Mucinous Cystadenocarcinoma of Pancreas / Mucinous Cystadenoma of Pancreas / Mucinous Cystic Tumor With Moderate Dysplasia1
1TerminatedTreatmentBrain and Central Nervous System Tumors1
1TerminatedTreatmentCancer of Pancreas / Cancer of the Pancreas / Malignant Neoplasm of Pancreas1
1TerminatedTreatmentCancer, Advanced1
1TerminatedTreatmentCancer: Solid Tumors1
1TerminatedTreatmentCholestasis / Neoplasms, Pancreatic1
1TerminatedTreatmentEstrogen Receptor Negative / HER2/Neu Negative / Progesterone Receptor Negative / Stage IIA Breast Cancer / Stage IIB Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Triple-Negative Breast Carcinoma1
1TerminatedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer / Primary Peritoneal Carcinoma1
1TerminatedTreatmentFallopian Tube Neoplasms / Neoplasms / Neoplasms, Ovarian / Primary Peritoneal Neoplasms1
1TerminatedTreatmentHead and Neck Carcinoma1
1TerminatedTreatmentHodgkins Disease (HD) / Non-Hodgkin's Lymphoma (NHL)1
1TerminatedTreatmentMalignancies / Solid Cancers1
1TerminatedTreatmentMalignant Lymphomas / Neoplasms / Neoplasms Metastasis1
1TerminatedTreatmentMalignant Neoplasm of Pancreas2
1TerminatedTreatmentMalignant Neoplasm of Pancreas / Metastatic Cancers / Pancreatic Cancer Metastatic / Tumors, Solid1
1TerminatedTreatmentMelanoma1
1TerminatedTreatmentNeoplasms1
1TerminatedTreatmentNon-Small Cell Lunch Cancer / Non-Small Cell Lung Carcinoma (NSCLC)1
1TerminatedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)4
1TerminatedTreatmentOncology, Medical1
1TerminatedTreatmentOvarian Cancer1
1TerminatedTreatmentOvarian Cancer / Primary Peritoneal Cavity Cancer1
1TerminatedTreatmentPancreatic Ductal Adenocarcinoma1
1TerminatedTreatmentPrimary Peritoneal Carcinoma1
1TerminatedTreatmentProstate Cancer1
1TerminatedTreatmentStages II-III Breast Cancer1
1TerminatedTreatmentTumors, Solid3
1Unknown StatusTreatmentAdvanced Breast Cancer1
1Unknown StatusTreatmentAdvanced Gastric Carcinoma1
1Unknown StatusTreatmentAdvanced Solid Tumors2
1Unknown StatusTreatmentBreast Cancer1
1Unknown StatusTreatmentCancer of the Esophagus, Gastroesophageal Junction or Stomach1
1Unknown StatusTreatmentCervical Cancers1
1Unknown StatusTreatmentDrug/Agent Toxicity by Tissue/Organ / Unspecified Adult Solid Tumor, Protocol Specific1
1Unknown StatusTreatmentEpithelial Ovarian Carcinoma / Fallopian Tube Carcinoma / Primary Peritoneal Carcinoma1
1Unknown StatusTreatmentGastric Carcinoma1
1Unknown StatusTreatmentHead and Neck Carcinoma1
1Unknown StatusTreatmentMalignant Lymphomas2
1Unknown StatusTreatmentMelanoma1
1Unknown StatusTreatmentMetastatic Non-hematologic Malignancies1
1Unknown StatusTreatmentProstate Cancer1
1Unknown StatusTreatmentTumors, Solid1
1Unknown StatusTreatmentUnspecified Adult Solid Tumor, Protocol Specific2
1WithdrawnTreatmentAdenocarcinoma of the Lung / Large Cell Lung Cancer / Squamous Cell Carcinoma of Lung / Stage IIA Non-small Cell Lung Cancer / Stage IIB Non-small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
1WithdrawnTreatmentAdvanced and/or Metastatic Solid Tumors / Advanced/Metastatic Unresectable Malignant Pleural Mesothelioma / Stage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung Cancer1
1WithdrawnTreatmentBreast Cancer1
1WithdrawnTreatmentBreast Cancer / Cancer of the Breast1
1WithdrawnTreatmentCancer of Cervix / Tumors1
1WithdrawnTreatmentDuct Cell Adenocarcinoma of the Pancreas / Recurrent Pancreatic Cancer / Stage III Pancreatic Cancer / Stage IV Pancreatic Cancer / Unspecified Adult Solid Tumor, Protocol Specific1
1WithdrawnTreatmentEndometrial Cancer / Ovarian Cancer / Recurrent Endometrial Cancer / Recurrent Ovarian Cancer1
1WithdrawnTreatmentEpithelial Ovarian Carcinoma / Ovarian Carcinoma, Stage 3 or 4 / Primary Peritoneal Carcinoma1
1WithdrawnTreatmentEsophageal Cancers1
1WithdrawnTreatmentMalignancies / Non-Small Cell Lung Carcinoma (NSCLC) / Ovarian Epithelial Cancer1
1WithdrawnTreatmentMalignant Neoplasm of Pancreas1
1WithdrawnTreatmentMelanoma1
1WithdrawnTreatmentNeoplasms1
1WithdrawnTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Non-Squamous Non-Small Cell Lung Cancer1
1WithdrawnTreatmentOvarian Papillary Serous Carcinoma / Ovarian Serous Cystadenocarcinoma / Recurrent Fallopian Tube Cancer / Recurrent Ovarian Epithelial Cancer / Recurrent Ovarian Germ Cell Tumor / Recurrent Primary Peritoneal Cavity Cancer1
1WithdrawnTreatmentTumors1
1WithdrawnTreatmentTumors, Solid2
1WithdrawnTreatmentUnspecified Adult Solid Tumor, Protocol Specific1
1, 2Active Not RecruitingPreventionNon-Small Cell Lung Carcinoma (NSCLC)1
1, 2Active Not RecruitingTreatmentAcinar Cell Adenocarcinoma of the Pancreas / Duct Cell Adenocarcinoma of the Pancreas / Stage IV Pancreatic Cancer1
1, 2Active Not RecruitingTreatmentAdenocarcinoma of the Lung / Lung Adenocarcinoma, Mixed Subtype / Lung Large Cell Carcinoma / Lung Squamous Cell Carcinoma / Minimally Invasive Lung Adenocarcinoma / Stage III Lung Non-Small Cell Cancer AJCC v7 / Stage IIIA Lung Non-Small Cell Cancer AJCC v7 / Stage IIIB Lung Non-Small Cell Cancer AJCC v71
1, 2Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas1
1, 2Active Not RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Esophageal Cancers / Stage IB Esophageal Adenocarcinoma AJCC v7 / Stage II Esophageal Adenocarcinoma AJCC v7 / Stage IIA Esophageal Adenocarcinoma AJCC v7 / Stage IIB Esophageal Adenocarcinoma AJCC v7 / Stage IIIA Esophageal Adenocarcinoma AJCC v7 / Stage IIIB Esophageal Adenocarcinoma AJCC v71
1, 2Active Not RecruitingTreatmentAdvanced Gastric Adenocarcinoma1
1, 2Active Not RecruitingTreatmentAdvanced Solid Tumours1
1, 2Active Not RecruitingTreatmentAdvanced or Metastatic Breast Cancer / ER+ve Advanced or Metastatic Breast Cancer1
1, 2Active Not RecruitingTreatmentBladder Urothelial Carcinoma / Stage I Bladder Cancer AJCC v6 and v7 / Stage II Bladder Cancer AJCC v6 and v7 / Stage III Bladder Cancer AJCC v6 and v71
1, 2Active Not RecruitingTreatmentBreast Cancer2
1, 2Active Not RecruitingTreatmentBreast Cancer Triple Negative / Cervical Cancers / Endometrial Cancer / Ovarian Cancer / Tumors, Solid1
1, 2Active Not RecruitingTreatmentBreast Cancer / Cellular Diagnosis, Ovarian Epithelial Cancer / Tumors, Solid1
1, 2Active Not RecruitingTreatmentBreast Cancer / Ductal Carcinoma / Invasive Breast Carcinoma / Invasive Ductal Breast Carcinoma1
1, 2Active Not RecruitingTreatmentCarcinoma NOS / Pancreatic Adenocarcinoma Metastatic1
1, 2Active Not RecruitingTreatmentCervix Carcinoma Recurrent / Metastatic Carcinoma to the Uterine Cervix / Recurrent Carcinoma Cervix1
1, 2Active Not RecruitingTreatmentColorectal Cancers / Melanoma / Metastatic Breast Cancer / Non-Small Cell Lung Carcinoma (NSCLC) / Renal Cell Adenocarcinoma / Transitional Cell Carcinoma1
1, 2Active Not RecruitingTreatmentCutaneous Metastasis1
1, 2Active Not RecruitingTreatmentEsophageal Cancers1
1, 2Active Not RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC)1
1, 2Active Not RecruitingTreatmentFallopian Tube Carcinosarcoma / Fallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Serous Neoplasm / FIGO Stage III Ovarian Cancer / FIGO Stage IIIA Ovarian Cancer / FIGO Stage IIIA1 Ovarian Cancer / FIGO Stage IIIA2 Ovarian Cancer / FIGO Stage IIIB Ovarian Cancer / FIGO Stage IIIC Ovarian Cancer / FIGO Stage IVA Ovarian Cancer / FIGO Stage IVB Ovarian Cancer / High Grade Fallopian Tube Serous Adenocarcinoma / High Grade Ovarian Serous Adenocarcinoma / Ovarian Carcinosarcoma / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Primary Peritoneal High Grade Serous Adenocarcinoma / Primary Peritoneal Serous Adenocarcinoma / Stage III Fallopian Tube Cancer / Stage III Fallopian Tube Cancer AJCC v7 / Stage III Ovarian Cancer / Stage III Ovarian Cancer AJCC v6 and v7 / Stage III Primary Peritoneal Cancer / Stage III Primary Peritoneal Cancer AJCC v7 / Stage IIIA Fallopian Tube Cancer / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIA Primary Peritoneal Cancer / Stage IIIA Primary Peritoneal Cancer AJCC v7 / Stage IIIB Fallopian Tube Cancer / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIB Primary Peritoneal Cancer / Stage IIIB Primary Peritoneal Cancer AJCC v7 / Stage IIIC Fallopian Tube Cancer / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IIIC Primary Peritoneal Cancer / Stage IIIC Primary Peritoneal Cancer AJCC v7 / Stage IV Fallopian Tube Cancer / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer / Stage IV Ovarian Cancer AJCC v6 and v7 / Stage IV Primary Peritoneal Cancer / Stage IV Primary Peritoneal Cancer AJCC v71
1, 2Active Not RecruitingTreatmentFallopian Tube Cancer / Malignant Neoplasms of Female Genital Organs / Ovarian Cancer / Primary Peritoneal Carcinoma / Stage III Fallopian Tube Cancer AJCC v7 / Stage III Ovarian Cancer AJCC v6 and v7 / Stage III Primary Peritoneal Cancer AJCC v7 / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIA Primary Peritoneal Cancer AJCC v7 / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIB Primary Peritoneal Cancer AJCC v7 / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IIIC Primary Peritoneal Cancer AJCC v7 / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer AJCC v6 and v7 / Stage IV Primary Peritoneal Cancer AJCC v71
1, 2Active Not RecruitingTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cavity Cancer1
1, 2Active Not RecruitingTreatmentFallopian Tube Cancer / Ovarian Epithelial Cancer / Primary Peritoneal Cancer1
1, 2Active Not RecruitingTreatmentHead and Neck Squamous Cell Carcinoma (HNSCC) / Stage IVA Oropharyngeal Carcinoma AJCC v7 / Stage IVB Oropharyngeal Carcinoma AJCC v71
1, 2Active Not RecruitingTreatmentInoperable stage IIIA/B non-small cell lung cancer / Stage IIIA/B NSCLC / inoperable lung cancer1
1, 2Active Not RecruitingTreatmentLung Cancers1
1, 2Active Not RecruitingTreatmentMalignancies1
1, 2Active Not RecruitingTreatmentMalignant Neoplasm of Pancreas6
1, 2Active Not RecruitingTreatmentMetastatic Breast Cancer1
1, 2Active Not RecruitingTreatmentMetastatic Breast Cancer / Metastatic Triple Negative Breast Cancer1
1, 2Active Not RecruitingTreatmentMetastatic Breast Cancer / Recurrent Breast Cancer1
1, 2Active Not RecruitingTreatmentMCRC / Metastatic Colorectal Cancer (MCRC)1
1, 2Active Not RecruitingTreatmentNeoplasms / Neoplasms, Pancreatic1
1, 2Active Not RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)3
1, 2Active Not RecruitingTreatmentOvarian Carcinoma1
1, 2Active Not RecruitingTreatmentPancreatic Adenocarcinoma Metastatic4
1, 2Active Not RecruitingTreatmentPancreatic Adenocarcinoma Metastatic / Recurrent Pancreatic Carcinoma / Stage III Pancreatic Cancer / Stage IV Pancreatic Cancer1
1, 2Active Not RecruitingTreatmentPancreatic Adenocarcinoma Metastatic / Stage III Pancreatic Cancer AJCC v6 and v7 / Stage IV Pancreatic Cancer AJCC v6 and v7 / Unresectable Pancreatic Carcinoma1
1, 2Active Not RecruitingTreatmentPancreatic Cancer (Unresectable)1
1, 2Active Not RecruitingTreatmentPancreatic Cancer Metastatic1
1, 2Active Not RecruitingTreatmentSquamous Cell Carcinoma (SCC)1
1, 2Active Not RecruitingTreatmentStage III Ovarian Cancer / Stage IV Ovarian Cancer / Uterine Malignancies1
1, 2Active Not RecruitingTreatmentTriple Negative Breast Cancer (TNBC)2
1, 2Active Not RecruitingTreatmentTumors, Solid1
1, 2CompletedTreatmentAdenocarcinoma of the Pancreas / Adenocarcinoma of Unknown Primary / Adult Cholangiocarcinoma / Advanced Gastric Cancer / Carcinoma of Gallbladder / Gastric Adenocarcinoma / Malignant Gastrointestinal Neoplasm / Pancreatic Adenocarcinoma Metastatic / Stage III Ampulla of Vater Cancer / Stage III Pancreatic Cancer / Stage IIIA Gallbladder Cancer / Stage IIIA Gastric Cancer / Stage IIIB Gallbladder Cancer / Stage IIIB Gastric Cancer / Stage IV Ampulla of Vater Cancer / Stage IV Gallbladder Cancer / Stage IV Pancreatic Cancer1
1, 2CompletedTreatmentAdvanced Breast Cancer / Advanced Malignant Solid Tumors / Neoplasms, Breast1
1, 2CompletedTreatmentAdvanced Gastric Cancer1
1, 2CompletedTreatmentAdvanced Gastric Cancer / Tumors, Solid1
1, 2CompletedTreatmentAdvanced Melanoma / B-cell Malignancy, Low-grade / Malignant Solid Tumours / Ovarian Cancer / Triple Negative Breast Cancer (TNBC)1
1, 2CompletedTreatmentAdvanced Pancreatic Cancer1
1, 2CompletedTreatmentAdvanced or Metastatic Breast Cancer / Advanced or Metastatic Solid Tumors1
1, 2CompletedTreatmentBrain and Central Nervous System Tumors / Extragonadal Germ Cell Tumor / Ovarian Cancer / Teratoma / Testicular germ cell tumour1
1, 2CompletedTreatmentBreast Cancer15
1, 2CompletedTreatmentBreast Cancer / Male Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer1
1, 2CompletedTreatmentBreast Cancer / Metastatic Breast Cancer1
1, 2CompletedTreatmentBreast Cancer / Neoplasms, Breast1
1, 2CompletedTreatmentBreast Cancer / Neoplasms / Neoplasms, Breast1
1, 2CompletedTreatmentCancer, Anaplastic Thyroid1
1, 2CompletedTreatmentCancer, Bladder2
1, 2CompletedTreatmentCancer, Bladder / Fallopian Tube Cancer / Ovarian Cancer / Ovarian Epithelial Cancer1
1, 2CompletedTreatmentCancer, Bladder / Transitional Cell Cancer of the Renal Pelvis and Ureter1
1, 2CompletedTreatmentCarcinoma of Unknown Primary / Head and Neck Carcinoma1
1, 2CompletedTreatmentCervical Cancers1
1, 2CompletedTreatmentClinical Oncology / Dermatofibrosarcoma / Ewing's Sarcoma (ES) / Ewing's Tumor / Fibrosarcomas malignant / Histiocytoma / Malignancies / Melanoma / Melanoma, Malignant / Neoplasms / Neuroblastomas / Oncology, Medical / Osteosarcoma Tumor / Pediatrics, Osteosarcoma / Rhabdomyosarcomas / Sarcoma, Osteogenic / Sarcoma, Spindle Cell / Sarcomas, Epitheliod / Soft Tissue Sarcoma (STS) / Tumors1
1, 2CompletedTreatmentCoronary Artery Restenosis1
1, 2CompletedTreatmentCutaneous Malignant Melanoma1
1, 2CompletedTreatmentDrug/Agent Toxicity by Tissue/Organ / Lung Cancers / Radiation Toxicity1
1, 2CompletedTreatmentEsophageal Cancers1
1, 2CompletedTreatmentEsophageal Cancers / Therapeutic Agent Toxicity1
1, 2CompletedTreatmentExtragonadal Germ Cell Tumor / Ovarian Cancer / Testicular germ cell tumour1
1, 2CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cavity Cancer1
1, 2CompletedTreatmentGastric Adenocarcinoma1
1, 2CompletedTreatmentHER-2 Positive Advanced Gastric Cancer1
1, 2CompletedTreatmentHead and Neck Carcinoma2
1, 2CompletedTreatmentHead and Neck Carcinoma / Oral Complications1
1, 2CompletedTreatmentHead and Neck Carcinoma / Squamous Cell Cancer1
1, 2CompletedTreatmentInoperable Locally Advanced Breast Cancer / Metastatic Breast Cancer1
1, 2CompletedTreatmentLeukemias1
1, 2CompletedTreatmentLeukemias / Malignant Lymphomas / Sarcomas / Unspecified Adult Solid Tumor, Protocol Specific1
1, 2CompletedTreatmentLung Cancers5
1, 2CompletedTreatmentLung Cancers / Non-Small Cell Lung Carcinoma (NSCLC)1
1, 2CompletedTreatmentMale Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
1, 2CompletedTreatmentMalignancies1
1, 2CompletedTreatmentMalignant Lymphomas1
1, 2CompletedTreatmentMalignant Neoplasm of Pancreas2
1, 2CompletedTreatmentMalignant Neoplasm of Pancreas / Metastatic Cancers / Pancreatic Cancer Metastatic / Tumors, Solid1
1, 2CompletedTreatmentMalignant Neoplasm of Stomach2
1, 2CompletedTreatmentMelanoma1
1, 2CompletedTreatmentMetastatic Breast Cancer2
1, 2CompletedTreatmentMetastatic Pancreatic Ductal Adenocarcinoma1
1, 2CompletedTreatmentNasopharyngeal Carcinoma2
1, 2CompletedTreatmentNeoplasms Metastasis / Neoplasms, Esophageal / Stomach Neoplasms1
1, 2CompletedTreatmentNeoplasms, Esophageal2
1, 2CompletedTreatmentNon-Small Cell Lung Cancer Recurrent / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
1, 2CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)8
1, 2CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Tumors, Solid1
1, 2CompletedTreatmentOvarian Cancer2
1, 2CompletedTreatmentOvarian Cancer / Testicular germ cell tumour1
1, 2CompletedTreatmentOvarian Cancer / Tumors, Solid1
1, 2CompletedTreatmentOvarian Epithelial Cancer Stage III / Stage IV Breast Cancer / Stage IV Ovarian Cancer1
1, 2CompletedTreatmentPancreatic Adenocarcinoma Metastatic / Pancreatic Cancer Metastatic1
1, 2CompletedTreatmentPancreatic Cancer Metastatic3
1, 2CompletedTreatmentPeripheral Neuropathy Due to Chemotherapy1
1, 2CompletedTreatmentPlatinum Resistant Ovarian Cancer1
1, 2CompletedTreatmentProstate Cancer3
1, 2CompletedTreatmentRecurrent Breast Cancer / Stage IIIB Breast Cancer / Stage IV Breast Cancer1
1, 2CompletedTreatmentStage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
1, 2CompletedTreatmentStage IV Non-Small Cell Lung Cancer1
1, 2CompletedTreatmentStage IV Pancreatic Cancer3
1, 2CompletedTreatmentUnspecified Adult Solid Tumor, Protocol Specific1
1, 2CompletedTreatmentUterine Malignancies1
1, 2Not Yet RecruitingDiagnosticUterine Carcinoma1
1, 2Not Yet RecruitingTreatmentAdenocarcinoma of the Lung / NSCLC, Recurrent1
1, 2Not Yet RecruitingTreatmentAdenocarcinomas / Non-Small Cell Lung Carcinoma (NSCLC) / Squamous Cell Carcinoma (SCC)1
1, 2Not Yet RecruitingTreatmentAdvanced Gastric Cancer1
1, 2Not Yet RecruitingTreatmentAdvanced Gastric or Gastroesophageal Junction Cancer1
1, 2Not Yet RecruitingTreatmentAdvanced or Metastatic Solid Tumors / Non-Small Cell Lung Carcinoma (NSCLC)1
1, 2Not Yet RecruitingTreatmentCastration-Resistant Prostate Cancer (CRPC)1
1, 2Not Yet RecruitingTreatmentMalignant Neoplasm of Pancreas1
1, 2Not Yet RecruitingTreatmentTransitional Cell Carcinoma1
1, 2Not Yet RecruitingTreatmentTriple Negative Breast Cancer (TNBC)1
1, 2Not Yet RecruitingTreatmentTriple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)1
1, 2RecruitingTreatmentAdenocarcinoma Of Esophagus / Adenocarcinoma of the Pancreas / Adenocarcinomas of the Gastroesophageal Junction / Castration-Resistant Prostate Cancer (CRPC) / Esophageal Squamous Cell Carcinoma (ESCC) / Gastric Adenocarcinoma / Microsatellite Stable Colorectal Cancer / Triple Negative Breast Cancer (TNBC)1
1, 2RecruitingTreatmentAdenocarcinoma of the Pancreas1
1, 2RecruitingTreatmentAdenocarcinoma of the Pancreas / Bone Cancer / Bone Metastases / Bone Neoplasms / Breast Cancer / Cancer, Bladder / Glioblastoma Multiforme (GBM) / Gliomas, Malignant / Malignancies / Malignancies Multiple / Malignant Lymphomas / Malignant Neoplasm of Pancreas / Neoplasm of Bone / Neoplasm of Lung / Neoplasms Metastasis / Neoplasms Pancreatic / Neoplasms, Breast / Neoplasms, Colorectal / Neoplasms, Pancreatic / Ovarian Cancer / Refractory Brain Tumor / Refractory Cancer / Refractory Neoplasm / Refractory Non-Hodgkin's lymphoma / Renal Cancers / Resistant Cancer / Sarcomas1
1, 2RecruitingTreatmentAdenocarcinoma of the Pancreas / Malignant Neoplasm of Pancreas / Pancreatic Ductal Adenocarcinoma1
1, 2RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Gastric Cardia Adenocarcinoma / Malignant Neoplasm of Stomach Stage II / Stage IB Gastric Cancer / Stage IB Gastric Cancer AJCC v7 / Stage II Gastric Cancer AJCC v7 / Stage IIA Gastric Cancer / Stage IIA Gastric Cancer AJCC v7 / Stage IIB Gastric Cancer / Stage IIB Gastric Cancer AJCC v7 / Stage IIIA Gastric Cancer / Stage IIIA Gastric Cancer AJCC v7 / Stage IIIB Gastric Cancer / Stage IIIB Gastric Cancer AJCC v71
1, 2RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Malignant Neoplasm of Stomach1
1, 2RecruitingTreatmentAdenocarcinomas / Digestive System Diseases / Digestive System Neoplasms / Endocrine Gland Neoplasms / Endocrine System Diseases / Neoplasm, Glandular / Neoplasms / Neoplasms Pancreatic / Neoplasms, Pancreatic / Pancreatic Diseases1
1, 2RecruitingTreatmentAdvanced (Stage IIIB-C-IV) Ovarian, Primary Peritoneal and Fallopian Tube Cancer1
1, 2RecruitingTreatmentAdvanced Gastric Adenocarcinoma / Advanced Urothelial Carcinoma / Metastatic Colorectal Adenocarcinoma / Metastatic Renal Cell Carcinoma1
1, 2RecruitingTreatmentAdvanced Gastric Cancer1
1, 2RecruitingTreatmentAdvanced Gastric Cancer / Intraperitoneal Paclitaxel / MFOLFOX6 / Peritoneal Carcinomatosis1
1, 2RecruitingTreatmentAdvanced Ovarian Cancer / Fallopian Tube Cancer / Malignant Peritoneal Neoplasm1
1, 2RecruitingTreatmentAdvanced Solid Tumors1
1, 2RecruitingTreatmentAdvanced Triple Negative Breast Cancer1
1, 2RecruitingTreatmentAlbumin-bound Paxlitaxel / Chemoradiotherapy / Esophageal Cancers / Unresectable Malignant Neoplasm1
1, 2RecruitingTreatmentAnatomic Stage IV Breast Cancer AJCC v8 / Metastatic Triple-Negative Breast Carcinoma / Prognostic Stage IV Breast Cancer AJCC v81
1, 2RecruitingTreatmentBiliary Tract Cancer (BTC)1
1, 2RecruitingTreatmentBiliary Tract Cancer (BTC) / Colorectal Cancer (CRC) / Endometrial Cancer / Gastroesophageal Cancer (GC) / Ovarian Cancer / Tumors, Solid1
1, 2RecruitingTreatmentBladder Cancer Cell Transitional / Cancer, Bladder / Genitourinary tract neoplasm / Non-muscle Invasive Bladder Cancer (NMIBC) / Transitional Cell Carcinoma of the Bladder / Urinary Bladder / Urinary Bladder Diseases / Urinary Bladder Neoplasms / Urologic Diseases / Urologic Neoplasms1
1, 2RecruitingTreatmentBreast Cancer3
1, 2RecruitingTreatmentBreast Cancer / Breast cancer male / Breast Cancer, Male / HER2 Positive Breast Cancers / Malignant Neoplasm of Female Breast1
1, 2RecruitingTreatmentBreast Cancer / Combination Chemotherapy / HER2 Positive1
1, 2RecruitingTreatmentBreast Cancer / Luminal B / Triple Negative Breast Cancer (TNBC)1
1, 2RecruitingTreatmentCancer of Pancreas1
1, 2RecruitingTreatmentCervical Carcinoma / Endometrial Carcinoma / Fallopian Tube Carcinoma / Ovarian Carcinoma / Primary Peritoneal Carcinoma1
1, 2RecruitingTreatmentCholangiocarcinomas1
1, 2RecruitingTreatmentColorectal Cancers / Malignant Neoplasm of Pancreas1
1, 2RecruitingTreatmentColorectal Cancers / Non-Small Cell Lung Carcinoma (NSCLC) / Pancreatic Ductal Adenocarcinoma / Triple Negative Breast Cancer (TNBC)1
1, 2RecruitingTreatmentCutaneous Angiosarcoma1
1, 2RecruitingTreatmentERBB2 Gene Amplification / Estrogen Receptor Positive / Inflammatory Breast Carcinoma / Malignant Neoplasm of Breast / Metastatic Breast Carcinoma / Progesterone Receptor Positive / Stage III Breast Cancer AJCC V7 / Stage IIIA Breast Cancer AJCC v7 / Stage IIIB Breast Cancer AJCC v7 / Stage IIIC Breast Cancer AJCC v7 / Stage IV Breast Cancer AJCC v6 and v71
1, 2RecruitingTreatmentElderly Patients / Oesophagus Cancer1
1, 2RecruitingTreatmentEndometrial Cancer / Squamous Cell Carcinoma of Lung / Squamous Non-Small Cell Lung Cancer1
1, 2RecruitingTreatmentEsophageal Cancers2
1, 2RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC)1
1, 2RecruitingTreatmentGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma1
1, 2RecruitingTreatmentGastroesophageal Cancer (GC) / Resectable Esophageal Cancer1
1, 2RecruitingTreatmentLocally Advanced Pancreatic Cancer1
1, 2RecruitingTreatmentLocally Advanced Pancreatic Cancer (LAPC)1
1, 2RecruitingTreatmentLocally Advanced and Metastatic Pancreatic Cancer1
1, 2RecruitingTreatmentLocally Advanced or Metastatic Solid Tumor1
1, 2RecruitingTreatmentMalignancies1
1, 2RecruitingTreatmentMalignant Neoplasm of Pancreas3
1, 2RecruitingTreatmentMalignant Neoplasm of Pancreas / Pancreas Metastases / Pancreatic Adenocarcinoma Resectable / Pancreatic Ductal Adenocarcinoma1
1, 2RecruitingTreatmentMalignant Neoplasm of Stomach / Tumors, Solid1
1, 2RecruitingTreatmentMetastatic Gastric Cancers1
1, 2RecruitingTreatmentNeoplasms, Ovarian / Ovarian Cancer1
1, 2RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)2
1, 2RecruitingTreatmentOvarian Cancer3
1, 2RecruitingTreatmentPancreatic Ductal Adenocarcinoma1
1, 2RecruitingTreatmentPancreatic Neoplasms (Locally Advanced Non-metastatic)1
1, 2RecruitingTreatmentRecurrent Ovarian Cancer1
1, 2RecruitingTreatmentSmall Cell Lung Cancer (SCLC)1
1, 2RecruitingTreatmentSoft Tissue Sarcoma (STS)1
1, 2RecruitingTreatmentTriple Negative Breast Cancer (TNBC)2
1, 2RecruitingTreatmentTriple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)2
1, 2RecruitingTreatmentTriple Negative Breast Neoplasms1
1, 2TerminatedOtherNon-Small Cell Lung Carcinoma (NSCLC)1
1, 2TerminatedTreatmentAdenocarcinoma of the Esophagus / Adenocarcinomas of the Gastroesophageal Junction1
1, 2TerminatedTreatmentAdenocarcinomas / Tumors / Unknown Primary Tumors1
1, 2TerminatedTreatmentAdvanced Malignancies / Metastatic Cancers / Tumors, Solid1
1, 2TerminatedTreatmentAdvanced Squamous Non-Small Cell Lung Cancer1
1, 2TerminatedTreatmentBasaloid Squamous Cell Carcinoma / Carcinoma, Adenosquamous Cell / Carcinoma, Undifferentiated / Squamous Cell Carcinoma of the Head and Neck (SCCHN)1
1, 2TerminatedTreatmentBreast Adenocarcinoma / Estrogen Receptor Positive / HER2/Neu Negative / Recurrent Breast Carcinoma / Stage IIB Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
1, 2TerminatedTreatmentBreast Cancer3
1, 2TerminatedTreatmentBreast Cancer / Cancer, Advanced / Malignant Neoplasm of Pancreas / Ovarian / Sarcomas / Small Cell Lung Cancer (SCLC)1
1, 2TerminatedTreatmentBreast Cancer / HER2 Positive Breast Cancers1
1, 2TerminatedTreatmentBreast Cancer / Lung Cancers / Unspecified Adult Solid Tumor, Protocol Specific1
1, 2TerminatedTreatmentCancer, Advanced / Solid Tumors and Hematologic Malignancy / Tumors, Solid1
1, 2TerminatedTreatmentFallopian Tube Cancer / Intestinal Obstruction / Malignant Peritoneal Neoplasm / Ovarian Cancer1
1, 2TerminatedTreatmentFallopian Tube Cancer / Ovarian Epithelial Cancer / Primary Peritoneal Cancer1
1, 2TerminatedTreatmentGlioblastoma Multiforme (GBM) / Neoplasms, Brain1
1, 2TerminatedTreatmentHER2 Negative Breast Cancer / HER2-Negative Breast Cancer / Inflammatory Breast Cancer (IBC) / Male Breast Cancer / Recurrent Breast Cancer / Stage IV Breast Cancer1
1, 2TerminatedTreatmentLocally Advanced Non-Small Cell Lung Cancer1
1, 2TerminatedTreatmentLung Cancers4
1, 2TerminatedTreatmentMalignant Neoplasm of Pancreas2
1, 2TerminatedTreatmentMetastatic Breast Cancer1
1, 2TerminatedTreatmentMetastatic Cancers1
1, 2TerminatedTreatmentNeoplasm Metastases / Neoplasms, Breast1
1, 2TerminatedTreatmentNeoplasms1
1, 2TerminatedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)1
1, 2TerminatedTreatmentNon-Squamous Non-Small Cell Lung Cancer / Squamous Non-Small Cell Lung Cancer1
1, 2TerminatedTreatmentOvarian Cancer2
1, 2TerminatedTreatmentPancreatic Cancer Metastatic1
1, 2TerminatedTreatmentPancreatic Cancer, Adult1
1, 2TerminatedTreatmentPancreatic Ductal Adenocarcinoma / Resectable Pancreatic Adenocarcinoma1
1, 2TerminatedTreatmentRecurrent Fallopian Tube Cancer / Recurrent Ovarian Epithelial Cancer / Recurrent Primary Peritoneal Cavity Cancer1
1, 2TerminatedTreatmentRelapsed Or Refractory Multiple Myeloma1
1, 2TerminatedTreatmentSquamous Cell Carcinoma of the Head and Neck (SCCHN)1
1, 2TerminatedTreatmentStage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
1, 2TerminatedTreatmentStage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
1, 2TerminatedTreatmentStage IV (Metastatic) Breast Cancer1
1, 2Unknown StatusSupportive CareDrug/Agent Toxicity by Tissue/Organ / Head and Neck Carcinoma / Radiation Toxicity1
1, 2Unknown StatusTreatmentAdvanced Metastatic Gastric Cancer / Recurrent Gastric Cancer1
1, 2Unknown StatusTreatmentBrain and Central Nervous System Tumors / Extragonadal Germ Cell Tumor / Ovarian Cancer / Testicular germ cell tumour1
1, 2Unknown StatusTreatmentBreast Cancer3
1, 2Unknown StatusTreatmentBreast Cancer / Malignant Neoplasm of Stomach / Unspecified Adult Solid Tumor, Protocol Specific1
1, 2Unknown StatusTreatmentBreast Cancer / Metastatic Melanoma / Non-Small Cell Lung Carcinoma (NSCLC) / Tumors, Solid1
1, 2Unknown StatusTreatmentCancer, Bladder1
1, 2Unknown StatusTreatmentEsophageal Cancers1
1, 2Unknown StatusTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cavity Cancer1
1, 2Unknown StatusTreatmentLung Cancers1
1, 2Unknown StatusTreatmentNeoplasms, Breast1
1, 2Unknown StatusTreatmentOvarian Cancer1
1, 2Unknown StatusTreatmentRecurrent, Platinum-resistant Ovarian Cancer1
1, 2WithdrawnTreatmentBreast Cancer1
1, 2WithdrawnTreatmentColorectal Cancers1
1, 2WithdrawnTreatmentHead and Neck Squamous Cell Carcinoma (HNSCC)1
1, 2WithdrawnTreatmentHepatocellular Carcinoma Non-resectable / Recurrent Hepatocellular Carcinoma1
1, 2WithdrawnTreatmentLung Cancers2
1, 2WithdrawnTreatmentMalignant Neoplasm of Pancreas / Pancreatic Adenocarcinoma Resectable / Pancreatic Cancer Metastatic / Pancreatic Ductal Adenocarcinoma / Pancreatic Metastasis2
1, 2WithdrawnTreatmentMalignant Neoplasm of Stomach1
1, 2WithdrawnTreatmentMelanoma1
1, 2WithdrawnTreatmentMetastatic Melanoma / Tumors Metastatic to Brain1
1, 2WithdrawnTreatmentNeuroendocrine Carcinoma of the Skin1
1, 2WithdrawnTreatmentNon-Hodgkin's Lymphoma (NHL)1
1, 2WithdrawnTreatmentNon-Small Cell Lung Carcinoma (NSCLC)1
1, 2WithdrawnTreatmentOvarian Cancer1
1, 2WithdrawnTreatmentPancreatic Cancer Metastatic1
1, 2WithdrawnTreatmentTransitional Cell Carcinoma1
1, 2WithdrawnTreatmentTriple Negative Breast Cancer (TNBC)1
2Active Not RecruitingNot AvailablePeritoneal Carcinomatosis1
2Active Not RecruitingOtherBreast Cancer / Locally Advanced Malignant Neoplasm1
2Active Not RecruitingOtherNon-Small Cell Lung Carcinoma (NSCLC)1
2Active Not RecruitingSupportive CareBreast Cancer1
2Active Not RecruitingTreatmentAdenocarcinoma Breast Stage IV1
2Active Not RecruitingTreatmentAdenocarcinoma Of Esophagus1
2Active Not RecruitingTreatmentAdenocarcinoma Of Esophagus / Adenocarcinomas of the Gastroesophageal Junction / Esophageal Squamous Cell Carcinoma (ESCC) / Recurrent Esophageal Carcinoma / Stage IV Esophageal Cancer AJCC v71
2Active Not RecruitingTreatmentAdenocarcinoma of the Lung / Adenosquamous Lung Carcinoma / Bronchioloalveolar Carcinoma / Large Cell Lung Carcinoma / Non-Small Cell Lung Carcinoma (NSCLC) / Recurrent Non-Small Cell Lung Carcinoma / Squamous Cell Lung Carcinoma / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
2Active Not RecruitingTreatmentAdenocarcinoma of the Lung / Adenosquamous Lung Carcinoma / Bronchioloalveolar Carcinoma / Lung Adenosquamous Carcinoma / Malignant Pericardial Effusion / Malignant Pleural Effusions / Minimally Invasive Lung Adenocarcinoma / Stage IIIB Lung Non-Small Cell Cancer AJCC v7 / Stage IIIb Non-small Cell Lung Cancer / Stage IIIB Non-Small Cell Lung Cancer AJCC v7 / Stage IV Lung Non-Small Cell Cancer AJCC v7 / Stage IV Non-Small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer AJCC v71
2Active Not RecruitingTreatmentAdenocarcinoma of the Ovaries / Fallopian Tube Adenocarcinoma / Fallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Mucinous Adenocarcinoma / Fallopian Tube Serous Adenocarcinoma / Fallopian Tube Transitional Cell Carcinoma / Fallopian Tube Undifferentiated Carcinoma / Malignant Neoplasms of Female Genital Organs / Malignant Ovarian Brenner Tumor / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Adenocarcinoma / Ovarian Seromucinous Carcinoma / Ovarian Serous Adenocarcinoma / Ovarian Transitional Cell Carcinoma / Ovarian Undifferentiated Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma1
2Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas2
2Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas / Resectable Pancreatic Cancers / Resectable Pancreatic Carcinoma1
2Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas / Resectable Pancreatic Carcinoma1
2Active Not RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction1
2Active Not RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Esophageal Cancers1
2Active Not RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Metastatic Gastric Adenocarcinoma1
2Active Not RecruitingTreatmentAdvanced Pancreatic Cancer2
2Active Not RecruitingTreatmentAnal Basaloid Carcinoma / Anal Canal Cloacogenic Carcinoma / Anal Squamous Cell Carcinoma / Metastatic Anal Canal Carcinoma / Recurrent Anal Canal Carcinoma / Stage IIIB Anal Canal Cancer / Stage IV Anal Canal Cancer1
2Active Not RecruitingTreatmentBenign Prostatic Hyperplasia (BPH) / Benign Prostatic Hypertrophy1
2Active Not RecruitingTreatmentBiliary Tract Cancer / Stage III Intrahepatic Cholangiocarcinoma AJCC v7 / Stage IIIA Gallbladder Cancer AJCC v7 / Stage IIIB Gallbladder Cancer AJCC v7 / Stage IVA Gallbladder Cancer AJCC v7 / Stage IVA Intrahepatic Cholangiocarcinoma AJCC v7 / Stage IVB Gallbladder Cancer AJCC v7 / Stage IVB Intrahepatic Cholangiocarcinoma AJCC v7 / Unresectable Extrahepatic Bile Duct Carcinoma / Unresectable Gallbladder Carcinoma1
2Active Not RecruitingTreatmentBreast Adenocarcinoma / HER2 Positive Breast Cancers / Inflammatory Breast Carcinoma / Recurrent Breast Cancer / Stage IIA Breast Cancer / Stage IIB Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
2Active Not RecruitingTreatmentBreast Cancer27
2Active Not RecruitingTreatmentBreast Cancer / Carcinoma of the Breast1
2Active Not RecruitingTreatmentBreast Cancer / Carcinoma, Breast / Malignant Neoplasm of Breast / Tumors, Breast1
2Active Not RecruitingTreatmentBreast Cancer / Estrogen Receptor Positive Breast Cancer / Estrogen Receptor-Positive Breast Cancer1
2Active Not RecruitingTreatmentBreast Cancer / HER2 Negative Breast Cancer / HER2 Positive Breast Cancers / HER2-Negative Breast Cancer / Recurrent Breast Cancer / Stage IA Breast Cancer / Stage IB Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer1
2Active Not RecruitingTreatmentBreast Cancer / Triple Negative Breast Cancer (TNBC)1
2Active Not RecruitingTreatmentCancer of Head and Neck / Cancers of the Head and Neck / Carcinoma, Squamous Cell of the Head and Neck / Head and Neck Carcinoma / Neoplasms, Head and Neck / Squamous Cell Carcinoma of the Head and Neck (SCCHN)1
2Active Not RecruitingTreatmentCancer, Anaplastic Thyroid / Recurrent Thyroid Cancer1
2Active Not RecruitingTreatmentCancers of the Head and Neck / Esophageal Squamous Cell Carcinoma (ESCC) / Non-Small Cell Lung Carcinoma (NSCLC) / Transitional Cell Carcinoma / Urinary Bladder Neoplasms1
2Active Not RecruitingTreatmentCancers of the Head and Neck / Head and Neck Carcinoma / Head and Neck Squamous Cell Carcinoma (HNSCC)1
2Active Not RecruitingTreatmentCarcinoma, Non Small Cell Lung (NSCLC)1
2Active Not RecruitingTreatmentCarcinoma, Small Cell / Neuroendocrine Tumors / Non-Small Cell Lung Carcinoma (NSCLC) / Ovarian Epithelial Cancer1
2Active Not RecruitingTreatmentCarcinosarcoma / Endometrial Cancer / Ovarian Cancer / Uterine Malignancies1
2Active Not RecruitingTreatmentCervical Cancers2
2Active Not RecruitingTreatmentClear Cell Endometrial Cancer / Endometrial Cancer / Papillary Serous1
2Active Not RecruitingTreatmentDesmoid / Ewing's Sarcoma (ES) / Sarcomas / Tumor, Desmoplastic Small Round Cell, Adult / Tumor, Desmoplastic Small Round Cell, Childhood1
2Active Not RecruitingTreatmentDuctal Adenocarcinoma of the Pancreas / Resectable Pancreatic Cancers1
2Active Not RecruitingTreatmentEarly Breast Cancer1
2Active Not RecruitingTreatmentEndometrial Adenocarcinomas / Endometrial Adenosquamous Carcinoma / Endometrial Clear Cell Adenocarcinoma / Endometrial Serous Adenocarcinoma / Recurrent Uterine Corpus Carcinoma / Stage IIIA Uterine Corpus Cancer AJCC v7 / Stage IIIB Uterine Corpus Cancer AJCC v7 / Stage IIIC Uterine Corpus Cancer AJCC v7 / Stage IVA Uterine Corpus Cancer AJCC v7 / Stage IVB Uterine Corpus Cancer AJCC v71
2Active Not RecruitingTreatmentEndometrial Cancer3
2Active Not RecruitingTreatmentEsophageal Cancers / Malignant Neoplasm of Stomach1
2Active Not RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC)2
2Active Not RecruitingTreatmentEstrogen Receptor Negative / HER2/Neu Negative / Inflammatory Breast Cancer (IBC) / Progesterone Receptor Negative / Stage IIA Breast Cancer / Stage IIB Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)1
2Active Not RecruitingTreatmentEstrogen Receptor Positive Breast Cancer / Estrogen Receptor-negative Breast Cancer / Estrogen Receptor-Positive Breast Cancer / HER2 Negative Breast Cancer / HER2 Positive Breast Cancers / HER2-Negative Breast Cancer / Locally Advanced Breast Carcinoma / Male Breast Cancer / Metastatic Breast Carcinoma / Progesterone Receptor Positive Breast Cancer / Progesterone Receptor-negative Breast Cancer / Progesterone Receptor-positive Breast Cancer / Recurrent Breast Cancer / Recurrent Breast Carcinoma / Stage III Breast Cancer AJCC V7 / Stage IIIA Breast Cancer / Stage IIIA Breast Cancer AJCC v7 / Stage IIIB Breast Cancer / Stage IIIB Breast Cancer AJCC v7 / Stage IIIC Breast Cancer / Stage IIIC Breast Cancer AJCC v7 / Stage IV Breast Cancer / Stage IV Breast Cancer AJCC v6 and v7 / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)1
2Active Not RecruitingTreatmentFallopian Tube Cancer / Fallopian Tube Carcinoma / Fallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Mucinous Adenocarcinoma / Fallopian Tube Serous Adenocarcinoma / Fallopian Tube Transitional Cell Carcinoma / Fallopian Tube Undifferentiated Carcinoma / FIGO Stage III Ovarian Cancer / FIGO Stage IIIA Ovarian Cancer / FIGO Stage IIIA1 Ovarian Cancer / FIGO Stage IIIA1(i) Ovarian Cancer / FIGO Stage IIIA1(ii) Ovarian Cancer / FIGO Stage IIIA2 Ovarian Cancer / FIGO Stage IIIB Ovarian Cancer / FIGO Stage IIIC Ovarian Cancer / FIGO Stage IVA Ovarian Cancer / FIGO Stage IVB Ovarian Cancer / Malignant Ovarian Brenner Tumor / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Epithelial Cancer / Ovarian Mucinous Adenocarcinoma / Ovarian Seromucinous Carcinoma / Ovarian Serous Adenocarcinoma / Ovarian Transitional Cell Carcinoma / Ovarian Undifferentiated Carcinoma / Primary Peritoneal Carcinoma / Primary Peritoneal Serous Adenocarcinoma1
2Active Not RecruitingTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Carcinoma1
2Active Not RecruitingTreatmentGastroesophageal Cancer (GC)1
2Active Not RecruitingTreatmentGastrointestinal Neuroendocrine Carcinomas1
2Active Not RecruitingTreatmentGerm Cell Tumors2
2Active Not RecruitingTreatmentGynecologic Malignancies1
2Active Not RecruitingTreatmentHER2 Positive Breast Cancers / Inflammatory Breast Cancer (IBC) / Invasive Ductal Breast Carcinoma / Malignant Neoplasm of Female Breast / Mucinous Breast Cancer Stage II / Tubular Breast Cancer Stage II / Tubular Breast Cancer Stage III1
2Active Not RecruitingTreatmentHER2 Positive Breast Carcinoma / Stage I Breast Cancer AJCC v7 / Stage IA Breast Cancer / Stage IA Breast Cancer AJCC v7 / Stage IB Breast Cancer / Stage IB Breast Cancer AJCC v7 / Stage II Breast Cancer AJCC v6 and v7 / Stage IIA Breast Cancer / Stage IIA Breast Cancer AJCC v6 and v7 / Stage IIB Breast Cancer / Stage IIB Breast Cancer AJCC v6 and v71
2Active Not RecruitingTreatmentHead and Neck Carcinoma2
2Active Not RecruitingTreatmentHead and Neck Carcinoma / Metastatic Head and Neck Squamous Cell Carcinoma / Metastatic Squamous Cell Carcinoma of the Hypopharynx / Metastatic Squamous Cell Carcinoma of the Larynx / Metastatic Squamous Cell Carcinoma of the Oral Cavity / Metastatic Squamous Cell Carcinoma of the Oropharynx / Recurrent Head and Neck Squamous Cell Carcinoma / Recurrent Hypopharyngeal Squamous Cell Carcinoma / Recurrent Laryngeal Squamous Cell Carcinoma / Recurrent Oral Cavity Squamous Cell Carcinoma / Recurrent Oropharyngeal Squamous Cell Carcinoma / Squamous Cell Carcinoma (SCC)1
2Active Not RecruitingTreatmentHead and Neck Carcinoma / Neoplasms, Oral / Neoplasms, Pharyngeal / Squamous Cell Carcinoma (SCC)1
2Active Not RecruitingTreatmentHead and Neck Carcinoma / Squamous Cell Carcinoma of the Head and Neck (SCCHN)2
2Active Not RecruitingTreatmentHead and Neck Squamous Cell Carcinoma (HNSCC)1
2Active Not RecruitingTreatmentHuman Papilloma Virus Infection / Stage III Squamous Cell Carcinoma of the Oropharynx / Stage IVA Squamous Cell Carcinoma of the Oropharynx / Stage IVB Squamous Cell Carcinoma of the Oropharynx1
2Active Not RecruitingTreatmentInflammatory Breast Cancer (IBC) / Male Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer1
2Active Not RecruitingTreatmentInvasive Breast Carcinoma / Stage II Breast Cancer AJCC v6 and v7 / Stage IIA Breast Cancer AJCC v6 and v7 / Stage IIB Breast Cancer AJCC v6 and v7 / Stage III Breast Cancer AJCC V7 / Stage IIIA Breast Cancer AJCC v7 / Stage IIIB Breast Cancer AJCC v7 / Stage IIIC Breast Cancer AJCC v7 / Triple-Negative Breast Carcinoma1
2Active Not RecruitingTreatmentLocally Advanced Lung Cancer; Metastatic Lung Cancer / Locally Advanced or Metastatic Lung Cancer1
2Active Not RecruitingTreatmentLocally Advanced Pancreatic Cancer / Malignant Neoplasm of Pancreas1
2Active Not RecruitingTreatmentLung Cancers3
2Active Not RecruitingTreatmentLung Cancers / Non-Small Cell Lung Carcinoma (NSCLC)1
2Active Not RecruitingTreatmentMale Breast Carcinoma / Stage IIA Breast Cancer AJCC v6 and v7 / Stage IIB Breast Cancer AJCC v6 and v7 / Stage IIIA Breast Cancer AJCC v7 / Triple-Negative Breast Carcinoma1
2Active Not RecruitingTreatmentMalignant Melanoma of Skin / Melanoma (Skin)1
2Active Not RecruitingTreatmentMalignant Neoplasm of Breast1
2Active Not RecruitingTreatmentMalignant Neoplasm of Stomach1
2Active Not RecruitingTreatmentMalignant Neoplasm of Stomach Stage II / Malignant Neoplasm of Stomach Stage IV1
2Active Not RecruitingTreatmentMalignant Solid Tumours1
2Active Not RecruitingTreatmentMalignant Tumor of the Breast / Neoplasms, Breast1
2Active Not RecruitingTreatmentMelanoma1
2Active Not RecruitingTreatmentMetastatic Breast Cancer7
2Active Not RecruitingTreatmentMetastatic Malignant Melanoma1
2Active Not RecruitingTreatmentMetastatic Malignant Neoplasm in the Brain / Recurrent Non-Small Cell Lung Carcinoma / Stage IIA Non-Small Cell Lung Carcinoma / Stage IIB Non-Small Cell Lung Carcinoma / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
2Active Not RecruitingTreatmentMetastatic Non-Small Cell Lung Cancer / Non-Small Cell Carcinoma of Lung, TNM Stage 4 / Non-Small Cell Lung Cancer Recurrent / Non-Small Cell Lung Carcinoma (NSCLC) / Non-Small-Cell Lung Cancer Metastatic / Recurrent Non Small Cell Lung Cancer1
2Active Not RecruitingTreatmentNasopharyngeal Carcinoma1
2Active Not RecruitingTreatmentNeoplasms, Breast2
2Active Not RecruitingTreatmentNeoplasms, Endometrial1
2Active Not RecruitingTreatmentNeoplasms, Head and Neck1
2Active Not RecruitingTreatmentNeoplasms, Ovarian1
2Active Not RecruitingTreatmentNeoplasms, Ovarian / Ovarian Epithelial Cancer1
2Active Not RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)8
2Active Not RecruitingTreatmentNon-small Cell Lung Cancer NSCLC / Non-Small Cell Lung Carcinoma (NSCLC)1
2Active Not RecruitingTreatmentOvarian Cancer7
2Active Not RecruitingTreatmentOvarian Sex-cord Stromal Tumor1
2Active Not RecruitingTreatmentOvarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation1
2Active Not RecruitingTreatmentPancreatic Cancer Metastatic3
2Active Not RecruitingTreatmentPatients With Stage IV or Recurrent Adenocarcinoma of the Lung1
2Active Not RecruitingTreatmentRecurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma1
2Active Not RecruitingTreatmentRecurrent Non-Small Cell Lung Carcinoma / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
2Active Not RecruitingTreatmentRecurrent Non-Small Cell Lung Carcinoma / Stage IV Non-Small Cell Lung Cancer1
2Active Not RecruitingTreatmentRecurrent Ovarian Cancer1
2Active Not RecruitingTreatmentSquamous Cell Carcinoma of the Head and Neck (SCCHN)1
2Active Not RecruitingTreatmentStage IIB Non-small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
2Active Not RecruitingTreatmentStage III Lung Non-Small Cell Cancer AJCC v7 / Stage IIIA Lung Non-Small Cell Cancer AJCC v7 / Stage IIIB Lung Non-Small Cell Cancer AJCC v71
2Active Not RecruitingTreatmentThyroid Gland Anaplastic Carcinoma1
2Active Not RecruitingTreatmentTransitional Cell Carcinoma1
2Active Not RecruitingTreatmentTriple Negative Breast Cancer (TNBC)2
2Active Not RecruitingTreatmentTumors, Solid1
2Active Not RecruitingTreatmentUntreated Stage III Melanoma or Stage IV Melanoma1
2Active Not RecruitingTreatmentUrothelial Cancer1
2CompletedBasic ScienceStage II Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer1
2CompletedDiagnosticBreast Cancer1
2CompletedPreventionEndometrial Cancer / Ovarian Cancer / Uterine Cervical Cancer1
2CompletedSupportive CareLung Cancers / Neurologic toxicity / Ovarian Cancer1
2CompletedTreatmentAbdominal wall neoplasm / Colonic Neoplasms / Mesothelioma / Neoplasms, Abdominal1
2CompletedTreatmentAbdominal wall neoplasm / Fallopian Tube Cancer / Ovarian Cancer1
2CompletedTreatmentAbdominal wall neoplasm / Fallopian Tube Neoplasms / Neoplasms, Ovarian1
2CompletedTreatmentAbdominal wall neoplasm / Fallopian Tube Neoplasms / Ovarian Cancer2
2CompletedTreatmentAcinar Cell Adenocarcinoma of the Pancreas / Duct Cell Adenocarcinoma of the Pancreas / Recurrent Pancreatic Cancer / Stage III Pancreatic Cancer / Stage IV Pancreatic Cancer1
2CompletedTreatmentActinic Keratosis (AK)1
2CompletedTreatmentAdenocarcinoma of Colon / Adenocarcinoma of Rectum / Metastatic Disease1
2CompletedTreatmentAdenocarcinoma of the Cervix / Adenosquamous carcinoma of the cervix / Cervical Small Cell Carcinoma / Cervical Squamous Cell Carcinoma / Recurrent Cervical Carcinoma1
2CompletedTreatmentAdenocarcinoma of the Cervix / Adenosquamous carcinoma of the cervix / Cervical Squamous Cell Carcinoma / Recurrent Cervical Carcinoma / Stage IVA Cervical Cancer / Stage IVB Cervical Cancer1
2CompletedTreatmentAdenocarcinoma of the Lung1
2CompletedTreatmentAdenocarcinoma of the Lung / Adenosquamous Cell Lung Cancer / Bronchoalveolar Cell Lung Cancer / Large Cell Lung Cancer / Non-Small Cell Lung Cancer Recurrent / Squamous Cell Carcinoma of Lung / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
2CompletedTreatmentAdenocarcinoma of the Lung / Adenosquamous Cell Lung Cancer / Bronchoalveolar Cell Lung Cancer / Large Cell Lung Cancer / Squamous Cell Carcinoma of Lung / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
2CompletedTreatmentAdenocarcinoma of the Pancreas1
2CompletedTreatmentAdenocarcinoma of the Pancreas / Stage II Pancreatic Cancer / Stage III Pancreatic Cancer1
2CompletedTreatmentAdenocarcinoma of the Prostate1
2CompletedTreatmentAdenocarcinoma, Bronchiolo-Alveolar1
2CompletedTreatmentAdenocarcinomas of the Gastroesophageal Junction / Gastric Adenocarcinoma1
2CompletedTreatmentAdenocarcinomas / Esophageal Cancers / Gastro-esophageal Junction Cancer / Squamous Cell Carcinoma (SCC)1
2CompletedTreatmentAdenocarcinomas / Non-Small Cell Lung Carcinoma (NSCLC)1
2CompletedTreatmentAdenosquamous Cell Lung Cancer / Drug/Agent Toxicity by Tissue/Organ / Hemoptysis / Squamous Cell Carcinoma of Lung / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
2CompletedTreatmentAdult Type Ovarian Granulosa Cell Tumor / Ovarian Gynandroblastoma / Ovarian Sertoli-Leydig Cell Tumors / Ovarian Sex Cord Tumor With Annular Tubules / Ovarian Steroid Cell Tumor1
2CompletedTreatmentAdvanced Breast Cancer / Breast Cancer1
2CompletedTreatmentAdvanced Breast Cancer / Metastatic Breast Cancer1
2CompletedTreatmentAdvanced Gastric Cancer1
2CompletedTreatmentAdvanced Non Small Cell Lung Cancer1
2CompletedTreatmentAdvanced Non Small Cell Lung Cancer / Non-Small Cell Lung Cancer Recurrent / Non-Small Cell Lung Carcinoma (NSCLC)1
2CompletedTreatmentAdvanced Solid Tumors1
2CompletedTreatmentAdvanced or Metastatic Non-Small Cell Lung Cancer1
2CompletedTreatmentAdvanced/Metastatic Non-Small Cell Lung Cancer1
2CompletedTreatmentAngina Pectoris / Coronary Artery Disease (CAD)1
2CompletedTreatmentBRCA 1 /2 and / or HRD / Breast Cancer / HRpos Breast Neoplasms / Triple Negative Breast Neoplasms1
2CompletedTreatmentBrain and Central Nervous System Tumors2
2CompletedTreatmentBrain and Central Nervous System Tumors / Extragonadal Germ Cell Tumor / Ovarian Cancer / Teratoma / Testicular germ cell tumour2
2CompletedTreatmentBreast Cancer71
2CompletedTreatmentBreast Cancer / Cardiac Toxicity1
2CompletedTreatmentBreast Cancer / Early Breast Cancer / Stage II Breast Cancer1
2CompletedTreatmentBreast Cancer / Effects of Chemotherapy / HER2 Positive Breast Cancers1
2CompletedTreatmentBreast Cancer / ErbB1 Expressing / ErbB2 Overexpressing / Inflammatory / Neoplasms, Breast / Newly Diagnosed1
2CompletedTreatmentBreast Cancer / HER2 Negative Breast Cancer / HER2-Negative Breast Cancer1
2CompletedTreatmentBreast Cancer / HER2 Positive1
2CompletedTreatmentBreast Cancer / Inflammatory Breast Cancer (IBC) / Locally Advanced Breast Cancer (LABC)1
2CompletedTreatmentBreast Cancer / Locally Advanced / Stage IIB Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IV Breast Cancer1
2CompletedTreatmentBreast Cancer / Lung Cancers / Ovarian Cancer1
2CompletedTreatmentBreast Cancer / Metastatic Breast Cancer1
2CompletedTreatmentBreast Cancer / Metastatic Breast Cancer / Stage IV Breast Cancer / Triple Negative Breast Cancer (TNBC)1
2CompletedTreatmentBreast Cancer / Metastatic Breast Cancer / Tumors, Solid1
2CompletedTreatmentBreast Cancer / Neoplasms Metastasis1
2CompletedTreatmentBreast Cancer / Neoplasms, Breast4
2CompletedTreatmentBreast Cancer / Stage II Breast Cancer / Stage III Breast Cancer1
2CompletedTreatmentBrenner Tumor / Fallopian Tube Cancer / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mixed Epithelial Carcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Serous Cystadenocarcinoma / Ovarian Undifferentiated Adenocarcinoma / Peritoneal Cavity Cancer / Recurrent Ovarian Epithelial Cancer / Stage III Ovarian Epithelial Cancer / Stage IV Ovarian Epithelial Cancer1
2CompletedTreatmentBrenner Tumor / Fallopian Tube Cancer / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Serous Cystadenocarcinoma / Ovarian Undifferentiated Adenocarcinoma / Stage III Ovarian Epithelial Cancer / Stage IV Ovarian Epithelial Cancer1
2CompletedTreatmentCNS Germ Cell Tumor1
2CompletedTreatmentCancer of Gastrointestinal Tract / Colorectal Cancers1
2CompletedTreatmentCancer of Head and Neck1
2CompletedTreatmentCancer, Bladder4
2CompletedTreatmentCancer, Bladder / Transitional Cell Cancer of the Renal Pelvis and Ureter2
2CompletedTreatmentCancer, Bladder / Transitional Cell Cancer of the Renal Pelvis and Ureter / Urethral Cancer2
2CompletedTreatmentCancer, Bladder / Transitional Cell Carcinoma1
2CompletedTreatmentCancer, Bladder / Urethral Cancer2
2CompletedTreatmentCarcinoma NOS1
2CompletedTreatmentCarcinoma NOS / Non-Squamous Non-Small Cell Lung Cancer / Non-Squamous Non-Small-Cell Lung Cancer1
2CompletedTreatmentCarcinoma of Unknown Primary1
2CompletedTreatmentCarcinoma of Unknown Primary Origin1
2CompletedTreatmentCarcinoma of Unknown Primary / Lung Cancers1
2CompletedTreatmentCarcinoma, Breast / Fallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Carcinoma1
2CompletedTreatmentCarcinoma, Squamous Cell of the Head and Neck1
2CompletedTreatmentCervical Cancer, Cancer, Metastatic Cancers / Cervical Cancers1
2CompletedTreatmentCervical Cancers4
2CompletedTreatmentCervical Cancers / Vaginal Cancers1
2CompletedTreatmentCervix Diseases / Malignancies / Neoplasms, Ovarian / Ovarian Epithelial Cancer / Primary Peritoneal Carcinoma / Tumors / Uterine Diseases1
2CompletedTreatmentChemotherapeutic Agent Toxicity / Dry Mouth / Head and Neck Carcinoma / Mucositis / Radiation Toxicity1
2CompletedTreatmentChildhood Extracranial Germ Cell Tumor / Childhood Extragonadal Germ Cell Tumor / Childhood Extragonadal Malignant Germ Cell Tumor / Childhood Malignant Ovarian Germ Cell Tumor / Childhood Malignant Testicular Germ Cell Tumor / Ovarian Choriocarcinoma / Ovarian Embryonal Carcinoma / Ovarian Yolk Sac Tumor / Recurrent Childhood Malignant Germ Cell Tumor / Recurrent Malignant Testicular Germ Cell Tumor / Recurrent Ovarian Germ Cell Tumor / Testicular Choriocarcinoma / Testicular Choriocarcinoma and Embryonal Carcinoma / Testicular Choriocarcinoma and Yolk Sac Tumor / Testicular Embryonal Carcinoma / Testicular Embryonal Carcinoma and Yolk Sac Tumor / Testicular Mixed Choriocarcinoma and Embryonal Carcinoma / Testicular Mixed Choriocarcinoma and Yolk Sac Tumor / Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor / Testicular Yolk Sac Tumor1
2CompletedTreatmentCholangiocarcinomas2
2CompletedTreatmentCiliary Body and Choroid Melanoma, Medium/Large Size / Extraocular Extension Melanoma / Iris Melanoma / Metastatic Intraocular Melanoma / Recurrent Intraocular Melanoma1
2CompletedTreatmentCiliary Body and Choroid Melanoma, Medium/Large Size / Extraocular Extension Melanoma / Iris Melanoma / Recurrent Intraocular Melanoma / Recurrent Melanoma / Stage IV Melanoma1
2CompletedTreatmentClear Cell Mullerian Tumor / Fallopian Tube Cancer / Ovarian Cancer / Papillary Serous Mullerian Tumor / Primary Peritoneal Cancer1
2CompletedTreatmentColorectal Adenocarcinoma1
2CompletedTreatmentColorectal Cancers1
2CompletedTreatmentConcomitant Radiochemotherapy / NSCLC Stage IIIB1
2CompletedTreatmentConcurrent Chemoradiotherapy / Esophageal Cancers / Oxaliplatin / Paclitaxel1
2CompletedTreatmentDistal Urethral Cancer / Metastatic Bladder Cancer / Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter / Proximal Urethral Cancer / Recurrent Bladder Cancer / Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter / Recurrent Urethral Cancer / Regional Transitional Cell Cancer of the Renal Pelvis and Ureter / Stage III Bladder Cancer / Transitional Cell Carcinoma of the Bladder / Urethral Cancer Associated With Invasive Bladder Cancer1
2CompletedTreatmentDrug/Agent Toxicity by Tissue/Organ / Lung Cancers1
2CompletedTreatmentER Positive, Her2 Negative Breast Cancer Patients / Triple Negative Breast Cancer Patients1
2CompletedTreatmentEarly Breast Cancer / Stage IA Breast Cancer / Stage IB Breast Cancer / Stage II Breast Cancer / Stage IIA Breast Cancer / Stage IIB Breast Cancer1
2CompletedTreatmentEarly Triple Negative Breast Cancer1
2CompletedTreatmentEndometrial Adenocarcinomas / Endometrial Adenosquamous Carcinoma / Endometrial Adenosquamous Cell Carcinoma / Endometrial Clear Cell Adenocarcinoma / Endometrial Clear Cell Carcinoma / Endometrial Papillary Serous Carcinoma / Endometrial Serous Adenocarcinoma / Stage I Endometrial Carcinoma / Stage IA Uterine Corpus Cancer AJCC v7 / Stage IB Uterine Corpus Cancer AJCC v7 / Stage II Endometrial Carcinoma / Stage II Uterine Corpus Cancer AJCC v7 / Stage III Endometrial Carcinoma / Stage IIIA Uterine Corpus Cancer AJCC v7 / Stage IIIB Uterine Corpus Cancer AJCC v7 / Stage IIIC Uterine Corpus Cancer AJCC v7 / Stage IV Endometrial Carcinoma / Stage IVA Uterine Corpus Cancer AJCC v7 / Stage IVB Uterine Corpus Cancer AJCC v71
2CompletedTreatmentEndometrial Cancer6
2CompletedTreatmentEndometrial Cancer / Fallopian Tube Cancer / Ovarian Cancer / Sarcomas1
2CompletedTreatmentEndometrial Carcinoma1
2CompletedTreatmentEsophageal Cancer Stage III / Esophageal Cancer, Stage II1
2CompletedTreatmentEsophageal Cancers16
2CompletedTreatmentEsophageal Cancers / Malignant Neoplasm of Stomach10
2CompletedTreatmentEsophageal Carcinoma1
2CompletedTreatmentEsophageal Squamous Cell Carcinoma (ESCC)1
2CompletedTreatmentEsophagus Cancer1
2CompletedTreatmentEstrogen Receptor Positive Breast Cancer / Estrogen Receptor-negative Breast Cancer / Estrogen Receptor-Positive Breast Cancer / HER2 Positive Breast Cancers / Progesterone Receptor Positive Breast Cancer / Progesterone Receptor-negative Breast Cancer / Progesterone Receptor-positive Breast Cancer / Stage IA Breast Cancer / Stage IB Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer1
2CompletedTreatmentEstrogen Receptor Positive Breast Cancer / Estrogen Receptor-Positive Breast Cancer / HER2 Positive Breast Cancers / Stage IA Breast Cancer / Stage IB Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
2CompletedTreatmentEstrogen Receptor-negative Breast Cancer / HER2 Negative Breast Cancer / HER2-Negative Breast Cancer / Progesterone Receptor-negative Breast Cancer / Recurrent Breast Cancer / Stage IV Breast Cancer / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)1
2CompletedTreatmentEstrogen Receptor-negative Breast Cancer / HER2 Negative Breast Cancer / HER2-Negative Breast Cancer / Progesterone Receptor-negative Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)1
2CompletedTreatmentFallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Epithelial Cancer1
2CompletedTreatmentFallopian Tube Cancer / Malignant Tumor of Peritoneum / Ovarian Cancer1
2CompletedTreatmentFallopian Tube Cancer / Metastatic Cancers / Ovarian Cancer / Peritoneal Cavity Cancer1
2CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Peritoneal Cavity Cancer3
2CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary PERITONEUM1
2CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer2
2CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cavity Cancer1
2CompletedTreatmentFallopian Tube Carcinoma / Primary Peritoneal Carcinoma / Recurrent Ovarian Carcinoma1
2CompletedTreatmentFallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Mucinous Adenocarcinoma / Fallopian Tube Serous Adenocarcinoma / Fallopian Tube Transitional Cell Carcinoma / Fallopian Tube Undifferentiated Carcinoma / Malignant Ovarian Mixed Epithelial Tumor / Ovarian Brenner Tumor / Ovarian Clear Cell Adenocarcinoma / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Adenocarcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Seromucinous Carcinoma / Ovarian Serous Adenocarcinoma / Ovarian Serous Cystadenocarcinoma / Ovarian Transitional Cell Tumor / Ovarian Undifferentiated Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Undifferentiated Fallopian Tube Carcinoma / Undifferentiated Ovarian Carcinoma1
2CompletedTreatmentGastro-oesophageal Junction Cancer / Malignant Neoplasm of Stomach1
2CompletedTreatmentGastrointestinal Stromal Tumors1
2CompletedTreatmentGerm Cell Neoplasms / Testicular Cancer1
2CompletedTreatmentHER2 Positive Breast Cancers1
2CompletedTreatmentHER2 Positive Breast Cancers / Stage II Breast Cancer / Stage IIIA Breast Cancer1
2CompletedTreatmentHER2-Positive Early Stage Breast Cancer1
2CompletedTreatmentHER2-positive Newly Diagnosed, Primary Breast Cancer / HER2-positive, Newly Diagnosed, Primary Breast Cancer, Neoadjuvant Therapy, Trastuzumab1
2CompletedTreatmentHead and Neck Carcinoma20
2CompletedTreatmentHead and Neck Carcinoma / Lung Cancers1
2CompletedTreatmentHead and Neck Carcinoma / Precancerous Conditions1
2CompletedTreatmentHemangiosarcoma / Paclitaxel1
2CompletedTreatmentHuman Immunodeficiency Virus (HIV) Infections / Kaposi s Sarcoma (KS)1
2CompletedTreatmentHuman Papilloma Virus Infection / Stage III Squamous Cell Carcinoma of the Hypopharynx / Stage III Squamous Cell Carcinoma of the Larynx / Stage III Squamous Cell Carcinoma of the Oropharynx / Stage III Verrucous Carcinoma of the Larynx / Stage IV Squamous Cell Carcinoma of the Hypopharynx / Stage IV Verrucous Carcinoma of the Larynx / Stage IVA Squamous Cell Carcinoma of the Larynx / Stage IVA Squamous Cell Carcinoma of the Oropharynx / Stage IVA Verrucous Carcinoma of the Larynx / Stage IVB Squamous Cell Carcinoma of the Larynx / Stage IVB Squamous Cell Carcinoma of the Oropharynx / Stage IVB Verrucous Carcinoma of the Larynx / Stage IVC Squamous Cell Carcinoma of the Larynx / Stage IVC Squamous Cell Carcinoma of the Oropharynx / Stage IVC Verrucous Carcinoma of the Larynx1
2CompletedTreatmentInflammatory Breast Cancer (IBC) / Invasive Ductal Breast Carcinoma / Mucinous Breast Cancer / Tubular Breast Carcinoma1
2CompletedTreatmentIntraocular Melanoma1
2CompletedTreatmentInvasive Breast Cancer1
2CompletedTreatmentLeukemias / Malignant Lymphomas1
2CompletedTreatmentLocally Advanced Non-Small Cell Lung Cancer / Non-Small Cell Lung Carcinoma (NSCLC)1
2CompletedTreatmentLocally Advanced and Recurrent/Metastatic Gastric Cancer1
2CompletedTreatmentLocally Recurrent and Metastatic Breast Cancer1
2CompletedTreatmentLocally Recurrent or Metastatic Breast Cancer1
2CompletedTreatmentLung Cancers39
2CompletedTreatmentLung Cancers / Neoplasms Metastasis / Non-Small Cell Lung Carcinoma (NSCLC)1
2CompletedTreatmentLung Cancers / Non-Small Cell Lung Carcinoma (NSCLC)1
2CompletedTreatmentLung Cancers / Non-Small Cell Lung Carcinoma (NSCLC) / Small Cell Lung Cancer (SCLC)1
2CompletedTreatmentLung Cancers / Non-Small Cell Lung Carcinoma (NSCLC) / Swallowing Disorders1
2CompletedTreatmentLung Cancers / Untreated Stage IV or Recurrent Squamous Cell Lung Cancers1
2CompletedTreatmentMale Breast Cancer / Metastases to skin / Recurrent Breast Cancer / Stage IV Breast Cancer1
2CompletedTreatmentMale Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer1
2CompletedTreatmentMalignancies / Tumors1
2CompletedTreatmentMalignant Lymphomas3
2CompletedTreatmentMalignant Lymphomas / Unspecified Adult Solid Tumor, Protocol Specific / Unspecified Childhood Solid Tumor, Protocol Specific1
2CompletedTreatmentMalignant Melanoma of Skin / Melanoma (Skin)3
2CompletedTreatmentMalignant Neoplasm of Female Breast1
2CompletedTreatmentMalignant Neoplasm of Pancreas8
2CompletedTreatmentMalignant Neoplasm of Stomach5
2CompletedTreatmentMalignant Neoplasm of Stomach / Peritoneal Carcinomatosis1
2CompletedTreatmentMalignant Pleural Effusions / Non-Small Cell Lung Cancer Recurrent / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
2CompletedTreatmentMalignant Pleural Effusions / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
2CompletedTreatmentMelanoma3
2CompletedTreatmentMelanoma, Malignant2
2CompletedTreatmentMelanoma / Metastases1
2CompletedTreatmentMetastatic Bladder Cancer / Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter / Recurrent Bladder Cancer / Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter / Squamous Cell Carcinoma of the Bladder / Transitional Cell Carcinoma of the Bladder1
2CompletedTreatmentMetastatic Breast Cancer16
2CompletedTreatmentMetastatic Malignant Melanoma1
2CompletedTreatmentMetastatic Melanoma2
2CompletedTreatmentMetastatic Melanoma / Mucosal Melanoma / Recurrent Melanoma / Stage IV Cutaneous Melanoma AJCC v6 and v7 / Stage IV Skin Melanoma / Stage IV Uveal Melanoma / Stage IV Uveal Melanoma AJCC v7 / Unresectable Melanoma1
2CompletedTreatmentMetastatic Non-Small Cell Lung Cancer1
2CompletedTreatmentMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma / Recurrent Metastatic Squamous Neck Cancer With Occult Primary / Recurrent Salivary Gland Cancer / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Recurrent Squamous Cell Carcinoma of the Larynx / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Recurrent Squamous Cell Carcinoma of the Oropharynx / Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Recurrent Verrucous Carcinoma of the Larynx / Recurrent Verrucous Carcinoma of the Oral Cavity / Salivary Gland Squamous Cell Carcinoma / Stage IV Salivary Gland Cancer / Stage IV Squamous Cell Carcinoma of the Hypopharynx / Stage IV Squamous Cell Carcinoma of the Larynx / Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Stage IV Squamous Cell Carcinoma of the Oropharynx / Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IV Verrucous Carcinoma of the Larynx / Stage IV Verrucous Carcinoma of the Oral Cavity / Tongue Cancer / Untreated Metastatic Squamous Neck Cancer With Occult Primary1
2CompletedTreatmentMetastatic Triple Negative Breast Cancer1
2CompletedTreatmentMetastatic or Recurrent Squamous Cell Carcinoma of the Lung1
2CompletedTreatmentMixed Tumor, Mullerian1
2CompletedTreatmentMultiple Myeloma and Plasma Cell Neoplasm2
2CompletedTreatmentNasopharyngeal Neoplasms1
2CompletedTreatmentNeoplasm Metastases / Neoplasms, Breast1
2CompletedTreatmentNeoplasms, Bladder / Transitional Cell Carcinoma / Ureteral Neoplasms / Urethral Neoplasms1
2CompletedTreatmentNeoplasms, Breast13
2CompletedTreatmentNeoplasms, Colorectal1
2CompletedTreatmentNeoplasms, Germ Cell and Embryonal1
2CompletedTreatmentNeoplasms, Lung / Non-Small Cell Lung Carcinoma (NSCLC)2
2CompletedTreatmentNeoplasms, Ovarian3
2CompletedTreatmentNeoplasms, Ovarian / Ovarian Cancer1
2CompletedTreatmentNeoplasms, Pancreatic3
2CompletedTreatmentNeuroendocrine Carcinomas1
2CompletedTreatmentNon Small Cell Lung Carcinoma (NSCLC) / Non-Small Cell Lung Carcinoma (NSCLC)2
2CompletedTreatmentNon-Hodgkin's Lymphoma (NHL)1
2CompletedTreatmentNon-Small Cell Lung Cancer Recurrent / Recurrent Non-Small Cell Lung Carcinoma / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
2CompletedTreatmentNon-Small Cell Lung Cancer Recurrent / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer3
2CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)47
2CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Stage IIIB or IV1
2CompletedTreatmentNon-Squamous Non-Small Cell Lung Cancer5
2CompletedTreatmentOral Cancers1
2CompletedTreatmentOvarian Cancer22
2CompletedTreatmentOvarian Cancer / Testicular germ cell tumour1
2CompletedTreatmentOvarian Carcinoma1
2CompletedTreatmentOvarian Clear Cell Cystadenocarcinoma / Stage III Ovarian Cancer / Stage IV Ovarian Cancer1
2CompletedTreatmentOvarian Epithelial Cancer1
2CompletedTreatmentOvarian Epithelial Cancer / Primary Peritoneal Cancer1
2CompletedTreatmentOvarian Epithelial Cancer / Primary Peritoneal Carcinoma1
2CompletedTreatmentPancreatic Acinar Cell Carcinoma / Pancreatic Ductal Adenocarcinoma / Recurrent Pancreatic Carcinoma / Stage IV Pancreatic Cancer1
2CompletedTreatmentPancreatic Adenocarcinoma Advanced or Metastatic1
2CompletedTreatmentPancreatic Adenocarcinoma Metastatic1
2CompletedTreatmentPancreatic Cancer Metastatic3
2CompletedTreatmentPancreatic Cancer Stage II1
2CompletedTreatmentPancreatic Ductal Carcinoma1
2CompletedTreatmentPenile Cancer1
2CompletedTreatmentPrimary Breast Cancer1
2CompletedTreatmentProstate Cancer10
2CompletedTreatmentProstatic Neoplasms1
2CompletedTreatmentProsthesis Survival1
2CompletedTreatmentPsoriasis1
2CompletedTreatmentRecurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma3
2CompletedTreatmentRecurrent Melanoma / Stage IV Melanoma1
2CompletedTreatmentRecurrent Ovarian Cancer2
2CompletedTreatmentRecurrent or Metastatic Gastric Cancer1
2CompletedTreatmentRenal Cancers1
2CompletedTreatmentResectable Pancreatic Cancers1
2CompletedTreatmentRheumatoid Arthritis1
2CompletedTreatmentSarcomas4
2CompletedTreatmentSmall Cell Lung Cancer (SCLC)4
2CompletedTreatmentSquamous Cell Carcinoma (SCC)2
2CompletedTreatmentSquamous Non Small Cell Lung Cancer1
2CompletedTreatmentStage IA Pancreatic Adenocarcinoma / Stage IB Pancreatic Adenocarcinoma / Stage IIA Pancreatic Adenocarcinoma / Stage IIB Pancreatic Adenocarcinoma1
2CompletedTreatmentStage III Melanoma / Stage IV Melanoma / Unresectable Melanoma1
2CompletedTreatmentStage III Ovarian Cancer / Stage IV Ovarian Cancer1
2CompletedTreatmentStomach and Gastro-Esophageal Junction (GEJ) Cancer1
2CompletedTreatmentTNBC - Triple-Negative Breast Cancer / Triple Negative Breast Cancer (TNBC)1
2CompletedTreatmentTesticular Neoplasms1
2CompletedTreatmentTesticular germ cell tumour1
2CompletedTreatmentAdvanced thymic carcinoma / Thymic Carcinoma1
2CompletedTreatmentTransitional Cell Carcinoma2
2CompletedTreatmentTriple Negative Breast Cancer (TNBC)1
2CompletedTreatmentTriple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)1
2CompletedTreatmentTumors1
2CompletedTreatmentUnilateral HER2 Positive Breast Cancer1
2CompletedTreatmentUnknown Primary Neoplasms1
2CompletedTreatmentUnspecified Adult Solid Tumor, Protocol Specific1
2CompletedTreatmentUrologic Neoplasms3
2CompletedTreatmentUterine Carcinosarcoma1
2CompletedTreatmentUterine Malignancies3
2CompletedTreatmentVulvar Cancers1
2CompletedTreatmentWomen With Primary Breast Cancer1
2CompletedTreatmentMetastatic pancreatic endocrine carcinoma1
2Enrolling by InvitationTreatmentBorderline Resectable Pancreatic Cancer1
2Not Yet RecruitingPreventionIntrahepatic Cholangiocarcinoma1
2Not Yet RecruitingTreatmentAdenocarcinoma of Lung Stage IV1
2Not Yet RecruitingTreatmentAdenocarcinoma of the Cervix / Adenosquamous carcinoma of the cervix / Cervical Squamous Cell Carcinoma, Not Otherwise Specified / FIGO Stage IIB / FIGO Stage IIB Cervix Carcinoma / FIGO Stage III Cervix Carcinoma / FIGO Stage IIIA / FIGO Stage IIIB / FIGO Stage IVA / FIGO Stage IVA Cervix Carcinoma / Human Immunodeficiency Virus (HIV) Infections1
2Not Yet RecruitingTreatmentAdenocarcinoma of the Pancreas1
2Not Yet RecruitingTreatmentAdenocarcinoma of the Stomach1
2Not Yet RecruitingTreatmentAdenocarcinoma, Prostate / Genital Neoplasms, Male / Genitourinary tract neoplasm / Localized Cancer / Prostate Cancer / Prostate Cancer Adenocarcinoma / Prostatic Neoplasms1
2Not Yet RecruitingTreatmentAdenocarcinomas / Gastroesophageal Cancer (GC) / Malignant Neoplasm of Stomach1
2Not Yet RecruitingTreatmentAdvanced Breast Cancer / Metastatic Breast Cancer / Triple Negative Breast Cancer (TNBC)1
2Not Yet RecruitingTreatmentAdvanced Gastric Adenocarcinoma1
2Not Yet RecruitingTreatmentAdvanced Gastric Cancer1
2Not Yet RecruitingTreatmentAdvanced Gastric and Gastro-esophageal Junction Adenocarcinoma1
2Not Yet RecruitingTreatmentAnatomic Stage I Breast Cancer AJCC v8 / Anatomic Stage IA Breast Cancer AJCC v8 / Anatomic Stage IB Breast Cancer AJCC v8 / Anatomic Stage II Breast Cancer AJCC v8 / Anatomic Stage IIA Breast Cancer AJCC v8 / Anatomic Stage IIB Breast Cancer AJCC v8 / Anatomic Stage III Breast Cancer AJCC v8 / Anatomic Stage IIIA Breast Cancer AJCC v8 / Anatomic Stage IIIB Breast Cancer AJCC v8 / Anatomic Stage IIIC Breast Cancer AJCC v8 / Prognostic Stage I Breast Cancer AJCC v8 / Prognostic Stage IA Breast Cancer AJCC v8 / Prognostic Stage IB Breast Cancer AJCC v8 / Prognostic Stage II Breast Cancer AJCC v8 / Prognostic Stage IIA Breast Cancer AJCC v8 / Prognostic Stage IIB Breast Cancer AJCC v8 / Prognostic Stage III Breast Cancer AJCC v8 / Prognostic Stage IIIA Breast Cancer AJCC v8 / Prognostic Stage IIIB Breast Cancer AJCC v8 / Prognostic Stage IIIC Breast Cancer AJCC v81
2Not Yet RecruitingTreatmentAnatomic Stage IV Breast Cancer AJCC v8 / Estrogen Receptor Negative / HER2/Neu Negative / Metastatic Triple-Negative Breast Carcinoma / Progesterone Receptor Negative / Prognostic Stage IV Breast Cancer AJCC v81
2Not Yet RecruitingTreatmentBiopsy-proven, Positive Lymph Node(s) / Hormone Receptor Positive (HR+), HER2-negative Breast Cancer / Triple Negative Breast Cancer (TNBC)1
2Not Yet RecruitingTreatmentBreast Cancer2
2Not Yet RecruitingTreatmentBreast Cancer Stage1
2Not Yet RecruitingTreatmentBreast Cancer / HER2 Positive Breast Cancers / Stage II Breast Cancer / Stage III Breast Cancer1
2Not Yet RecruitingTreatmentBreast Cancer / Triple Negative Breast Cancer (TNBC)1
2Not Yet RecruitingTreatmentCancer of Pancreas1
2Not Yet RecruitingTreatmentCervical Cancers / Locally Advanced Cancer1
2Not Yet RecruitingTreatmentChemotherapy Effect / Malignant Neoplasm of Pancreas1
2Not Yet RecruitingTreatmentCirculating Tumor DNA / Non-Small Cell Lung Carcinoma (NSCLC)1
2Not Yet RecruitingTreatmentEGFRmutant Stage IIIB/C or IV Non-squamous NSCLC1
2Not Yet RecruitingTreatmentEarly Breast Cancer1
2Not Yet RecruitingTreatmentEndometrial Cancer1
2Not Yet RecruitingTreatmentEsophageal Cancers1
2Not Yet RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC)2
2Not Yet RecruitingTreatmentFallopian Tube Cancer / Ovarian Epithelial Cancer / Primary Peritoneal Cancer1
2Not Yet RecruitingTreatmentGM-CSF / Non-Small Cell Lung Carcinoma (NSCLC) / SBRT1
2Not Yet RecruitingTreatmentGastric Cancer With Positive Exfoliative Cancer Cells1
2Not Yet RecruitingTreatmentGastroesophageal Cancer (GC) / Malignant Neoplasm of Stomach1
2Not Yet RecruitingTreatmentHER2 Positive Breast Cancers1
2Not Yet RecruitingTreatmentHead and Neck Squamous Cell Cancer1
2Not Yet RecruitingTreatmentInvasive Breast Cancer1
2Not Yet RecruitingTreatmentLocally Advanced Cervical Cancer1
2Not Yet RecruitingTreatmentLocally Advanced Esophageal Squamous Cell Carcinoma1
2Not Yet RecruitingTreatmentLocally Advanced Non-Small Cell Lung Cancer1
2Not Yet RecruitingTreatmentLocally Advanced Pancreatic Cancer1
2Not Yet RecruitingTreatmentLung Cancer Stage II / Non-Small Cell Lung Carcinoma (NSCLC) / PD-1 Antibody1
2Not Yet RecruitingTreatmentLung Cancers / Neoplasm of Lung / Non-Small Cell Lung Carcinoma (NSCLC) / Small Cell Lung Cancer (SCLC)1
2Not Yet RecruitingTreatmentMalignant Neoplasm of Nasopharynx / Nasopharyngeal Carcinoma / Nasopharynx Cancer1
2Not Yet RecruitingTreatmentMalignant Neoplasm of Pancreas3
2Not Yet RecruitingTreatmentMalignant Neoplasm of Stomach4
2Not Yet RecruitingTreatmentMalignant Ovarian Epithelial Tumor / Platinum-Resistant Fallopian Tube Carcinoma / Platinum-Resistant Ovarian Carcinoma / Platinum-Resistant Primary Peritoneal Carcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Refractory Fallopian Tube Carcinoma / Refractory Ovarian Carcinoma / Refractory Primary Peritoneal Carcinoma1
2Not Yet RecruitingTreatmentMammary Cancer1
2Not Yet RecruitingTreatmentMetastatic Angiosarcoma1
2Not Yet RecruitingTreatmentMetastatic Breast Cancer1
2Not Yet RecruitingTreatmentMetastatic Pancreatic Ductal Adenocarcinoma1
2Not Yet RecruitingTreatmentMetastatic Small Intestinal Adenocarcinoma / Stage III Small Intestinal Adenocarcinoma AJCC v8 / Stage IIIA Small Intestinal Adenocarcinoma AJCC v8 / Stage IIIB Small Intestinal Adenocarcinoma AJCC v8 / Stage IV Small Intestinal Adenocarcinoma AJCC v81
2Not Yet RecruitingTreatmentNasopharyngeal Neoplasms1
2Not Yet RecruitingTreatmentNeoplasms1
2Not Yet RecruitingTreatmentNeoplasms, Breast1
2Not Yet RecruitingTreatmentNeoplasms, Lung1
2Not Yet RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)1
2Not Yet RecruitingTreatmentOvarian Cancer3
2Not Yet RecruitingTreatmentPancreatic Adenocarcinoma Metastatic / Stage IV Pancreatic Cancer AJCC v81
2Not Yet RecruitingTreatmentPlatinum-resistant Ovarian Cancer1
2Not Yet RecruitingTreatmentPulmonary Adenosquamous Carcinoma1
2Not Yet RecruitingTreatmentPulmonary Large Cell Neuroendocrine Carcinoma1
2Not Yet RecruitingTreatmentRecurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma1
2Not Yet RecruitingTreatmentRecurrent, Platinum-resistant Ovarian Cancer1
2Not Yet RecruitingTreatmentSkin angiosarcoma / Skin Radiation-Related Angiosarcoma / Visceral Angiosarcoma1
2Not Yet RecruitingTreatmentSquamous Cell Carcinoma of the Head and Neck (SCCHN)1
2Not Yet RecruitingTreatmentStage IIIA Non-Small Cell Lung Cancer1
2Not Yet RecruitingTreatmentStaging IV NSCLC1
2Not Yet RecruitingTreatmentTransitional Cell Carcinoma2
2Not Yet RecruitingTreatmentUrothelial carcinoma ureter metastatic1
2RecruitingDiagnosticPancreatic Cancer Metastatic1
2RecruitingHealth Services ResearchSmall Cell Lung Cancer (SCLC)1
2RecruitingOtherHigh Grade Serous Ovarian Cancer1
2RecruitingPreventionBreast Cancer1
2RecruitingSupportive CareAnatomic Stage I Breast Cancer AJCC v8 / Anatomic Stage IA Breast Cancer AJCC v8 / Anatomic Stage IB Breast Cancer AJCC v8 / Anatomic Stage II Breast Cancer AJCC v8 / Anatomic Stage IIA Breast Cancer AJCC v8 / Anatomic Stage IIB Breast Cancer AJCC v8 / Anatomic Stage III Breast Cancer AJCC v8 / Anatomic Stage IIIA Breast Cancer AJCC v8 / Anatomic Stage IIIB Breast Cancer AJCC v8 / Anatomic Stage IIIC Breast Cancer AJCC v8 / Invasive Breast Carcinoma / Prognostic Stage I Breast Cancer AJCC v8 / Prognostic Stage IA Breast Cancer AJCC v8 / Prognostic Stage IB Breast Cancer AJCC v8 / Prognostic Stage II Breast Cancer AJCC v8 / Prognostic Stage IIA Breast Cancer AJCC v8 / Prognostic Stage IIB Breast Cancer AJCC v8 / Prognostic Stage III Breast Cancer AJCC v8 / Prognostic Stage IIIA Breast Cancer AJCC v8 / Prognostic Stage IIIB Breast Cancer AJCC v8 / Prognostic Stage IIIC Breast Cancer AJCC v81
2RecruitingSupportive CareCord Compression1
2RecruitingSupportive CareLocally Advanced Unresectable Pancreatic Adenocarcinoma / Pancreatic Adenocarcinoma Metastatic / Recurrent Pancreatic Adenocarcinoma / Stage III Pancreatic Cancer AJCC v8 / Stage IV Pancreatic Cancer AJCC v81
2RecruitingTreatmentAdenocarcinoma Of Esophagus / Adenocarcinomas of the Gastroesophageal Junction1
2RecruitingTreatmentAdenocarcinoma of the Esophagus / Adenocarcinoma of the Gastric Cardia / Adenocarcinomas of the Gastroesophageal Junction / Stage IIIA Esophageal Cancer / Stage IIIB Esophageal Cancer / Stage IIIC Esophageal Cancer1
2RecruitingTreatmentAdenocarcinoma of the Pancreas / Adenocarcinomas / Malignant Neoplasm of Pancreas / Pancreas Metastases / Pancreatic Ductal Adenocarcinoma1
2RecruitingTreatmentAdenocarcinoma of the Pancreas / Malignant Neoplasm of Pancreas / Pancreas Ductal Adenocarcinoma1
2RecruitingTreatmentAdenocarcinoma of the Pancreas / Neoadjuvant Pancreatic Cancer / Resectable Pancreatic Cancers / Unresectable Pancreatic Cancer1
2RecruitingTreatmentAdenocarcinoma of the Pancreas / Pancreatic Cancer Metastatic1
2RecruitingTreatmentAdenocarcinoma of the Pancreas / Resectable Pancreatic Cancers1
2RecruitingTreatmentAdenocarcinoma of the Stomach / Adenocarcinomas of the Gastroesophageal Junction1
2RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Gastric Adenocarcinoma1
2RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Malignant Neoplasm of Stomach1
2RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Malignant Neoplasm of Stomach / Stomach Neoplasms1
2RecruitingTreatmentAdenocarcinomas / Cancer of Pancreas / Cancer of the Pancreas / Malignant Neoplasm of Pancreas / Neoplasms, Pancreatic / Pancreas Neoplasms1
2RecruitingTreatmentAdvanced Biliary Tract Cancer1
2RecruitingTreatmentAdvanced Biliary Tract Cancers1
2RecruitingTreatmentAdvanced Biliary Tract Carcinoma1
2RecruitingTreatmentAdvanced Gastric Adenocarcinoma1
2RecruitingTreatmentAdvanced Gastric Cancer2
2RecruitingTreatmentAdvanced Melanoma1
2RecruitingTreatmentAdvanced Pancreatic Cancer1
2RecruitingTreatmentAnatomic Stage I Breast Cancer AJCC v8 / Anatomic Stage IA Breast Cancer AJCC v8 / Anatomic Stage IB Breast Cancer AJCC v8 / Anatomic Stage II Breast Cancer AJCC v8 / Anatomic Stage IIA Breast Cancer AJCC v8 / Anatomic Stage IIB Breast Cancer AJCC v8 / Anatomic Stage III Breast Cancer AJCC v8 / Anatomic Stage IIIA Breast Cancer AJCC v8 / Anatomic Stage IIIB Breast Cancer AJCC v8 / Anatomic Stage IIIC Breast Cancer AJCC v8 / Prognostic Stage I Breast Cancer AJCC v8 / Prognostic Stage IA Breast Cancer AJCC v8 / Prognostic Stage IB Breast Cancer AJCC v8 / Prognostic Stage II Breast Cancer AJCC v8 / Prognostic Stage IIA Breast Cancer AJCC v8 / Prognostic Stage IIB Breast Cancer AJCC v8 / Prognostic Stage III Breast Cancer AJCC v8 / Prognostic Stage IIIA Breast Cancer AJCC v8 / Prognostic Stage IIIB Breast Cancer AJCC v8 / Prognostic Stage IIIC Breast Cancer AJCC v8 / Refractory Breast Carcinoma / Triple-Negative Breast Carcinoma1
2RecruitingTreatmentAnatomic Stage II Breast Cancer AJCC v8 / Anatomic Stage IIA Breast Cancer AJCC v8 / Anatomic Stage IIB Breast Cancer AJCC v8 / Anatomic Stage IIIA Breast Cancer AJCC v8 / Invasive Breast Carcinoma / Prognostic Stage II Breast Cancer AJCC v8 / Prognostic Stage IIA Breast Cancer AJCC v8 / Prognostic Stage IIB Breast Cancer AJCC v8 / Prognostic Stage IIIA Breast Cancer AJCC v81
2RecruitingTreatmentAnatomic Stage IV Breast Cancer AJCC v8 / Breast Carcinoma Metastatic in the Bone / Metastatic Breast Carcinoma / Metastatic Triple-Negative Breast Carcinoma / Prognostic Stage IV Breast Cancer AJCC v81
2RecruitingTreatmentAndrogen Receptor Positive / Breast Cancer / Estrogen Receptor Negative / HER2/Neu Negative / Invasive Breast Carcinoma / Progesterone Receptor Negative / Stage I Breast Cancer AJCC v7 / Stage IA Breast Cancer AJCC v7 / Stage IB Breast Cancer AJCC v7 / Stage II Breast Cancer AJCC v6 and v7 / Stage IIA Breast Cancer AJCC v6 and v7 / Stage IIB Breast Cancer AJCC v6 and v7 / Stage III Breast Cancer AJCC V7 / Stage IIIA Breast Cancer AJCC v7 / Stage IIIB Breast Cancer AJCC v7 / Stage IIIC Breast Cancer AJCC v7 / Triple-Negative Breast Carcinoma1
2RecruitingTreatmentAnti-PD-1 Antibody / Cancer treatment / Immunotherapy / Persistent Advanced Cervical Carcinoma / Recurrent Cervical Carcinoma1
2RecruitingTreatmentBRCA1 Hereditary Breast and Ovarian Cancer Syndrome1
2RecruitingTreatmentBiliary Tract Cancer1
2RecruitingTreatmentBorderline Resectable Pancreatic Cancer1
2RecruitingTreatmentBreast - Female / Male Breast Cancer1
2RecruitingTreatmentBreast Adenocarcinoma / Estrogen Receptor Negative / HER2/Neu Negative / Invasive Breast Carcinoma / Progesterone Receptor Negative / Triple-Negative Breast Carcinoma1
2RecruitingTreatmentBreast Adenocarcinoma / Estrogen Receptor Positive Breast Cancer / Estrogen Receptor- Negative Breast Cancer / Estrogen Receptor-Positive Breast Cancer / HER2/Neu Negative / Invasive Breast Carcinoma / Progesterone Receptor Negative / Progesterone Receptor Positive Tumor / Stage II Breast Cancer / Stage IIA Breast Cancer / Stage IIB Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Triple-Negative Breast Carcinoma1
2RecruitingTreatmentBreast Cancer10
2RecruitingTreatmentBreast Cancer Stage II / Breast Cancer Stage III1
2RecruitingTreatmentBreast Cancer / Estrogen Receptor Negative / HER2/Neu Negative / Progesterone Receptor Negative / Stage I Breast Cancer AJCC v7 / Stage IA Breast Cancer AJCC v7 / Stage IB Breast Cancer AJCC v7 / Stage II Breast Cancer AJCC v6 and v7 / Stage IIA Breast Cancer AJCC v6 and v7 / Stage IIB Breast Cancer AJCC v6 and v7 / Stage III Breast Cancer AJCC V7 / Stage IIIA Breast Cancer AJCC v7 / Stage IIIB Breast Cancer AJCC v7 / Stage IIIC Breast Cancer AJCC v7 / Triple-Negative Breast Carcinoma1
2RecruitingTreatmentBreast Cancer / Estrogen Receptor Positive Tumor / HER2 Positive Breast Cancers1
2RecruitingTreatmentBreast Cancer / HER2 Positive Breast Cancers1
2RecruitingTreatmentBreast Cancer / HER2 Positive Breast Cancers / Triple Negative Breast Cancer (TNBC)1
2RecruitingTreatmentBreast Cancer / Hemangiosarcoma / Neoplasms, Breast / Tumors, Breast1
2RecruitingTreatmentBreast Cancer / Nab-paclitaxel / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)1
2RecruitingTreatmentBreast Cancer / Neoadjuvant Chemotherapy1
2RecruitingTreatmentBreast Cancer / Renal Cell Adenocarcinoma1
2RecruitingTreatmentBreast Lump / Carcinoma, Breast / Edema / Erythemas / Estrogen Receptor Negative / HER2/Neu Negative / Inflammatory Breast Carcinoma / Invasive Breast Carcinoma / Malignant Neoplasm of Breast / Peau d'orange / Progesterone Receptor Negative / Triple-Negative Breast Carcinoma1
2RecruitingTreatmentCancer of Stomach1
2RecruitingTreatmentCancer of Unknown Primary Site1
2RecruitingTreatmentCancer, Bladder1
2RecruitingTreatmentCancers Harbouring an EGFR Mutation, (Excluding Non-squamous Non- Small Cell Lung Cancer, a Registered Indication), a HER2 Mutation or a HER3 Mutation1
2RecruitingTreatmentCarcinoma Breast Stage IV1
2RecruitingTreatmentCarcinoma, Breast1
2RecruitingTreatmentCarcinosarcoma / Neoplasms, Endometrial1
2RecruitingTreatmentCervical Cancer Metastatic / Cervical Cancers / Recurrent Cervical Cancer1
2RecruitingTreatmentCervical Cancers3
2RecruitingTreatmentCetuximab Effect / Chemotherapy Effect / Esophageal Cancer, Squamous Cell1
2RecruitingTreatmentChildhood Germ Cell Tumor / Ovarian Cancer / Teratoma1
2RecruitingTreatmentChildren / Nasopharyngeal Carcinoma1
2RecruitingTreatmentConcurrent Chemoradiotherapy / Neoplasms, Esophageal / Squamous Cell Carcinoma (SCC)1
2RecruitingTreatmentDigestive System Neoplasms / Esophageal Cancers / Neoplasms / Neoplasms, Esophageal1
2RecruitingTreatmentEarly-Stage Breast Carcinoma / Estrogen Receptor Positive Tumor1
2RecruitingTreatmentEndometrial Adenocarcinomas / Endometrial Cancer1
2RecruitingTreatmentEndometrial Cancer1
2RecruitingTreatmentEndometrial Clear Cell Carcinoma / Ovarian Clear Cell Carcinoma1
2RecruitingTreatmentEpithelial Ovarian Carcinoma1
2RecruitingTreatmentEsophageal Cancer, Squamous Cell1
2RecruitingTreatmentEsophageal Cancers / Gastroesophageal Cancer (GC)1
2RecruitingTreatmentEsophageal Cancers / Laryngeal Cancer / Lip Cancer / Oral Cancers / Oropharynx Cancers / Squamous Cell Carcinoma (SCC)1
2RecruitingTreatmentEsophageal Cancers / Induction chemotherapy1
2RecruitingTreatmentEsophageal Carcinoma1
2RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC)7
2RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC) / Immunotherapy1
2RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC) / Stage III1
2RecruitingTreatmentEsophageal Squamous Cell Carcinoma Resectable1
2RecruitingTreatmentEsophageal Squamous Cell Carcinoma by AJCC V8 Stage / Resectable Esophageal Cancer1
2RecruitingTreatmentEsophagogastric Junction / Gastric Adenocarcinoma / Malignant Neoplasm of Stomach / Peritoneal Carcinomatosis1
2RecruitingTreatmentEsophagus Cancer1
2RecruitingTreatmentEstrogen Receptor Negative / Estrogen Receptor Positive / Estrogen Receptor Positive Breast Cancer / Estrogen Receptor-negative Breast Cancer / Estrogen Receptor-Positive Breast Cancer / HER2 Negative Breast Cancer / HER2 Positive Breast Cancers / HER2-Negative Breast Cancer / HER2/Neu Negative / HER2/Neu Positive / Invasive Breast Carcinoma / Progesterone Receptor Negative / Progesterone Receptor Positive / Progesterone Receptor Positive Breast Cancer / Progesterone Receptor-negative Breast Cancer / Progesterone Receptor-positive Breast Cancer / Stage IA Breast Cancer / Stage II Breast Cancer / Stage IIA Breast Cancer / Stage IIB Breast Cancer / Stage III Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC) / Triple-Negative Breast Carcinoma1
2RecruitingTreatmentEstrogen Receptor-negative Breast Cancer / HER2 Negative Breast Cancer / HER2-Negative Breast Cancer / Progesterone Receptor-negative Breast Cancer / Stage IIA Breast Cancer / Stage IIB Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)1
2RecruitingTreatmentEwing's Sarcoma (ES) / Rhabdomyosarcomas / Sarcoma, Osteogenic / Soft Tissue Sarcoma (STS)1
2RecruitingTreatmentExtensive Stage Small Cell Lung Cancer1
2RecruitingTreatmentExtensive-Stage Small Cell Lung Cancer1
2RecruitingTreatmentFallopian Tube Cancer / Fallopian Tube Carcinoma / Ovarian Carcinoma / Ovarian Epithelial Cancer / Primary Peritoneal Carcinoma / Stage III Ovarian Cancer / Stage IV Ovarian Cancer1
2RecruitingTreatmentFallopian Tube Cancer / Fallopian Tube Neoplasms / Neoplasms, Ovarian / Ovarian Cancer / Ovarian Carcinosarcoma / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Serous Adenocarcinoma / Primary Peritoneal Carcinoma / Primary Peritoneal Serous Adenocarcinoma1
2RecruitingTreatmentFallopian Tube Cancer / Ovarian Cancer / Ovarian Epithelial Cancer1
2RecruitingTreatmentFallopian Tube Carcinoma / Ovarian Cancer / Primary Peritoneal Cancer1
2RecruitingTreatmentFallopian Tube Carcinoma / Ovarian Epithelial Cancer / Primary Peritoneal Cancer1
2RecruitingTreatmentFallopian Tube Endometrioid Adenocarcinoma / High Grade Fallopian Tube Serous Adenocarcinoma / High Grade Ovarian Serous Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Platinum-Resistant Ovarian Carcinoma / Primary Peritoneal High Grade Serous Adenocarcinoma / Refractory Fallopian Tube Carcinoma / Refractory Ovarian Carcinoma / Refractory Primary Peritoneal Carcinoma1
2RecruitingTreatmentFallopian Tube Transitional Cell Carcinoma / Malignant Ovarian Clear Cell Tumor / Malignant Ovarian Endometrioid Tumor / Malignant Ovarian Mixed Epithelial Tumor / Malignant Ovarian Serous Tumor / Ovarian Seromucinous Carcinoma / Ovarian Transitional Cell Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Undifferentiated Fallopian Tube Carcinoma / Undifferentiated Ovarian Carcinoma1
2RecruitingTreatmentGastric Adenocarcinoma1
2RecruitingTreatmentGastric Cancer Stage1
2RecruitingTreatmentGastro-esophageal Junction Adenocarcinoma / Malignant Neoplasm of Stomach1
2RecruitingTreatmentGastroesophageal Junction Cancer / Malignant Neoplasm of Stomach1
2RecruitingTreatmentGastrointestinal Stromal Tumors1
2RecruitingTreatmentGerm Cell Tumors1
2RecruitingTreatmentHER2 Negative Breast Cancer / HER2-Negative Breast Cancer1
2RecruitingTreatmentHER2 Negative Metastatic Breast Cancer1
2RecruitingTreatmentHER2 Positive Breast Cancers1
2RecruitingTreatmentHER2 Positive Breast Cancers / Operable Breast Cancer1
2RecruitingTreatmentHER2 Positive Breast Carcinoma / Stage III Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
2RecruitingTreatmentHNSCC / HPV-Related Squamous Cell Carcinoma1
2RecruitingTreatmentHNSCC / HPV-Related Squamous Cell Carcinoma / Human Papilloma Virus (HPV) / Squamous Cell Carcinoma (SCC) / Squamous Cell Carcinoma of the Head and Neck (SCCHN)1
2RecruitingTreatmentHead and Neck Squamous Cell Carcinoma (HNSCC)2
2RecruitingTreatmentHemangiosarcoma1
2RecruitingTreatmentHepatocellular,Carcinoma1
2RecruitingTreatmentHigh Grade Malignant Neuroendocrine Carcinoma (Diagnosis)1
2RecruitingTreatmentInflammatory Breast Cancer (IBC)2
2RecruitingTreatmentLarge Cell Lung Carcinoma Metastatic / Metastatic Lung Adenocarcinoma / Metastatic Lung Cancer / Non-Small Cell Lung Carcinoma (NSCLC)1
2RecruitingTreatmentLocally Advanced Breast Cancer (LABC)1
2RecruitingTreatmentLocally Advanced Gastric Cancer1
2RecruitingTreatmentLocally Advanced Gastric Cancer / Metastatic Gastric Cancers1
2RecruitingTreatmentLocally Advanced Malignant Solid Neoplasm / Metastatic Malignant Solid Neoplasm1
2RecruitingTreatmentLocally Advanced Pancreatic Adenocarcinoma1
2RecruitingTreatmentLocally Advanced Pancreatic Cancer1
2RecruitingTreatmentLocally Advanced Thymic Carcinoma / Metastatic Thymic Carcinoma / Recurrent Thymic Carcinoma / Unresectable Thymic Carcinoma1
2RecruitingTreatmentLocally Advanced, Squamous Cell Carcinoma of the Vulva1
2RecruitingTreatmentLung1
2RecruitingTreatmentLung Cancers1
2RecruitingTreatmentLung Non-Small Cell Carcinoma / Stage IIIB Lung Cancer AJCC v8 / Stage IV Lung Cancer AJCC v8 / Stage IVA Lung Cancer AJCC v8 / Stage IVB Lung Cancer AJCC v81
2RecruitingTreatmentMalignant Neoplasm of Female Breast1
2RecruitingTreatmentMalignant Neoplasm of Pancreas5
2RecruitingTreatmentMalignant Neoplasm of Pancreas / Neoadjuvant Chemotherapy1
2RecruitingTreatmentMalignant Neoplasm of Pancreas / Pancreatic Adenocarcinoma Metastatic / Pancreatic Cancer Metastatic1
2RecruitingTreatmentMalignant Neoplasm of Pancreas / Pancreatic Ductal Adenocarcinoma1
2RecruitingTreatmentMalignant Neoplasm of Stomach5
2RecruitingTreatmentMelanoma1
2RecruitingTreatmentMetastatic Adenocarcinoma of the Pancreas / Recurrent Adenocarcinoma of the Pancreas1
2RecruitingTreatmentMetastatic Breast Cancer2
2RecruitingTreatmentMetastatic Cholangiocarcinoma / Metastatic Hepatocellular Carcinoma / Stage III Hepatocellular Carcinoma AJCC v8 / Stage III Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IIIA Hepatocellular Carcinoma AJCC v8 / Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IIIB Hepatocellular Carcinoma AJCC v8 / Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IV Hepatocellular Carcinoma AJCC v8 / Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IVA Hepatocellular Carcinoma AJCC v8 / Stage IVB Hepatocellular Carcinoma AJCC v8 / Unresectable Cholangiocarcinoma / Unresectable Hepatocellular Carcinoma / Unresectable Intrahepatic Cholangiocarcinoma1
2RecruitingTreatmentMetastatic Gastric Adenocarcinoma1
2RecruitingTreatmentMetastatic Lung Non-Small Cell Squamous Carcinoma / Metastatic Lung Non-Squamous Non-Small Cell Carcinoma / Stage IIIB Lung Cancer AJCC v8 / Stage IV Lung Cancer AJCC v8 / Stage IVA Lung Cancer AJCC v8 / Stage IVB Lung Cancer AJCC v8 / Unresectable Lung Non-Small Cell Carcinoma / Unresectable Lung Non-Squamous Non-Small Cell Carcinoma1
2RecruitingTreatmentMetastatic Lung Non-Squamous Non-Small Cell Carcinoma / Recurrent Lung Non-Squamous Non-Small Cell Carcinoma / Stage III Lung Cancer AJCC v8 / Stage IIIA Lung Cancer AJCC v8 / Stage IIIB Lung Cancer AJCC v8 / Stage IIIC Lung Cancer AJCC v8 / Stage IVA Lung Cancer AJCC v8 / Unresectable Lung Non-Squamous Non-Small Cell Carcinoma1
2RecruitingTreatmentMetastatic Non-Small Cell Lung Cancer / NSCLC Stage IV1
2RecruitingTreatmentMetastatic Squamous Cell Carcinoma of the Vulva1
2RecruitingTreatmentMetastatic Thyroid Gland Carcinoma / Poorly Differentiated Thyroid Gland Carcinoma / Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v8 / Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8 / Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8 / Thyroid Gland Anaplastic Carcinoma / Unresectable Thyroid Gland Carcinoma1
2RecruitingTreatmentMetastatic Urothelial Cancer1
2RecruitingTreatmentNasopharyngeal Carcinoma2
2RecruitingTreatmentNasopharyngeal Neoplasms1
2RecruitingTreatmentNeoadjuvant Chemotherapy / Pancreatic Adenocarcinoma Resectable1
2RecruitingTreatmentNeoplasms1
2RecruitingTreatmentNeoplasms Metastasis1
2RecruitingTreatmentNeoplasms Pancreatic / Neoplasms, Pancreatic2
2RecruitingTreatmentNeoplasms, Breast1
2RecruitingTreatmentNeoplasms, Esophageal2
2RecruitingTreatmentNeoplasms, Esophageal / Squamous Cell Carcinoma (SCC)1
2RecruitingTreatmentNeoplasms, Pancreatic1
2RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)18
2RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Oligometastasis / Stage IV1
2RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Squamous Cell Carcinoma (SCC)2
2RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Stage III Non-small-Cell Lung Cancer1
2RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Performance status1
2RecruitingTreatmentOropharyngeal Squamous Cell Cancer1
2RecruitingTreatmentOropharynx Cancers1
2RecruitingTreatmentOvarian Cancer1
2RecruitingTreatmentOvarian Cancer, Epithelial1
2RecruitingTreatmentOvarian Cancer / Ovarian Cancer Metastatic / Stage III Fallopian Tube Cancer AJCC v7 / Stage III Ovarian Cancer AJCC v6 and v7 / Stage III Primary Peritoneal Cancer AJCC v7 / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIA Primary Peritoneal Cancer AJCC v7 / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIB Primary Peritoneal Cancer AJCC v7 / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IIIC Primary Peritoneal Cancer AJCC v7 / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer AJCC v6 and v7 / Stage IV Primary Peritoneal Cancer AJCC v71
2RecruitingTreatmentOvarian Epithelial Cancer1
2RecruitingTreatmentOvarian Granulosa Cell Tumor / Ovarian Gynandroblastoma / Ovarian Sertoli-Leydig Cell Tumors / Ovarian Sex Cord Tumor With Annular Tubules / Ovarian Sex Cord-Stromal Tumor / Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types / Ovarian Steroid Cell Tumor1
2RecruitingTreatmentPancreatic Adenocarcinoma Metastatic / Stage IV Pancreatic Cancer AJCC v81
2RecruitingTreatmentPancreatic Cancer Metastatic6
2RecruitingTreatmentPancreatic Ductal Adenocarcinoma3
2RecruitingTreatmentPancreatic Ductal Carcinoma / Resectable Pancreatic Cancers1
2RecruitingTreatmentPeritoneal Adhesion1
2RecruitingTreatmentPlatinum-resistant Recurrent Ovarian Cancer1
2RecruitingTreatmentRecurrent Cervical Cancer1
2RecruitingTreatmentRecurrent Endometrial Endometrioid Adenocarcinoma / Recurrent Uterine Corpus Carcinoma / Stage III Uterine Corpus Cancer AJCC v7 / Stage IIIA Uterine Corpus Cancer AJCC v7 / Stage IIIB Uterine Corpus Cancer AJCC v7 / Stage IIIC Uterine Corpus Cancer AJCC v7 / Stage IV Uterine Corpus Cancer AJCC v7 / Stage IVA Uterine Corpus Cancer AJCC v7 / Stage IVB Uterine Corpus Cancer AJCC v71
2RecruitingTreatmentRecurrent Fallopian Tube Carcinoma / Recurrent Ovarian Cancer / Recurrent Primary Peritoneal Carcinoma1
2RecruitingTreatmentRecurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma1
2RecruitingTreatmentRecurrent Head and Neck Squamous Cell Carcinoma / Stage IV Head and Neck Cancer1
2RecruitingTreatmentRecurrent or Metastatic Breast Cancer1
2RecruitingTreatmentResectable Cholangiocarcinoma / Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 / Stage II Intrahepatic Cholangiocarcinoma AJCC v8 / Stage III Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v81
2RecruitingTreatmentSalivary Gland Cancers1
2RecruitingTreatmentSmall Cell Lung Cancer (SCLC)1
2RecruitingTreatmentSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations1
2RecruitingTreatmentSquamous Cell Carcinoma (SCC)1
2RecruitingTreatmentSquamous Cell Carcinoma of the Anus1
2RecruitingTreatmentSquamous Cell Carcinoma of the Esophagus1
2RecruitingTreatmentSquamous Cell Carcinoma of the Head and Neck (SCCHN)2
2RecruitingTreatmentStage IA Pancreatic Adenocarcinoma / Stage IB Pancreatic Adenocarcinoma / Stage IIA Pancreatic Adenocarcinoma / Stage IIB Pancreatic Adenocarcinoma1
2RecruitingTreatmentStage III-IV or Recurrent Endometrial Cancer1
2RecruitingTreatmentSystematic Review of the pCR Rate of Apatinib Combined With Albumin Paclitaxel and Carboplatin Regimen for Neoadjuvant Therapy of Triple-negative Breast Cancer1
2RecruitingTreatmentTNBC - Triple-Negative Breast Cancer1
2RecruitingTreatmentAdvanced thymic carcinoma / Thymic Carcinoma1
2RecruitingTreatmentTransitional Cell Carcinoma1
2RecruitingTreatmentTriple Negative Breast Cancer (TNBC)4
2RecruitingTreatmentTriple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)2
2RecruitingTreatmentUnknown Primary Tumors1
2RecruitingTreatmentUnresectable Biliary Tract Cancer1
2RecruitingTreatmentUnresectable Esophageal Cancer1
2RecruitingTreatmentUnresectable Pancreatic Carcinoma1
2RecruitingTreatmentUntreated Metastatic Pancreatic Ductal Adenocarcinoma1
2SuspendedTreatmentInvasive Breast Cancer1
2SuspendedTreatmentMalignant Melanoma of Skin / Melanoma (Skin)1
2SuspendedTreatmentName Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma / Stage II Oropharyngeal Squamous Cell Carcinoma / Stage III Hypopharyngeal Squamous Cell Carcinoma / Stage III Laryngeal Squamous Cell Carcinoma / Stage III Oral Cavity Squamous Cell Carcinoma / Stage III Oropharyngeal Squamous Cell Carcinoma / Stage IV Hypopharyngeal Squamous Cell Carcinoma / Stage IV Laryngeal Squamous Cell Carcinoma / Stage IV Oral Cavity Squamous Cell Carcinoma / Stage IV Oropharyngeal Squamous Cell Carcinoma / Stage IVA Hypopharyngeal Squamous Cell Carcinoma / Stage IVA Laryngeal Squamous Cell Carcinoma / Stage IVA Oral Cavity Squamous Cell Carcinoma / Stage IVA Oropharyngeal Squamous Cell Carcinoma / Stage IVB Hypopharyngeal Squamous Cell Carcinoma / Stage IVB Laryngeal Squamous Cell Carcinoma / Stage IVB Oral Cavity Squamous Cell Carcinoma / Stage IVB Oropharyngeal Squamous Cell Carcinoma / Stage IVC Hypopharyngeal Squamous Cell Carcinoma / Stage IVC Laryngeal Squamous Cell Carcinoma / Stage IVC Oral Cavity Squamous Cell Carcinoma / Stage IVC Oropharyngeal Squamous Cell Carcinoma1
2SuspendedTreatmentOropharynx Squamous Cell Carcinoma1
2SuspendedTreatmentStage III Fallopian Tube Cancer / Stage III Ovarian Cancer / Stage III Primary Peritoneal Cancer / Stage IIIA Fallopian Tube Cancer / Stage IIIA Ovarian Cancer / Stage IIIA Primary Peritoneal Cancer / Stage IIIB Fallopian Tube Cancer / Stage IIIB Ovarian Cancer / Stage IIIB Primary Peritoneal Cancer / Stage IIIC Fallopian Tube Cancer / Stage IIIC Ovarian Cancer / Stage IIIC Primary Peritoneal Cancer / Stage IV Fallopian Tube Cancer / Stage IV Ovarian Cancer / Stage IV Primary Peritoneal Cancer1
2TerminatedDiagnosticBreast Cancer1
2TerminatedPreventionHemodialysis Graft Dysfunction1
2TerminatedPreventionPeripheral Vascular Disease Patient1
2TerminatedSupportive CareCervical Cancers / Endometrial Cancer / Fallopian Tube Cancer / Neurologic toxicity / Ovarian Cancer / Primary Peritoneal Cavity Cancer / Sarcomas1
2TerminatedTreatmentAdenocarcinoma of Ampulla / Ductal Adenocarcinoma of Pancreas1
2TerminatedTreatmentAdenocarcinoma of the Distal Esophagus / Adenocarcinoma of the Proximal Stomach / Adenocarcinomas of the Gastroesophageal Junction / Gastroesophageal Adenocarcinoma1
2TerminatedTreatmentAdenocarcinoma of the Esophagus / Esophageal Cancers / Squamous Cell Carcinoma (SCC)1
2TerminatedTreatmentAdenocarcinoma of the Lung / Bronchioloalveolar Carcinoma / Bronchioloalveolar Lung Carcinoma / Large Cell Lung Carcinoma / Recurrent Non-Small Cell Lung Carcinoma / Stage IV Non-Small Cell Lung Cancer1
2TerminatedTreatmentAdenocarcinoma of the Lung / Non-Small Cell Lung Carcinoma (NSCLC)1
2TerminatedTreatmentAdenocarcinoma of the Pancreas1
2TerminatedTreatmentAdenocarcinoma of the Pancreas / Stage III Pancreatic Cancer1
2TerminatedTreatmentAdenocarcinomas1
2TerminatedTreatmentAdvanced Gastric Adenocarcinoma1
2TerminatedTreatmentAdvanced Non Small Cell Lung Cancer1
2TerminatedTreatmentAdvanced Non-squamous NSCLC1
2TerminatedTreatmentBladder Carcinoma / Transitional Cell Carcinoma1
2TerminatedTreatmentBorderline Resectable Pancreatic Cancer1
2TerminatedTreatmentBreast Cancer11
2TerminatedTreatmentBreast Cancer / Estrogen Receptor Negative Neoplasm / HER2 Positive Breast Cancers1
2TerminatedTreatmentBreast Cancer / Locally Recurrent and Metastatic Breast Cancer / Neoplasms, Breast / Tumors, Breast1
2TerminatedTreatmentBreast Cancer / Recurrent Breast Cancer / Stage IV Breast Cancer1
2TerminatedTreatmentCancer, Bladder1
2TerminatedTreatmentCancer, Bladder / Transitional Cell Cancer of the Renal Pelvis and Ureter / Urethral Cancer1
2TerminatedTreatmentCancer, Bladder / Transitional Cell Carcinoma1
2TerminatedTreatmentCancer, Bladder / Urothelial Cancer1
2TerminatedTreatmentCarcinoma, Ductal, Breast1
2TerminatedTreatmentCervical Cancers2
2TerminatedTreatmentCervical Cancers / Uterine Malignancies1
2TerminatedTreatmentChildhood Germ Cell Tumor / Extragonadal Germ Cell Tumor / Ovarian Cancer / Testicular germ cell tumour1
2TerminatedTreatmentCutaneous Squamous Cell Carcinoma1
2TerminatedTreatmentDrug/Agent Toxicity by Tissue/Organ / Head and Neck Carcinoma / Oral Complications / Radiation Toxicity1
2TerminatedTreatmentEarly Breast Cancer / Estrogen Receptor Positive Breast Cancer / Estrogen Receptor-Positive Breast Cancer / HER2 Negative Breast Cancer / HER2-Negative Breast Cancer / Progesterone Receptor Positive Breast Cancer / Progesterone Receptor-positive Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer1
2TerminatedTreatmentEndometrial Adenocarcinomas / Stage IA Uterine Corpus Cancer / Stage IB Uterine Corpus Cancer / Stage II Uterine Corpus Cancer / Stage IIIA Uterine Corpus Cancer / Stage IIIB Uterine Corpus Cancer / Stage IIIC Uterine Corpus Cancer / Stage IVA Uterine Corpus Cancer / Stage IVB Uterine Corpus Cancer1
2TerminatedTreatmentEndometrial Serous Adenocarcinoma / Stage IIIA Uterine Corpus Cancer / Stage IIIB Uterine Corpus Cancer / Stage IIIC1 Uterine Corpus Cancer / Stage IIIC2 Uterine Corpus Cancer / Stage IVA Uterine Corpus Cancer / Stage IVB Uterine Corpus Cancer1
2TerminatedTreatmentEpithelial Ovarian Carcinoma1
2TerminatedTreatmentEsophageal Cancers2
2TerminatedTreatmentEsophageal Diseases1
2TerminatedTreatmentEsophagus Cancer / Gastroesophageal Junction Cancer / HER-2 Gene Amplification / Malignant Neoplasm of Stomach1
2TerminatedTreatmentFallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Cancer / Stage 3 Cancer / Stage 4 Cancer1
2TerminatedTreatmentFallopian Tube Cancer / Mixed Tumor, Mesodermal / Ovarian Cancer / Primary Peritoneal Carcinoma1
2TerminatedTreatmentFallopian Tube Cancer / Ovarian Cancer / Peritoneal Cavity Cancer1
2TerminatedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Carcinoma / Uterine Malignancies1
2TerminatedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cavity Cancer1
2TerminatedTreatmentFallopian Tube Cancer / Ovarian Epithelial Cancer / Primary Peritoneal Cancer1
2TerminatedTreatmentFistula Stenosis1
2TerminatedTreatmentHER2 Negative Breast Cancer / HER2-Negative Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer1
2TerminatedTreatmentHead and Neck Carcinoma3
2TerminatedTreatmentHead and Neck Squamous Cell Carcinoma (HNSCC) / Platinum Pre-treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma1
2TerminatedTreatmentLocally Advanced HER2-negative Breast Cancer1
2TerminatedTreatmentLoco-regional Esophageal Cancer1
2TerminatedTreatmentLower Oesophagus Cancer / Oesophageal Junction Cancer / Stomach Neoplasms1
2TerminatedTreatmentLung Cancers5
2TerminatedTreatmentMalignancies1
2TerminatedTreatmentMalignant Melanoma of Skin / Melanoma (Skin)1
2TerminatedTreatmentMalignant Neoplasm of Pancreas1
2TerminatedTreatmentMalignant Neoplasm of Stomach1
2TerminatedTreatmentMalignant Ovarian Mixed Epithelial Tumor / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Serous Cystadenocarcinoma / Primary Peritoneal Carcinoma / Stage III Ovarian Cancer / Undifferentiated Ovarian Carcinoma1
2TerminatedTreatmentMalignant Peritoneal Neoplasm / Ovarian Cancer1
2TerminatedTreatmentMelanoma2
2TerminatedTreatmentMetastatic Breast Cancer6
2TerminatedTreatmentMetastatic Cancer Pancreas1
2TerminatedTreatmentMetastatic Pancreatic Ductal Adenocarcinoma1
2TerminatedTreatmentMetastatic, Gastric or Gastro-oesophageal Junction, Cancer1
2TerminatedTreatmentNasopharyngeal Carcinoma1
2TerminatedTreatmentNeoplasms Metastasis / Neoplasms, Breast1
2TerminatedTreatmentNeoplasms, Breast1
2TerminatedTreatmentNeoplasms, Breast / Relapsed Breast Cancer1
2TerminatedTreatmentNeoplasms, Head and Neck / Squamous Cell Carcinoma (SCC)1
2TerminatedTreatmentNeoplasms, Ovarian1
2TerminatedTreatmentNeuroendocrine Carcinoma of the Skin1
2TerminatedTreatmentNon-Small Cell Lung Cancer Recurrent / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
2TerminatedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)12
2TerminatedTreatmentOvarian Cancer4
2TerminatedTreatmentOvarian Cancer / Primary Peritoneal Cavity Cancer2
2TerminatedTreatmentPancreatic Cancer Metastatic1
2TerminatedTreatmentPancreatic Cancer Resectable1
2TerminatedTreatmentPancreatic Carcinoma Non-resectable / Stage IV Pancreatic Cancer1
2TerminatedTreatmentPatients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy1
2TerminatedTreatmentPenile Squamous Cell Carcinoma Stage IV1
2TerminatedTreatmentProstate Cancer1
2TerminatedTreatmentProstatic Neoplasms1
2TerminatedTreatmentRefractory Plasma Cell Myeloma1
2TerminatedTreatmentSarcomas1
2TerminatedTreatmentSmall Cell Lung Cancer (SCLC)1
2TerminatedTreatmentSquamous Non Small Cell Lung Cancer1
2TerminatedTreatmentStage IB Esophageal Adenocarcinoma / Stage IIA Esophageal Adenocarcinoma / Stage IIB Esophageal Adenocarcinoma / Stage IIIA Esophageal Adenocarcinoma / Stage IIIB Esophageal Adenocarcinoma / Stage IIIC Esophageal Adenocarcinoma1
2TerminatedTreatmentStage III Non-Small Cell Lung Cancer AJCC v7 / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer AJCC v7 / Stage IIIb Non-small Cell Lung Cancer / Stage IIIB Non-Small Cell Lung Cancer AJCC v71
2TerminatedTreatmentStage IIIA Non-Small Cell Lung Cancer1
2TerminatedTreatmentTesticular Cancer1
2TerminatedTreatmentAdvanced thymic carcinoma / Thymic Carcinoma1
2TerminatedTreatmentTriple Negative Breast Cancer (TNBC)1
2TerminatedTreatmentTriple Negative Metastatic Breast Cancer1
2TerminatedTreatmentUrinary Bladder Neoplasms1
2TerminatedTreatmentUterine Malignancies1
2TerminatedTreatmentUterine Neoplasms1
2Unknown StatusDiagnosticBreast Cancer1
2Unknown StatusDiagnosticLung Cancers1
2Unknown StatusSupportive CareNausea / Vomiting1
2Unknown StatusTreatmentAdenocarincoma of Pancreas / Stage III Pancreatic Cancer / Stage IVA Pancreatic Cancer / Stage IVB Pancreatic Cancer1
2Unknown StatusTreatmentAdrenocortical Carcinoma1
2Unknown StatusTreatmentAdvanced Gastric Cancer1
2Unknown StatusTreatmentAdvanced Gastric Carcinoma1
2Unknown StatusTreatmentAdvanced Pancreatic Cancer1
2Unknown StatusTreatmentAdvanced or Recurrent Esophageal Squamous Cell Carcinoma / Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel / First Line Chemotherapy1
2Unknown StatusTreatmentBladder (Urothelial, Transitional Cell) Cancer / Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable / Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy) / Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) / Cancer, Bladder1
2Unknown StatusTreatmentBreast Cancer8
2Unknown StatusTreatmentCancer, Bladder1
2Unknown StatusTreatmentCarcinoma NOS / Unknown Primary Neoplasms1
2Unknown StatusTreatmentCervical Cancers3
2Unknown StatusTreatmentDrug Safety / Surgically-Created Resection Cavity1
2Unknown StatusTreatmentEGFR Gene Mutations / HER2-expression / Non-Small Cell Lung Carcinoma (NSCLC)1
2Unknown StatusTreatmentEndometrial Cancer1
2Unknown StatusTreatmentErbB2-Positive Stage I-III Breast Cancer1
2Unknown StatusTreatmentEsophageal Cancers6
2Unknown StatusTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer1
2Unknown StatusTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cavity Cancer2
2Unknown StatusTreatmentGastric Adenocarcinoma1
2Unknown StatusTreatmentGastric Caner1
2Unknown StatusTreatmentHER2 Positive Breast Cancers1
2Unknown StatusTreatmentHead and Neck Carcinoma3
2Unknown StatusTreatmentHead and Neck Squamous Carcinoma / Nasopharyngeal Carcinoma1
2Unknown StatusTreatmentHemangiosarcoma / Soft Tissue Sarcoma (STS)1
2Unknown StatusTreatmentLiver Metastasis / Malignant Neoplasm of Nasopharynx / Non-Small Cell Lung Carcinoma (NSCLC)1
2Unknown StatusTreatmentLung Cancers8
2Unknown StatusTreatmentMalignant Melanoma of Skin Stage III / Metastatic Melanoma1
2Unknown StatusTreatmentMalignant Neoplasm of Esophagus1
2Unknown StatusTreatmentMalignant Neoplasm of Stomach / Metastases to Perineum1
2Unknown StatusTreatmentNeoplasms, Head and Neck1
2Unknown StatusTreatmentNon-Small Cell Lung Carcinoma (NSCLC)5
2Unknown StatusTreatmentOvarian Cancer3
2Unknown StatusTreatmentOvarian Cancer With Malignant Ascites1
2Unknown StatusTreatmentOvarian Cancer / Primary Peritoneal Cavity Cancer1
2Unknown StatusTreatmentProstate Cancer1
2Unknown StatusTreatmentSmall Cell Lung Cancer (SCLC)1
2Unknown StatusTreatmentSquamous Cell Carcinoma of Lung1
2Unknown StatusTreatmentThyroid Cancers1
2Unknown StatusTreatmentTriple Negative Breast Cancer (TNBC)1
2Unknown StatusTreatmentUterine Cervical Cancer1
2WithdrawnNot AvailableNeoplasms, Lung / Non-Small Cell Lung Carcinoma (NSCLC)1
2WithdrawnTreatmentAdenocarcinoma of the Pancreas1
2WithdrawnTreatmentArteriovenous Access Fistula Stenosis1
2WithdrawnTreatmentBiliary Tract Cancer / Esophageal Cancers / Gastroesophageal Cancer (GC) / Hepatobiliary Neoplasms1
2WithdrawnTreatmentBreast Cancer3
2WithdrawnTreatmentBreast Cancer / Breast Cancer Stage II / Breast Cancer Stage III1
2WithdrawnTreatmentBreast Cancer / ER-Negative PR-Negative HER2-Negative Breast Cancer / ER-Negative PR-Negative HER2-Negative Breast Neoplasms / Triple Negative Breast Cancer (TNBC) / Triple Negative Breast Neoplasms / Triple-Negative Breast Cancer (TNBC) / Triple-Negative Breast Neoplasms1
2WithdrawnTreatmentCancer of Head and Neck1
2WithdrawnTreatmentCancer of the Stomach / Gastroesophageal Junction / Malignant Neoplasm of Stomach1
2WithdrawnTreatmentCancer, Bladder / Urothelial Cancer1
2WithdrawnTreatmentCervical Intraepithelial Neoplasia (CIN)1
2WithdrawnTreatmentEsophageal Cancers1
2WithdrawnTreatmentEsophageal Cancers / Gastroesophageal Cancer (GC) / Her-2 Positive Gastric Cancer1
2WithdrawnTreatmentEsophageal Squamous Cell Carcinoma (ESCC)1
2WithdrawnTreatmentLocally Advanced Non-Small Cell Lung Cancer / Non-small Cell Lung Cancer, Stage III1
2WithdrawnTreatmentLung Cancers2
2WithdrawnTreatmentMalignant Neoplasm of Stomach1
2WithdrawnTreatmentMetastatic Melanoma1
2WithdrawnTreatmentNeoplasms, Breast4
2WithdrawnTreatmentNon-Small Cell Lung Carcinoma (NSCLC)3
2WithdrawnTreatmentOvarian Cancer1
2WithdrawnTreatmentPancreatic Cancer Metastatic1
2WithdrawnTreatmentPancreatic Ductal Adenocarcinoma1
2WithdrawnTreatmentProstate Cancer2
2WithdrawnTreatmentRecurrent Bladder Urothelial Carcinoma / Stage IV Bladder Urothelial Carcinoma1
2WithdrawnTreatmentRelapse/Refractory Multiple Myeloma1
2WithdrawnTreatmentResectable Pancreatic Cancers1
2WithdrawnTreatmentTriple Negative Breast Cancer (TNBC)1
2WithdrawnTreatmentUnknown Primary Tumors1
2, 3Active Not RecruitingSupportive CareMalignancies1
2, 3Active Not RecruitingTreatmentBreast Cancer2
2, 3Active Not RecruitingTreatmentEndometrial Adenocarcinomas / Endometrial Clear Cell Adenocarcinoma / Endometrial Serous Adenocarcinoma / Endometrial Undifferentiated Carcinoma / Recurrent Uterine Corpus Carcinoma / Stage III Uterine Corpus Cancer / Stage III Uterine Corpus Cancer AJCC v7 / Stage IIIA Uterine Corpus Cancer / Stage IIIA Uterine Corpus Cancer AJCC v7 / Stage IIIB Uterine Corpus Cancer / Stage IIIB Uterine Corpus Cancer AJCC v7 / Stage IIIC Uterine Corpus Cancer / Stage IIIC Uterine Corpus Cancer AJCC v7 / Stage IV Uterine Corpus Cancer / Stage IV Uterine Corpus Cancer AJCC v7 / Stage IVA Uterine Corpus Cancer / Stage IVA Uterine Corpus Cancer AJCC v7 / Stage IVB Uterine Corpus Cancer / Stage IVB Uterine Corpus Cancer AJCC v71
2, 3Active Not RecruitingTreatmentEsophageal Cancers / Neoplasms, Esophageal1
2, 3Active Not RecruitingTreatmentFallopian Tube Cancer / Ovarian Epithelial Cancer / Primary Peritoneal Carcinoma1
2, 3Active Not RecruitingTreatmentHead and Neck Carcinoma1
2, 3Active Not RecruitingTreatmentInflammatory Breast Cancer (IBC) / Invasive Ductal Breast Carcinoma / Mucinous Breast Cancer / Tubular Breast Carcinoma1
2, 3Active Not RecruitingTreatmentLow Grade Ovarian Serous Adenocarcinoma / Micropapillary Serous Carcinoma / Ovarian Serous Adenocarcinoma / Primary Peritoneal Serous Adenocarcinoma / Recurrent Low Grade Ovarian Serous Adenocarcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Recurrent Primary Peritoneal Serous Adenocarcinoma1
2, 3CompletedTreatmentAdenocarcinoma of the Lung / Bronchoalveolar Cell Lung Cancer / Large Cell Lung Cancer / Non-Small Cell Lung Cancer Recurrent / Stage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
2, 3CompletedTreatmentBreast Cancer2
2, 3CompletedTreatmentBreast Cancer / Cancer of the Breast / Estrogen Receptor- Negative Breast Cancer / HER2 Negative Breast Cancer / HER2- Negative Breast Cancer / Metastatic Breast Cancer / Progesterone Receptor- Negative Breast Cancer / Recurrent Breast Cancer / Stage IV Breast Cancer / Triple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC) / Triple-negative Metastatic Breast Cancer / Tumors, Breast1
2, 3CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer1
2, 3CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cavity Cancer1
2, 3CompletedTreatmentHER2 Positive Breast Cancers / Inflammatory Breast Cancer (IBC) / Inflammatory carcinoma of breast stage IV / Invasive Ductal Breast Carcinoma / Malignant Neoplasm of Female Breast / Mucinous Breast Cancer Stage II / Tubular Breast Cancer Stage II / Tubular Breast Cancer Stage III1
2, 3CompletedTreatmentHead and Neck Carcinoma1
2, 3CompletedTreatmentLung Cancers2
2, 3CompletedTreatmentMalignant Neoplasm of Stomach1
2, 3CompletedTreatmentNeoplasms, Breast1
2, 3CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)1
2, 3Enrolling by InvitationTreatmentBreast Cancer1
2, 3Not Yet RecruitingTreatmentAdvanced Gastric or Gastroesophageal Junction Adenocarcinoma1
2, 3Not Yet RecruitingTreatmentAdvanced Hepatobiliary and Malignant Tumors1
2, 3Not Yet RecruitingTreatmentEndometrial Cancer / P53 Mutation / Serous Tumor1
2, 3Not Yet RecruitingTreatmentMalignant Tumor of Pancreas Metastatic to Liver1
2, 3RecruitingTreatmentAdenocarcinoma Of Esophagus / Adenocarcinomas of the Gastroesophageal Junction / Clinical Stage II Esophageal Adenocarcinoma AJCC v8 / Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 / Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 / Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage III Esophageal Adenocarcinoma AJCC v8 / Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 / Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v81
2, 3RecruitingTreatmentAdvanced Gastric or EGJ Cancer1
2, 3RecruitingTreatmentAtherosclerosis / Coronary Artery Disease (CAD) / Inflammatory Reaction1
2, 3RecruitingTreatmentBreast Cancer2
2, 3RecruitingTreatmentEpstein-Barr Virus Infections / Stage II Nasopharyngeal Carcinoma / Stage III Nasopharyngeal Carcinoma / Stage IVA Nasopharyngeal Carcinoma / Stage IVB Nasopharyngeal Carcinoma1
2, 3RecruitingTreatmentFIGO Stages II to IV / Primary Malignant Neoplasm of Ovary1
2, 3RecruitingTreatmentFallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Serous Adenocarcinoma / Fallopian Tube Transitional Cell Carcinoma / Fallopian Tube Undifferentiated Carcinoma / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Seromucinous Carcinoma / Ovarian Serous Adenocarcinoma / Ovarian Transitional Cell Carcinoma / Ovarian Undifferentiated Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma1
2, 3RecruitingTreatmentMalignant Neoplasm of Esophagus1
2, 3RecruitingTreatmentRecurrent or Metastatic Breast Cancer1
2, 3SuspendedTreatmentEsophageal Squamous Cell Carcinoma (ESCC)1
2, 3SuspendedTreatmentMetastatic Breast Cancer1
2, 3TerminatedTreatmentCancer, Anaplastic Thyroid1
2, 3TerminatedTreatmentDialysis Access Dysfunction1
2, 3TerminatedTreatmentEsophageal Cancers1
2, 3TerminatedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)1
2, 3TerminatedTreatmentOvarian Cancer / Primary Peritoneal Cavity Cancer1
2, 3TerminatedTreatmentStage IIIB or IV Non-Small Cell Lung Cancer1
2, 3Unknown StatusTreatmentBreast Cancer2
2, 3Unknown StatusTreatmentExtragonadal Germ Cell Tumor / Teratoma / Testicular germ cell tumour1
3Active Not RecruitingNot AvailableBreast Cancer1
3Active Not RecruitingTreatmentAbdominal wall neoplasm / Fallopian Tube Cancer / Ovarian Cancer1
3Active Not RecruitingTreatmentAbdominal wall neoplasm / Fallopian Tube Neoplasms / Genital Diseases, Female / Neoplasms, Ovarian / Ovarian Diseases1
3Active Not RecruitingTreatmentAdenocarcinoma Of Esophagus / Adenocarcinomas of the Gastroesophageal Junction / Stage IB Esophageal Cancer AJCC v7 / Stage IIA Esophageal Cancer AJCC v7 / Stage IIB Esophageal Cancer AJCC v7 / Stage IIIA Esophageal Cancer AJCC v7 / Stage IIIB Esophageal Cancer AJCC v71
3Active Not RecruitingTreatmentAdenocarcinoma of Lung Stage IV / Recurrent Large Cell Lung Carcinoma / Recurrent Lung Adenocarcinoma / Recurrent Squamous Cell Lung Carcinoma / Stage IV Large Cell Lung Carcinoma / Stage IV Squamous Cell Lung Carcinoma1
3Active Not RecruitingTreatmentAdenocarcinoma of the Cervix / Adenosquamous carcinoma of the cervix / Cervical Squamous Cell Carcinoma / Cervical Squamous Cell Carcinoma, Not Otherwise Specified / Chemotherapeutic Agent Toxicity / Cognitive Side Effects of Cancer Therapy / Psychological Impact of Cancer / Radiation Toxicity / Sexual Dysfunction and Infertility / Stage IB Cervical Cancer / Stage IIA Cervical Cancer / Stage IIB Cervical Cancer / Stage III Cervical Cancer / Stage IIIB Cervical Cancer / Stage IVA Cervical Cancer1
3Active Not RecruitingTreatmentAdenocarcinoma, Mucinous / Carcinoma, Undifferentiated / Clear Cell Adenocarcinoma / Fallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Mucinous Adenocarcinoma / Fallopian Tube Serous Adenocarcinoma / Fallopian Tube Undifferentiated Carcinoma / Malignant Ovarian Mixed Epithelial Tumor / Ovarian Brenner Tumor / Ovarian Clear Cell Adenocarcinofibroma / Ovarian Endometrioid Adenocarcinoma / Ovarian Seromucinous Carcinoma / Ovarian Serous Adenocarcinoma / Ovarian Undifferentiated Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Undifferentiated Fallopian Tube Carcinoma / Undifferentiated Ovarian Carcinoma1
3Active Not RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Gastric Adenocarcinoma1
3Active Not RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Neoplasm, Gastric1
3Active Not RecruitingTreatmentAdvanced Non Small Cell Lung Cancer1
3Active Not RecruitingTreatmentAntimetabolites, Antineoplastic / Digestive System Diseases / Digestive System Neoplasms / Endocrine Gland Neoplasms / Endocrine System Diseases / Gemcitabine / Neoplasms / Neoplasms by Site / Neoplasms, Pancreatic / Pancreatic Diseases1
3Active Not RecruitingTreatmentArtery Diseases, Peripheral / Atherosclerosis / Occlusive Arterial Disease / Peripheral Artery Disease (PAD) / Plaque, Atherosclerotic1
3Active Not RecruitingTreatmentBMI >30 kg/m2 / Endometrial Clear Cell Adenocarcinoma / Endometrial Serous Adenocarcinoma / Fatigue / Neurotoxicity Syndrome / Stage I Uterine Corpus Cancer / Stage I Uterine Corpus Cancer AJCC v7 / Stage II Uterine Corpus Cancer / Stage II Uterine Corpus Cancer AJCC v71
3Active Not RecruitingTreatmentBorderline Ovarian Mucinous Tumor / Ovarian Mucinous Cystadenocarcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Stage IA Fallopian Tube Cancer AJCC v6 and v7 / Stage IA Ovarian Cancer AJCC v6 and v7 / Stage IB Fallopian Tube Cancer AJCC v6 and v7 / Stage IB Ovarian Cancer AJCC v6 and v7 / Stage IC Fallopian Tube Cancer AJCC v6 and v7 / Stage IC Ovarian Cancer AJCC v6 and v7 / Stage IIA Fallopian Tube Cancer AJCC v6 and v7 / Stage IIA Ovarian Cancer AJCC V6 and v7 / Stage IIB Fallopian Tube Cancer AJCC v6 and v7 / Stage IIB Ovarian Cancer AJCC v6 and v7 / Stage IIC Fallopian Tube Cancer AJCC v6 and v7 / Stage IIC Ovarian Cancer AJCC v6 and v7 / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer AJCC v6 and v71
3Active Not RecruitingTreatmentBreast Adenocarcinoma1
3Active Not RecruitingTreatmentBreast Adenocarcinoma / HER2 Positive Breast Carcinoma / Stage IA Breast Cancer / Stage IA Breast Cancer AJCC v7 / Stage IB Breast Cancer / Stage IB Breast Cancer AJCC v7 / Stage IIA Breast Cancer / Stage IIA Breast Cancer AJCC v6 and v7 / Stage IIB Breast Cancer / Stage IIB Breast Cancer AJCC v6 and v7 / Stage IIIA Breast Cancer / Stage IIIA Breast Cancer AJCC v71
3Active Not RecruitingTreatmentBreast Cancer11
3Active Not RecruitingTreatmentBreast Cancer / HER2 Positive1
3Active Not RecruitingTreatmentBreast Cancer / Metastasis1
3Active Not RecruitingTreatmentCancer of Cervix1
3Active Not RecruitingTreatmentCancer, Bladder / Ureteral Cancer / Urothelial Cancer1
3Active Not RecruitingTreatmentCarcinoma, Non-Squamous Non-Small Cell Lung1
3Active Not RecruitingTreatmentCervical Cancers1
3Active Not RecruitingTreatmentEarly Breast Cancer1
3Active Not RecruitingTreatmentEarly Primary Breast Cancer / Early Primary Breast Cancer in the Elderly1
3Active Not RecruitingTreatmentEndometrial Cancer1
3Active Not RecruitingTreatmentEndometrial Cancer / Recurrent Uterine Corpus Carcinoma / Stage IIIA Uterine Corpus Cancer / Stage IIIA Uterine Corpus Cancer AJCC v7 / Stage IIIB Uterine Corpus Cancer / Stage IIIB Uterine Corpus Cancer AJCC v7 / Stage IIIC Uterine Corpus Cancer / Stage IIIC Uterine Corpus Cancer AJCC v7 / Stage IVA Uterine Corpus Cancer / Stage IVA Uterine Corpus Cancer AJCC v7 / Stage IVB Uterine Corpus Cancer / Stage IVB Uterine Corpus Cancer AJCC v71
3Active Not RecruitingTreatmentEndometrial Clear Cell Adenocarcinoma / Endometrial Serous Adenocarcinoma / Stage IA Uterine Corpus Cancer / Stage IA Uterine Corpus Cancer AJCC v7 / Stage IB Uterine Corpus Cancer / Stage IB Uterine Corpus Cancer AJCC v7 / Stage II Uterine Corpus Cancer / Stage II Uterine Corpus Cancer AJCC v7 / Stage IIIA Uterine Corpus Cancer / Stage IIIA Uterine Corpus Cancer AJCC v7 / Stage IIIB Uterine Corpus Cancer / Stage IIIB Uterine Corpus Cancer AJCC v7 / Stage IIIC Uterine Corpus Cancer / Stage IIIC Uterine Corpus Cancer AJCC v7 / Stage IVA Uterine Corpus Cancer / Stage IVA Uterine Corpus Cancer AJCC v71
3Active Not RecruitingTreatmentEsophageal Cancers2
3Active Not RecruitingTreatmentEsophageal Carcinoma / Esophagogastric Junction Carcinoma2
3Active Not RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC)1
3Active Not RecruitingTreatmentEstrogen Receptor Negative / Estrogen Receptor Positive / HER2/Neu Negative / HER2/Neu Positive / Progesterone Receptor Negative / Progesterone Receptor Positive / Recurrent Breast Carcinoma / Stage IIIC Breast Cancer AJCC v6 / Stage IV Breast Cancer AJCC v6 and v71
3Active Not RecruitingTreatmentEstrogen Receptor Negative / Estrogen Receptor Positive / HER2/Neu Positive / Progesterone Receptor Negative / Progesterone Receptor Positive / Recurrent Breast Carcinoma / Stage IA Breast Cancer / Stage IA Breast Cancer AJCC v7 / Stage IB Breast Cancer / Stage IB Breast Cancer AJCC v7 / Stage IIA Breast Cancer / Stage IIA Breast Cancer AJCC v6 and v7 / Stage IIB Breast Cancer / Stage IIB Breast Cancer AJCC v6 and v7 / Stage IIIA Breast Cancer / Stage IIIA Breast Cancer AJCC v7 / Stage IIIC Breast Cancer / Stage IIIC Breast Cancer AJCC v71
3Active Not RecruitingTreatmentExtragonadal Germ Cell Tumor / Teratoma / Testicular germ cell tumour1
3Active Not RecruitingTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer1
3Active Not RecruitingTreatmentFallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Mucinous Adenocarcinoma / Fallopian Tube Serous Adenocarcinoma / Fallopian Tube Transitional Cell Carcinoma / Fallopian Tube Undifferentiated Carcinoma / Malignant Ovarian Mixed Epithelial Tumor / Ovarian Brenner Tumor / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Adenocarcinoma / Ovarian Seromucinous Carcinoma / Ovarian Serous Adenocarcinoma / Ovarian Transitional Cell Carcinoma / Ovarian Undifferentiated Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Stage IIIA Fallopian Tube Cancer / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIA Primary Peritoneal Cancer / Stage IIIA Primary Peritoneal Cancer AJCC v7 / Stage IIIB Fallopian Tube Cancer / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIB Primary Peritoneal Cancer / Stage IIIB Primary Peritoneal Cancer AJCC v7 / Stage IIIC Fallopian Tube Cancer / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IIIC Primary Peritoneal Cancer / Stage IIIC Primary Peritoneal Cancer AJCC v7 / Stage IV Fallopian Tube Cancer / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer / Stage IV Ovarian Cancer AJCC v6 and v7 / Stage IV Primary Peritoneal Cancer / Stage IV Primary Peritoneal Cancer AJCC v7 / Undifferentiated Fallopian Tube Carcinoma / Undifferentiated Ovarian Carcinoma1
3Active Not RecruitingTreatmentFallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Transitional Cell Carcinoma / Fallopian Tube Undifferentiated Carcinoma / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Tumor / Ovarian Seromucinous Carcinoma / Ovarian Serous Tumor / Ovarian Transitional Cell Carcinoma / Ovarian Undifferentiated Carcinoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Ovarian Endometrioid Adenocarcinoma / Recurrent Primary Peritoneal Carcinoma1
3Active Not RecruitingTreatmentFallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Mucinous Adenocarcinoma / Fallopian Tube Transitional Cell Carcinoma / Ovarian Brenner Tumor / Ovarian Clear Cell Adenocarcinofibroma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Adenocarcinoma / Ovarian Seromucinous Carcinoma / Ovarian Serous Adenocarcinoma / Ovarian Transitional Cell Carcinoma / Ovarian Undifferentiated Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Stage IIA Fallopian Tube Cancer AJCC v6 and v7 / Stage IIA Ovarian Cancer AJCC V6 and v7 / Stage IIB Fallopian Tube Cancer AJCC v6 and v7 / Stage IIB Ovarian Cancer AJCC v6 and v7 / Stage IIC Fallopian Tube Cancer AJCC v6 and v7 / Stage IIC Ovarian Cancer AJCC v6 and v7 / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIA Primary Peritoneal Cancer AJCC v7 / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIB Primary Peritoneal Cancer AJCC v7 / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IIIC Primary Peritoneal Cancer AJCC v7 / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer AJCC v6 and v7 / Stage IV Primary Peritoneal Cancer AJCC v71
3Active Not RecruitingTreatmentFirst Line Non-Small Cell Lung Cancer1
3Active Not RecruitingTreatmentHER2 Positive Breast Cancers / Inflammatory Breast Cancer (IBC) / Inflammatory carcinoma of breast stage IV / Invasive Ductal Breast Carcinoma / Malignant Neoplasm of Female Breast / Mucinous Breast Cancer Stage II / Tubular Breast Cancer Stage II / Tubular Breast Cancer Stage III1
3Active Not RecruitingTreatmentHER2-positive Locally Advanced or Metastatic Breast Cancer1
3Active Not RecruitingTreatmentHead and Neck Carcinoma1
3Active Not RecruitingTreatmentHuman Immunodeficiency Virus Type 1 (HIV-1) Infection1
3Active Not RecruitingTreatmentInvasive Breast Cancer1
3Active Not RecruitingTreatmentInvasive Ductal Breast Carcinoma1
3Active Not RecruitingTreatmentLung Cancers / Radiation Toxicity1
3Active Not RecruitingTreatmentMale Breast Carcinoma / Stage IIA Breast Cancer AJCC v6 and v7 / Stage IIB Breast Cancer AJCC v6 and v7 / Stage IIIA Breast Cancer AJCC v7 / Stage IIIB Breast Cancer AJCC v7 / Stage IIIC Breast Cancer AJCC v71
3Active Not RecruitingTreatmentMalignant Neoplasm of Stomach1
3Active Not RecruitingTreatmentMetastatic Breast Cancer5
3Active Not RecruitingTreatmentMixed Mesodermal (Mullerian) Tumor / Ovarian Carcinosarcoma / Recurrent Fallopian Tube Carcinoma / Recurrent Ovarian Carcinoma / Recurrent Primary Peritoneal Carcinoma / Recurrent Uterine Corpus Sarcoma / Stage I Ovarian Cancer / Stage I Ovarian Cancer AJCC v6 and v7 / Stage IA Fallopian Tube Cancer / Stage IA Fallopian Tube Cancer AJCC v6 and v7 / Stage IA Ovarian Cancer / Stage IA Ovarian Cancer AJCC v6 and v7 / Stage IA Uterine Sarcoma / Stage IA Uterine Sarcoma AJCC v7 / Stage IB Fallopian Tube Cancer / Stage IB Fallopian Tube Cancer AJCC v6 and v7 / Stage IB Ovarian Cancer / Stage IB Ovarian Cancer AJCC v6 and v7 / Stage IB Uterine Sarcoma / Stage IB Uterine Sarcoma AJCC v7 / Stage IC Fallopian Tube Cancer / Stage IC Fallopian Tube Cancer AJCC v6 and v7 / Stage IC Ovarian Cancer / Stage IC Ovarian Cancer AJCC v6 and v7 / Stage IC Uterine Sarcoma / Stage IC Uterine Sarcoma AJCC v7 / Stage II Ovarian Cancer / Stage II Ovarian Cancer AJCC v6 and v7 / Stage IIA Fallopian Tube Cancer / Stage IIA Fallopian Tube Cancer AJCC v6 and v7 / Stage IIA Ovarian Cancer / Stage IIA Ovarian Cancer AJCC V6 and v7 / Stage IIA Uterine Sarcoma / Stage IIA Uterine Sarcoma AJCC v7 / Stage IIB Fallopian Tube Cancer / Stage IIB Fallopian Tube Cancer AJCC v6 and v7 / Stage IIB Ovarian Cancer / Stage IIB Ovarian Cancer AJCC v6 and v7 / Stage IIB Uterine Sarcoma / Stage IIB Uterine Sarcoma AJCC v7 / Stage IIC Fallopian Tube Cancer / Stage IIC Fallopian Tube Cancer AJCC v6 and v7 / Stage IIC Ovarian Cancer / Stage IIC Ovarian Cancer AJCC v6 and v7 / Stage IIIA Fallopian Tube Cancer / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIA Primary Peritoneal Cancer / Stage IIIA Primary Peritoneal Cancer AJCC v7 / Stage IIIA Uterine Sarcoma / Stage IIIA Uterine Sarcoma AJCC v7 / Stage IIIB Fallopian Tube Cancer / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIB Primary Peritoneal Cancer / Stage IIIB Primary Peritoneal Cancer AJCC v7 / Stage IIIB Uterine Sarcoma / Stage IIIB Uterine Sarcoma AJCC v7 / Stage IIIC Fallopian Tube Cancer / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IIIC Primary Peritoneal Cancer / Stage IIIC Primary Peritoneal Cancer AJCC v7 / Stage IIIC Uterine Sarcoma / Stage IIIC Uterine Sarcoma AJCC v7 / Stage IV Fallopian Tube Cancer / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer / Stage IV Ovarian Cancer AJCC v6 and v7 / Stage IV Primary Peritoneal Cancer / Stage IV Primary Peritoneal Cancer AJCC v7 / Stage IVA Uterine Sarcoma / Stage IVA Uterine Sarcoma AJCC v7 / Stage IVB Uterine Sarcoma / Stage IVB Uterine Sarcoma AJCC v7 / Uterine Carcinosarcoma1
3Active Not RecruitingTreatmentNeoplasms, Breast1
3Active Not RecruitingTreatmentNeoplasms, Endometrial1
3Active Not RecruitingTreatmentNeoplasms, Esophageal1
3Active Not RecruitingTreatmentNeoplasms, Ovarian / Ovarian Cancer1
3Active Not RecruitingTreatmentNon Small Cell Lung Carcinoma NSCLC / Non-Small Cell Lung Carcinoma (NSCLC)2
3Active Not RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)17
3Active Not RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Non-Small-Cell Lung Carcinoma NSCLC1
3Active Not RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Non-Squamous Non-Small Cell Lung Cancer1
3Active Not RecruitingTreatmentNon-Squamous Non-Small Cell Lung Cancer1
3Active Not RecruitingTreatmentOvarian Brenner Tumor / Ovarian Clear Cell Cystadenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Cystadenocarcinoma / Ovarian Seromucinous Carcinoma / Ovarian Serous Cystadenocarcinoma / Ovarian Undifferentiated Carcinoma / Stage IIA Fallopian Tube Cancer AJCC v6 and v7 / Stage IIA Ovarian Cancer AJCC V6 and v7 / Stage IIB Fallopian Tube Cancer AJCC v6 and v7 / Stage IIB Ovarian Cancer AJCC v6 and v7 / Stage IIC Fallopian Tube Cancer AJCC v6 and v7 / Stage IIC Ovarian Cancer AJCC v6 and v7 / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIA Ovarian Cancer AJCC v6 and v7 / Stage IIIA Primary Peritoneal Cancer AJCC v7 / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIB Ovarian Cancer AJCC v6 and v7 / Stage IIIB Primary Peritoneal Cancer AJCC v7 / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IIIC Ovarian Cancer AJCC v6 and v7 / Stage IIIC Primary Peritoneal Cancer AJCC v71
3Active Not RecruitingTreatmentOvarian Cancer3
3Active Not RecruitingTreatmentPancreatic Ductal Carcinoma1
3Active Not RecruitingTreatmentPrimary Breast Cancer1
3Active Not RecruitingTreatmentRecurrent Ovarian Cancer1
3Active Not RecruitingTreatmentSquamous Non-Small Cell Lung Cancer1
3Active Not RecruitingTreatmentStage III Esophageal Squamous Cell Carcinoma1
3Active Not RecruitingTreatmentStage IV or Recurrent Non-Small Cell Lung Cancer1
3Active Not RecruitingTreatmentTriple Negative Breast Cancer (TNBC)4
3Active Not RecruitingTreatmentTriple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)2
3Active Not RecruitingTreatmentTriple Negative Breast Neoplasms1
3Active Not RecruitingTreatmentUnresectable or Metastatic Melanoma1
3Active Not RecruitingTreatmentUrothelial Cancer1
3CompletedPreventionMalignancies1
3CompletedSupportive CareBreast Cancer1
3CompletedSupportive CareChemotherapeutic Agent Toxicity / Neuropathies / Neurotoxicity Syndrome / Pain / Stage IIIA Fallopian Tube Cancer / Stage IIIA Ovarian Cancer / Stage IIIA Primary Peritoneal Cancer / Stage IIIB Fallopian Tube Cancer / Stage IIIB Ovarian Cancer / Stage IIIB Primary Peritoneal Cancer / Stage IIIC Fallopian Tube Cancer / Stage IIIC Ovarian Cancer / Stage IIIC Primary Peritoneal Cancer / Stage IV Fallopian Tube Cancer / Stage IV Ovarian Cancer / Stage IV Primary Peritoneal Cancer1
3CompletedSupportive CareDrug/Agent Toxicity by Tissue/Organ / Lung Cancers / Oral Complications / Radiation Toxicity1
3CompletedTreatmentAbdominal wall neoplasm / Fallopian Tube Neoplasms / Genital Neoplasms, Female / Neoplasms, Ovarian / Pelvic Neoplasms1
3CompletedTreatmentAbdominal wall neoplasm / Neoplasms, Ovarian1
3CompletedTreatmentAdenocarcinoma of the Cervix / Adenosquamous carcinoma of the cervix / Cervical Squamous Cell Carcinoma / Recurrent Cervical Carcinoma / Stage IVB Cervical Cancer2
3CompletedTreatmentAdenocarcinoma of the Lung / Adenosquamous Cell Lung Cancer / Bronchoalveolar Cell Lung Cancer / Large Cell Lung Cancer / Squamous Cell Carcinoma of Lung / Stage IB Non-small Cell Lung Cancer1
3CompletedTreatmentAdenocarcinoma of the Lung / Adenosquamous Cell Lung Cancer / Large Cell Lung Cancer / Squamous Cell Carcinoma of Lung / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
3CompletedTreatmentAdvanced Gastric Cancer1
3CompletedTreatmentAdvanced Gastric Cancer / Esophagogastric Junction Cancer1
3CompletedTreatmentBreast Cancer32
3CompletedTreatmentBreast Cancer Nos Metastatic Recurrent1
3CompletedTreatmentBreast Cancer / Chemotherapy, Adjuvant1
3CompletedTreatmentBreast Cancer / Neoplasms, Breast1
3CompletedTreatmentBreast Cancer / Stage IV Breast Cancer1
3CompletedTreatmentCancer of the Fallopian Tube / Malignant Peritoneal Neoplasm / Ovarian Cancer1
3CompletedTreatmentCancer, Bladder1
3CompletedTreatmentCancer, Bladder / Transitional Cell Cancer of the Renal Pelvis and Ureter / Urethral Cancer2
3CompletedTreatmentCancer, Bladder / Urethral Cancer1
3CompletedTreatmentCarcinoma, Squamous Cell of the Head and Neck1
3CompletedTreatmentCritical Ischemia1
3CompletedTreatmentEndometrial Adenocarcinomas / Endometrial Adenosquamous Carcinoma / Endometrial Clear Cell Adenocarcinoma / Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation / Endometrial Serous Adenocarcinoma / Stage III Uterine Corpus Cancer1
3CompletedTreatmentEndometrial Cancer2
3CompletedTreatmentEsophageal Squamous Cell Carcinoma (ESCC)1
3CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer3
3CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Ovarian Epithelial Cancer / Primary Peritoneal Carcinoma1
3CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Peritoneal Cavity Cancer2
3CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer1
3CompletedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cavity Cancer2
3CompletedTreatmentFallopian Tube Cancer / Ovarian Epithelial Cancer / Primary Peritoneal Cancer2
3CompletedTreatmentFallopian Tube Clear Cell Adenocarcinoma / Fallopian Tube Endometrioid Adenocarcinoma / Fallopian Tube Mucinous Adenocarcinoma / Fallopian Tube Serous Adenocarcinoma / Fallopian Tube Transitional Cell Carcinoma / Malignant Ovarian Mixed Epithelial Tumor / Ovarian Brenner Tumor / Ovarian Clear Cell Adenocarcinoma / Ovarian Endometrioid Adenocarcinoma / Ovarian Mucinous Adenocarcinoma / Ovarian Serous Adenocarcinoma / Ovarian Transitional Cell Carcinoma / Primary Peritoneal Serous Adenocarcinoma / Stage IIIA Fallopian Tube Cancer / Stage IIIA Ovarian Cancer / Stage IIIA Primary Peritoneal Cancer / Stage IIIB Fallopian Tube Cancer / Stage IIIB Ovarian Cancer / Stage IIIB Primary Peritoneal Cancer / Stage IIIC Fallopian Tube Cancer / Stage IIIC Ovarian Cancer / Stage IIIC Primary Peritoneal Cancer / Stage IV Fallopian Tube Cancer / Stage IV Ovarian Cancer / Stage IV Primary Peritoneal Cancer / Undifferentiated Fallopian Tube Carcinoma / Undifferentiated Ovarian Carcinoma1
3CompletedTreatmentGastric Cancer Third Line / Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma1
3CompletedTreatmentGastroesophageal Junction Cancer / Malignant Neoplasm of Stomach1
3CompletedTreatmentHER2 Negative Breast Cancer / HER2 Positive Breast Cancers / HER2-Negative Breast Cancer / Recurrent Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
3CompletedTreatmentHER2 Positive Breast Cancers / Inflammatory Breast Cancer (IBC) / Invasive Ductal Breast Carcinoma / Malignant Neoplasm of Female Breast / Mucinous Breast Cancer Stage II / Tubular Breast Cancer Stage II / Tubular Breast Cancer Stage III1
3CompletedTreatmentHER2-positive Metastatic Breast Cancer / Human Epithelial Receptor (HER)-2 Positive Breast Cancer1
3CompletedTreatmentHER2/Neu Positive / Stage IA Breast Cancer / Stage IB Breast Cancer / Stage II Breast Cancer / Stage IIIA Breast Cancer1
3CompletedTreatmentHead and Neck Carcinoma2
3CompletedTreatmentHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast / Metastatic Breast Cancer1
3CompletedTreatmentIll-defined Sites / Supportive1
3CompletedTreatmentKaposi's Sarcoma AIDS Related1
3CompletedTreatmentLung Cancer - Non Small Cell Squamous1
3CompletedTreatmentLung Cancers15
3CompletedTreatmentLung Cancers / Non-Small Cell Lung Carcinoma (NSCLC)1
3CompletedTreatmentMalignant Neoplasm of Stomach1
3CompletedTreatmentMelanoma1
3CompletedTreatmentMelanoma, Malignant1
3CompletedTreatmentMetastatic Breast Cancer4
3CompletedTreatmentMetastatic Non-Small Cell Lung Cancer1
3CompletedTreatmentMucosal Melanoma / Recurrent Melanoma / Stage IIIA Skin Melanoma / Stage IIIB Skin Melanoma / Stage IIIC Skin Melanoma / Stage IV Skin Melanoma1
3CompletedTreatmentNeoplasm Metastases / Neoplasms, Breast1
3CompletedTreatmentNeoplasms, Breast5
3CompletedTreatmentNeoplasms, Gastrointestinal Tract1
3CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)17
3CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC) / Non-Squamous Non-Small Cell Lung Cancer1
3CompletedTreatmentNon-Squamous Non-Small Cell Lung Cancer2
3CompletedTreatmentNon-small Cell Lung Cancer Stage I and II / Peri-operative Chemotherapy1
3CompletedTreatmentOvarian Cancer7
3CompletedTreatmentOvarian Cancer / Primary Peritoneal Cavity Cancer4
3CompletedTreatmentPancreatic Adenocarcinoma Metastatic1
3CompletedTreatmentPancreatic Cancer Metastatic1
3CompletedTreatmentPrimary Breast Cancer2
3CompletedTreatmentPrimary Peritoneal Carcinoma / Primary Peritoneal Cavity Cancer / Stage III Ovarian Cancer / Stage III Ovarian Epithelial Cancer / Stage IV Ovarian Cancer / Stage IV Ovarian Epithelial Cancer1
3CompletedTreatmentProstate Cancer2
3CompletedTreatmentSarcomas1
3CompletedTreatmentSquamous Cell Carcinoma, Non-Small-Cell Lung1
3CompletedTreatmentSquamous Non-Small Cell Lung Cancer1
3CompletedTreatmentTriple Negative Breast Cancer (TNBC)1
3CompletedTreatmentTumors, Solid1
3CompletedTreatmentUnknown Primary Neoplasms1
3CompletedTreatmentUnspecified Adult Solid Tumor, Protocol Specific1
3CompletedTreatmentUterine Cervical Neoplasms1
3Enrolling by InvitationTreatmentAnus Diseases / Anus Neoplasms / Carcinoma NOS / Neoplasms / Neoplasms, Squamous Cell / Squamous Cell Carcinoma (SCC)1
3Not Yet RecruitingPreventionChemotherapy Induced Peripheral Neuropathy (CIPN) / Chemotherapy-induced Peripheral Neuropathy (CIPN) / Fallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Carcinoma / Recurrent Ovarian Carcinoma1
3Not Yet RecruitingTreatmentAdvanced Gastric and Gastro-oesophageal Junction Adenocarcinoma1
3Not Yet RecruitingTreatmentAdvanced Non-squamous NSCLC1
3Not Yet RecruitingTreatmentAdvanced Non-squamous Non-small-cell Lung Cancer1
3Not Yet RecruitingTreatmentAnal Basaloid Carcinoma / Anal Canal Cloacogenic Carcinoma / Metastatic Anal Squamous Cell Carcinoma / Recurrent Anal Squamous Cell Carcinoma / Stage III Anal Cancer AJCC v8 / Stage IIIA Anal Cancer AJCC v8 / Stage IIIB Anal Cancer AJCC v8 / Stage IIIC Anal Cancer AJCC v8 / Stage IV Anal Cancer AJCC v8 / Unresectable Anal Squamous Cell Carcinoma1
3Not Yet RecruitingTreatmentBreast Cancer2
3Not Yet RecruitingTreatmentBreast Cancer / Triple Negative Breast Cancer (TNBC)1
3Not Yet RecruitingTreatmentCervical Cancer TNM Staging Regional Lymph Nodes (N)1
3Not Yet RecruitingTreatmentCervical Cancers3
3Not Yet RecruitingTreatmentEsophageal Cancer Stage IIB / Esophageal Cancer Stage III1
3Not Yet RecruitingTreatmentEsophageal Cancers1
3Not Yet RecruitingTreatmentHead and Neck Carcinoma1
3Not Yet RecruitingTreatmentMalignant Hydrothorax / Non-Small Cell Lung Carcinoma (NSCLC)1
3Not Yet RecruitingTreatmentMalignant Neoplasm of Stomach1
3Not Yet RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)4
3Not Yet RecruitingTreatmentNon-Squamous Cell Non-small Cell Lung Cancer1
3Not Yet RecruitingTreatmentOvarian Cancer1
3Not Yet RecruitingTreatmentPD-L1 Positive Non-small Cell Lung Cancer1
3Not Yet RecruitingTreatmentSquamous Non-Small Cell Lung Cancer1
3Not Yet RecruitingTreatmentStage IIIA Non-Small Cell Lung Cancer1
3Not Yet RecruitingTreatmentTriple Negative Breast Cancer (TNBC)2
3RecruitingOtherInvasive Breast Cancer1
3RecruitingOtherNeoplasms, Breast1
3RecruitingPreventionRecurrent Ovarian Carcinoma1
3RecruitingTreatment(FIGO Stage IIB-IVA) / Uterine Cervical Cancer1
3RecruitingTreatmentAbdominal wall neoplasm / Fallopian Tube Cancer / Ovarian Cancer1
3RecruitingTreatmentAdenocarcinoma of the Oesophago-gastric Junction / Adenocarcinoma of the Oesophagus / Junctional Tumours / Malignant Neoplasm of Esophagus / Oesophageal Tumours1
3RecruitingTreatmentAdenocarcinoma of the Pancreas2
3RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Esophageal Adenocarcinoma (UICC TNM7)1
3RecruitingTreatmentAdenocarcinomas of the Gastroesophageal Junction / Gastric Adenocarcinoma1
3RecruitingTreatmentAdvanced Esophageal Cancers1
3RecruitingTreatmentAdvanced Gastric Cancer2
3RecruitingTreatmentAdvanced Ovarian Cancer1
3RecruitingTreatmentAdvanced Ovarian Cancer / Fallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Cancer Stage IIIC1
3RecruitingTreatmentAngioplasty / Stenosis of Arteriovenous Fistula1
3RecruitingTreatmentBreast Adenocarcinoma / Estrogen Receptor Negative / HER2/Neu Negative / Progesterone Receptor Negative / Stage IB Breast Cancer / Stage IIA Breast Cancer / Stage IIB Breast Cancer / Stage IIIA Breast Cancer / Stage IIIC Breast Cancer / Triple-Negative Breast Carcinoma1
3RecruitingTreatmentBreast Adenocarcinoma / Metastatic Breast Adenocarcinoma / Recurrent Breast Carcinoma / Stage III Breast Cancer AJCC V7 / Stage IIIA Breast Cancer AJCC v7 / Stage IIIB Breast Cancer AJCC v7 / Stage IIIC Breast Cancer AJCC v7 / Stage IV Breast Cancer AJCC v6 and v7 / Unresectable Breast Carcinoma1
3RecruitingTreatmentBreast Cancer8
3RecruitingTreatmentBreast Cancer / HER 2 Negative Breast Cancer / Hormone Receptor Positive Tumor1
3RecruitingTreatmentBreast Cancer / HER2 Positive Breast Cancers / Neoplasms, Breast / Stage II Breast Cancer / Stage IIIA Breast Cancer1
3RecruitingTreatmentBreast Cancer / Triple Negative Breast Neoplasms1
3RecruitingTreatmentCancer Metastatic1
3RecruitingTreatmentCarcinoma of the Cervix, Stage IVB1
3RecruitingTreatmentCarcinoma, Squamous Cell, Non-small-cell Lung1
3RecruitingTreatmentCarcinoma,Non-Small-Cell Lung / Lung Carcinomas, Non-Small-Cell / Non-Small Cell Lung Carcinoma (NSCLC)1
3RecruitingTreatmentCervical Cancers4
3RecruitingTreatmentCervical Cancers / Chemotherapy, Adjuvant / Lymph Node Metastases / Radiations1
3RecruitingTreatmentCervical Carcinoma Stage IIB1
3RecruitingTreatmentChildhood Teratoma / Choriocarcinoma / Extragonadal Seminoma / Germ Cell Tumors / Germinoma / Malignant Germ Cell Neoplasm / Mixed Germ Cell Tumor / Non-seminomatous Germ Cell Tumors / Seminoma / Teratoma / Yolk Sac Tumor1
3RecruitingTreatmentClinical Stage I Esophageal Adenocarcinoma AJCC v8 / Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8 / Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage II Esophageal Adenocarcinoma AJCC v8 / Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 / Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 / Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8 / Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage III Esophageal Adenocarcinoma AJCC v8 / Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 / Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 / Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8 / Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 / Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage I Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage I Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IA Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IC Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IC Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage II Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIB Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage III Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Pathologic Stage IVA Esophageal Adenocarcinoma AJCC v8 / Pathologic Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 / Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage I Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage I Esophageal Squamous Cell Carcinoma AJCC v8 / Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8 / Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage III Esophageal Squamous Cell Carcinoma AJCC v8 / Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIA Esophageal Squamous Cell Carcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIB Esophageal Squamous Cell Carcinoma AJCC v8 / Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IVA Esophageal Adenocarcinoma AJCC v8 / Postneoadjuvant Therapy Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8 / Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 / Thoracic Esophagus Squamous Cell Carcinoma1
3RecruitingTreatmentEUS-FNA / Pancreatic Cysts1
3RecruitingTreatmentEarly Breast Cancer1
3RecruitingTreatmentEndometrial Cancer1
3RecruitingTreatmentEndometrial Clear Cell Adenocarcinoma / Endometrial Serous Adenocarcinoma / Stage IIIA Uterine Corpus Cancer / Stage IIIB Uterine Corpus Cancer / Stage IIIC Uterine Corpus Cancer / Stage IVA Uterine Corpus Cancer1
3RecruitingTreatmentEsophageal Cancers3
3RecruitingTreatmentEsophageal Squamous Cell Carcinoma (ESCC)5
3RecruitingTreatmentFallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Cancer / Ovarian Epithelial Cancer1
3RecruitingTreatmentFallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Epithelial Cancer1
3RecruitingTreatmentGestational Trophoblastic Neoplasms1
3RecruitingTreatmentIMRT With or Without Concurrent Chemotherapy for Esophageal Cancer1
3RecruitingTreatmentInflammatory Breast Cancer (IBC) / Invasive Ductal Breast Carcinoma / Mucinous Breast Cancer / Tubular Breast Carcinoma1
3RecruitingTreatmentInvasive Duct Carcinoma of Breast / Mucinous Breast Cancer / Tubular Breast Carcinoma1
3RecruitingTreatmentLocally Advanced Pancreatic Cancer1
3RecruitingTreatmentLow Grade Ovarian Serous Adenocarcinoma / Primary Peritoneal Low Grade Serous Adenocarcinoma / Stage II Ovarian Cancer AJCC v8 / Stage IIA Ovarian Cancer AJCC v8 / Stage IIB Ovarian Cancer AJCC v8 / Stage III Ovarian Cancer AJCC v8 / Stage IIIA Ovarian Cancer AJCC v8 / Stage IIIA1 Ovarian Cancer AJCC v8 / Stage IIIA2 Ovarian Cancer AJCC v8 / Stage IIIB Ovarian Cancer AJCC v8 / Stage IIIC Ovarian Cancer AJCC v8 / Stage IV Ovarian Cancer AJCC v8 / Stage IVA Ovarian Cancer AJCC v8 / Stage IVB Ovarian Cancer AJCC v8 / TP53 Negative1
3RecruitingTreatmentLung Cancers / Non-Small Cell Lung Carcinoma (NSCLC)1
3RecruitingTreatmentLung Non-Small Cell Carcinoma / Stage IB Lung Cancer AJCC v7 / Stage II Lung Cancer AJCC v7 / Stage IIA Lung Cancer AJCC v7 / Stage IIB Lung Cancer AJCC v7 / Stage IIIA Lung Cancer AJCC v71
3RecruitingTreatmentMalignant Neoplasm of Stomach2
3RecruitingTreatmentMalignant Neoplasm of Stomach / Stomach Neoplasms1
3RecruitingTreatmentMetastatic Adenocarcinoma of the Pancreas1
3RecruitingTreatmentMetastatic Breast Cancer1
3RecruitingTreatmentMetastatic Non-Small Cell Lung Cancer / Non Small Cell Lung Cancer Metastatic1
3RecruitingTreatmentMetastatic Pancreatic Ductal Adenocarcinoma1
3RecruitingTreatmentMetastatic nonsquamous non-small cell lung cancer / Metastatic Squamous Non-small Cell Lung Cancer1
3RecruitingTreatmentNeoplasms1
3RecruitingTreatmentNeoplasms, Endometrial3
3RecruitingTreatmentNeoplasms, Esophageal2
3RecruitingTreatmentNeoplasms, Head and Neck1
3RecruitingTreatmentNeoplasms, Lung / Non-Small Cell Lung Carcinoma (NSCLC)1
3RecruitingTreatmentNeoplasms, Ovarian1
3RecruitingTreatmentNeoplasms, Ovarian / Ovarian Cancer / Ovarian Germ Cell Cancer1
3RecruitingTreatmentNeoplasms, Ovarian / Ovarian Cancer / Ovarian Sex Cord Stromal Tumor1
3RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)6
3RecruitingTreatmentNon-Small-Cell Lung1
3RecruitingTreatmentNon-Squamous Non-Small Cell Lung Cancer1
3RecruitingTreatmentNon-small Cell Lung Cancer (NSCLC), Stage IV / Squamous Cell Carcinoma of Lung1
3RecruitingTreatmentOS / PFS / Quality of Life1
3RecruitingTreatmentOvarian Cancer4
3RecruitingTreatmentOvarian Epithelial Cancer1
3RecruitingTreatmentPancreatic Adenocarcinoma Metastatic / Pancreatic Cancer Metastatic1
3RecruitingTreatmentPancreatic Cancer Metastatic1
3RecruitingTreatmentPancreatic Cancer Non-resectable1
3RecruitingTreatmentProsthesis Survival1
3RecruitingTreatmentRecurrent Lung Non-Small Cell Carcinoma / Stage III Lung Cancer AJCC v8 / Stage IIIA Lung Cancer AJCC v8 / Stage IIIB Lung Cancer AJCC v8 / Stage IIIC Lung Cancer AJCC v8 / Unresectable Lung Non-Small Cell Carcinoma1
3RecruitingTreatmentRecurrent Ovarian Carcinoma1
3RecruitingTreatmentRecurrent Platinum Resistant Ovarian Cancer1
3RecruitingTreatmentSquamous Cell Carcinoma of the Penis, Usual Type1
3RecruitingTreatmentSquamous Non Small Cell Lung Cancer1
3RecruitingTreatmentStage II Non-Small Cell Lung Cancer AJCC v7 / Stage IIA Non-small Cell Lung Cancer / Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 / Stage IIB Non-small Cell Lung Cancer / Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 / Stage III Non-Small Cell Lung Cancer AJCC v7 / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer AJCC v7 / Stage IIIb Non-small Cell Lung Cancer / Stage IIIB Non-Small Cell Lung Cancer AJCC v71
3RecruitingTreatmentStage III Distal Bile Duct Cancer AJCC v8 / Stage III Gallbladder Cancer AJCC v8 / Stage III Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IIIA Distal Bile Duct Cancer AJCC v8 / Stage IIIA Gallbladder Cancer AJCC v8 / Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IIIB Distal Bile Duct Cancer AJCC v8 / Stage IIIB Gallbladder Cancer AJCC v8 / Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IV Distal Bile Duct Cancer AJCC v8 / Stage IV Gallbladder Cancer AJCC v8 / Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 / Stage IVA Gallbladder Cancer AJCC v8 / Stage IVB Gallbladder Cancer AJCC v8 / Unresectable Extrahepatic Bile Duct Carcinoma / Unresectable Gallbladder Carcinoma / Unresectable Intrahepatic Cholangiocarcinoma1
3RecruitingTreatmentStage ⅡA Pancreatic Cancer / Stage ⅡB Pancreatic Cancer1
3RecruitingTreatmentStomach Neoplasms1
3RecruitingTreatmentTriple Negative Breast Cancer (TNBC)2
3RecruitingTreatmentTriple Negative Breast Cancer (TNBC) / Triple-Negative Breast Cancer (TNBC)5
3RecruitingTreatmentTriple Negative Breast Neoplasms2
3SuspendedTreatmentBreast Adenocarcinoma / HER2/Neu Negative / Invasive Breast Carcinoma / Locally Recurrent Breast Cancer / Metastatic Breast Cancer / Stage IIIC Breast Cancer AJCC v7 / Stage IV Breast Cancer AJCC v6 and v71
3SuspendedTreatmentEndometrial Clear Cell Adenocarcinoma / Endometrial Dedifferentiated Carcinoma / Endometrial Endometrioid Adenocarcinoma / Endometrial Mixed Cell Adenocarcinoma / Endometrial Serous Adenocarcinoma / Endometrial Undifferentiated Carcinoma / Recurrent Endometrial Adenocarcinoma / Recurrent Endometrial Carcinoma / Recurrent Endometrial Clear Cell Adenocarcinoma / Recurrent Endometrial Dedifferentiated Carcinoma / Recurrent Endometrial Endometrioid Adenocarcinoma / Recurrent Endometrial Mixed Cell Adenocarcinoma / Recurrent Endometrial Serous Adenocarcinoma / Recurrent Endometrial Undifferentiated Carcinoma / Stage III Uterine Corpus Cancer AJCC v8 / Stage IIIA Uterine Corpus Cancer AJCC v8 / Stage IIIB Uterine Corpus Cancer AJCC v8 / Stage IIIC Uterine Corpus Cancer AJCC v8 / Stage IIIC1 Uterine Corpus Cancer AJCC v8 / Stage IIIC2 Uterine Corpus Cancer AJCC v8 / Stage IV Uterine Corpus Cancer AJCC v8 / Stage IVA Uterine Corpus Cancer AJCC v8 / Stage IVB Uterine Corpus Cancer AJCC v81
3SuspendedTreatmentPancreatic Adenocarcinoma Metastatic1
3TerminatedNot AvailableStage IIIb Non-small Cell Lung Cancer / Stage IV Non-Small Cell Lung Cancer1
3TerminatedTreatmentAdvanced Breast Cancer1
3TerminatedTreatmentAnemia / Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum / Platinum Sensitve Relapse1
3TerminatedTreatmentBreast Cancer1
3TerminatedTreatmentCarcinoma, Adenosquamous / Carcinoma, Large Cell / Non-Small Cell Lung Carcinoma (NSCLC) / Squamous Cell Carcinoma (SCC)1
3TerminatedTreatmentCarcinoma, Breast / HER2/Neu Positive / Male Breast Carcinoma / Recurrent Breast Carcinoma / Stage IV Breast Cancer1
3TerminatedTreatmentCardiac Toxicity / Inflammatory Breast Cancer (IBC) / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IV Breast Cancer1
3TerminatedTreatmentEndometrial Cancer2
3TerminatedTreatmentExtragonadal Germ Cell Tumor / Testicular germ cell tumour1
3TerminatedTreatmentFallopian Tube Cancer / Malignant Peritoneal Neoplasm / Ovarian Cancer1
3TerminatedTreatmentFirst Line Metastatic Breast Cancer1
3TerminatedTreatmentHead and Neck Carcinoma1
3TerminatedTreatmentLocally Advanced Malignant Neoplasm / Malignant Neoplasm of Pancreas / Pancreatic Carcinoma Non-resectable1
3TerminatedTreatmentLung Cancers2
3TerminatedTreatmentLung Cancers / Non-Small Cell Lung Carcinoma (NSCLC)1
3TerminatedTreatmentMelanoma2
3TerminatedTreatmentMetastatic Pancreatic Ductal Adenocarcinoma1
3TerminatedTreatmentNeoplasms, Breast1
3TerminatedTreatmentNeoplasms, Ovarian1
3TerminatedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)10
3TerminatedTreatmentOvarian Cancer2
3TerminatedTreatmentPancreatic Ductal Adenocarcinoma / Pancreatic Ductal Carcinoma / Stage IV Pancreatic Ductal Adenocarcinoma1
3Unknown StatusDiagnosticBreast Cancer1
3Unknown StatusTreatmentAdvanced Breast Cancer1
3Unknown StatusTreatmentBreast Cancer7
3Unknown StatusTreatmentCarcinoma of Unknown Primary1
3Unknown StatusTreatmentCervix Carcinoma1
3Unknown StatusTreatmentEsophageal Cancers1
3Unknown StatusTreatmentEsophageal Squamous Carcinoma1
3Unknown StatusTreatmentLung Cancers8
3Unknown StatusTreatmentMalignant Neoplasm of Stomach1
3Unknown StatusTreatmentMelanoma1
3Unknown StatusTreatmentMyocardial Ischemia / Stable or Unstable Angina Pectoris1
3Unknown StatusTreatmentNon-Small Cell Lung Carcinoma (NSCLC)1
3Unknown StatusTreatmentNon-squamous Nonsmall Cell Neoplasm of Lung1
3Unknown StatusTreatmentRecurrent, Persistent or Metastasized Cervical Cancer1
3WithdrawnTreatmentBreast Cancer1
3WithdrawnTreatmentCancer, Anaplastic Thyroid1
3WithdrawnTreatmentCervical Cancers1
3WithdrawnTreatmentEsophageal Cancers1
3WithdrawnTreatmentLung Cancers2
3WithdrawnTreatmentNon-Small Cell Lung Carcinoma (NSCLC)1
4Active Not RecruitingTreatmentAdenocarcinoma of the Pancreas1
4Active Not RecruitingTreatmentBreast Cancer1
4Active Not RecruitingTreatmentLung Squamous Cell Carcinoma / Squamous Non-small-cell Lung Cancer1
4Active Not RecruitingTreatmentOvarian Cancer1
4CompletedNot AvailableMalignancies1
4CompletedDiagnosticBreast Cancer1
4CompletedHealth Services ResearchBreast Cancer1
4CompletedTreatmentAdenocarcinomas / Carcinoma NOS / Carcinoma, Large Cell / Neoplasms, Lung / Non-Small Cell Lung Carcinoma (NSCLC) / Squamous Cell Carcinoma (SCC)1
4CompletedTreatmentBreast Cancer2
4CompletedTreatmentCarcinoma, Large Cell / Neuroendocrine Tumors1
4CompletedTreatmentCoronary Artery Disease (CAD)1
4CompletedTreatmentInstent Restenosis1
4CompletedTreatmentNon-Small Cell Lung Carcinoma (NSCLC)2
4Not Yet RecruitingTreatmentAdvanced Pancreatic Cancer1
4Not Yet RecruitingTreatmentBreast Cancer1
4Not Yet RecruitingTreatmentEfficacy and Safety1
4RecruitingTreatmentAdenocarcinoma of the Pancreas / Chemotherapy Effect1
4RecruitingTreatmentBreast Cancer1
4RecruitingTreatmentMetastatic Breast Cancer1
4RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)1
4Unknown StatusTreatmentBreast Cancer1
4Unknown StatusTreatmentMetastatic Breast Cancer1
4Unknown StatusTreatmentRecurrent Breast Cancer1
4Unknown StatusTreatmentTumors, Solid1
4WithdrawnTreatmentBreast Cancer1
Not AvailableActive Not RecruitingNot AvailableBreast Cancer1
Not AvailableActive Not RecruitingNot AvailableBreast Cancer / Metastatic1
Not AvailableActive Not RecruitingNot AvailableEsophageal Cancers / Lung Cancers1
Not AvailableActive Not RecruitingNot AvailableNon-Small Cell Lung Carcinoma (NSCLC)1
Not AvailableActive Not RecruitingNot AvailablePancreatic Cancer Metastatic1
Not AvailableActive Not RecruitingNot AvailableStage I Ovarian Cancer / Stage I Ovarian Cancer AJCC v6 and v7 / Stage IA Fallopian Tube Cancer / Stage IA Fallopian Tube Cancer AJCC v6 and v7 / Stage IB Fallopian Tube Cancer / Stage IB Fallopian Tube Cancer AJCC v6 and v7 / Stage IC Fallopian Tube Cancer / Stage IC Fallopian Tube Cancer AJCC v6 and v7 / Stage II Ovarian Cancer / Stage II Ovarian Cancer AJCC v6 and v7 / Stage IIA Fallopian Tube Cancer / Stage IIA Fallopian Tube Cancer AJCC v6 and v7 / Stage IIB Fallopian Tube Cancer / Stage IIB Fallopian Tube Cancer AJCC v6 and v7 / Stage IIC Fallopian Tube Cancer / Stage IIC Fallopian Tube Cancer AJCC v6 and v7 / Stage III Ovarian Cancer / Stage III Ovarian Cancer AJCC v6 and v7 / Stage III Primary Peritoneal Cancer / Stage III Primary Peritoneal Cancer AJCC v7 / Stage IIIA Fallopian Tube Cancer / Stage IIIA Fallopian Tube Cancer AJCC v7 / Stage IIIB Fallopian Tube Cancer / Stage IIIB Fallopian Tube Cancer AJCC v7 / Stage IIIC Fallopian Tube Cancer / Stage IIIC Fallopian Tube Cancer AJCC v7 / Stage IV Fallopian Tube Cancer / Stage IV Fallopian Tube Cancer AJCC v6 and v7 / Stage IV Ovarian Cancer / Stage IV Ovarian Cancer AJCC v6 and v7 / Stage IV Primary Peritoneal Cancer / Stage IV Primary Peritoneal Cancer AJCC v71
Not AvailableActive Not RecruitingNot AvailableStage IV Gastric Cancer With Metastasis1
Not AvailableActive Not RecruitingTreatmentAdenocarcinoma of the Lung / Adenosquamous Cell Lung Cancer / Large Cell Lung Cancer / Non-Small Cell Lung Cancer Recurrent / Squamous Cell Carcinoma of Lung / Stage IIA Non-small Cell Lung Cancer / Stage IIB Non-small Cell Lung Cancer / Stage IIIA Non-Small Cell Lung Cancer / Stage IIIb Non-small Cell Lung Cancer1
Not AvailableActive Not RecruitingTreatmentCervical Cancers / Uterine Cervical Cancer / Uterine Cervical Neoplasms1
Not AvailableActive Not RecruitingTreatmentEfficacy and Safety1
Not AvailableActive Not RecruitingTreatmentNon-Small Cell Lung Carcinoma (NSCLC)1
Not AvailableActive Not RecruitingTreatmentResectable Pancreatic Cancers1
Not AvailableActive Not RecruitingTreatmentStage IIA Breast Cancer / Stage IIB Breast Cancer / Stage IIIA Breast Cancer / Stage IIIB Breast Cancer / Stage IIIC Breast Cancer / Stage IV Breast Cancer1
Not AvailableCompletedNot AvailableBreast Cancer2
Not AvailableCompletedNot AvailableBreast Cancer / Metastatic Breast Cancer1
Not AvailableCompletedNot AvailableBreast Cancer / Metastatic Cancers1
Not AvailableCompletedNot AvailableCervical Intraepithelial Neoplasia (CIN)2
Not AvailableCompletedNot AvailableLung Cancers2
Not AvailableCompletedNot AvailableMalignant Neoplasm of Pancreas1
Not AvailableCompletedNot AvailableMalignant Neoplasm of Pancreas / Pancreatic Cancer Metastatic1
Not AvailableCompletedNot AvailableMetastatic Breast Cancer1
Not AvailableCompletedNot AvailableNonsquamous Nonsmall Cell Neoplasm of Lung1
Not AvailableCompletedNot AvailableOvarian Cancer2
Not AvailableCompletedNot AvailableOvarian Carcinoma1
Not AvailableCompletedNot AvailablePeripheral Vascular Disease Patient1
Not AvailableCompletedPreventionPeripheral Vascular Disease Patient1
Not AvailableCompletedSupportive CareBreast Cancer / Neoplasms, Ovarian / Pain1
Not AvailableCompletedSupportive CareMalignant Airway Obstruction Secondary to Non-small Cell Lung Cancer1
Not AvailableCompletedTreatmentAdenocarcinoma of the Breast / Breast Cancer1
Not AvailableCompletedTreatmentAdenocarcinoma of the Pancreas1
Not AvailableCompletedTreatmentAngioplasty / Atherosclerosis / Peripheral Arterial Disease (PAD)1
Not AvailableCompletedTreatmentBreast Cancer3
Not AvailableCompletedTreatmentBreast / Cervical / Lung / Ovarian / Renal1
Not AvailableCompletedTreatmentCarcinoma, Breast / Pain, Acute / Pain, Neuropathic / Peripheral neuropathy1
Not AvailableCompletedTreatmentFemoropopliteal Artery Disease / Peripheral Artery Disease (PAD)1
Not AvailableCompletedTreatmentHead and Neck Carcinoma1
Not AvailableCompletedTreatmentHypermethylation / Lung Cancers / Non Small Cell Lung Carcinoma (NSCLC) / Non-Small Cell Lung Carcinoma (NSCLC)1
Not AvailableCompletedTreatmentLaryngeal Neoplasms / Neoplasms, Hypopharyngeal1
Not AvailableCompletedTreatmentLocally Recurrent Breast Cancer / Metastatic Breast Cancer1
Not AvailableCompletedTreatmentLung Cancers1
Not AvailableCompletedTreatmentMalignant Neoplasm of Pancreas1
Not AvailableCompletedTreatmentOvarian Epithelial Cancer1
Not AvailableCompletedTreatmentPancreatic Cysts1
Not AvailableCompletedTreatmentPeripheral Arterial Disease, Angioplasty1
Not AvailableCompletedTreatmentTumors, Solid1
Not AvailableCompletedTreatmentUterine Cervical Neoplasms1
Not AvailableNo Longer AvailableNot AvailableAdenocarcinomas of the Gastroesophageal Junction / Malignant Neoplasm of Stomach1
Not AvailableNot Yet RecruitingDiagnosticNon-Small Cell Lung Carcinoma (NSCLC)1
Not AvailableNot Yet RecruitingTreatmentAdvanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction1
Not AvailableNot Yet RecruitingTreatmentAdvanced Gastrointestinal Tumors1
Not AvailableNot Yet RecruitingTreatmentBorderline Resectable Pancreatic Cancer / Locally Advanced Pancreatic Cancer / Malignant Neoplasm of Pancreas / Neoadjuvant Therapy1
Not AvailableNot Yet RecruitingTreatmentBreast Cancer2
Not AvailableNot Yet RecruitingTreatmentBreast Cancer / Breast Diseases / Neoplasms, Breast1
Not AvailableNot Yet RecruitingTreatmentBreast Cancer / Cyclophosphamide / Epirubicin / Paclitaxel1
Not AvailableNot Yet RecruitingTreatmentCervical Cancers1
Not AvailableRecruitingNot AvailableBiliary Tract Cancer / Cancer of the Gallbladder / Colo-rectal Cancer / Esophageal Cancers / Liver Cancer / Malignant Neoplasm of Pancreas / Malignant Neoplasm of Stomach1
Not AvailableRecruitingNot AvailableBorderline Resectable Pancreatic Adenocarcinoma / Chemotherapy Effect / Locally Advanced Pancreatic Adenocarcinoma / Post-pancreatectomy1
Not AvailableRecruitingNot AvailableBreast Cancer4
Not AvailableRecruitingNot AvailableBreast Cancer / Neoplasms, Breast1
Not AvailableRecruitingNot AvailableCognition Disorders / Polyneuropathies1
Not AvailableRecruitingNot AvailableMalignant Neoplasm of Pancreas / Periampullary Adenocarcinoma / Periampullary Cancer1
Not AvailableRecruitingNot AvailableNon-Small Cell Lung Carcinoma (NSCLC)1
Not AvailableRecruitingBasic ScienceCatheter Related Complications1
Not AvailableRecruitingDiagnosticEsophagogastric Junction Cancer / Esophagus Cancer1
Not AvailableRecruitingDiagnosticNeoplasms, Breast1
Not AvailableRecruitingScreeningAdenocarcinoma of the Lung / Lung Large Cell Carcinoma / Resectable Lung Non-Small Cell Carcinoma / Stage IB Lung Non-Small Cell Carcinoma AJCC v7 / Stage IB Lung Squamous Cell Carcinoma AJCC v7 / Stage II Lung Non-Small Cell Cancer AJCC v7 / Stage II Lung Squamous Cell Carcinoma AJCC v7 / Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 / Stage IIA Lung Squamous Cell Carcinoma AJCC v7 / Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 / Stage IIB Lung Squamous Cell Carcinoma AJCC v7 / Stage IIIA Lung Non-Small Cell Cancer AJCC v7 / Stage IIIA Lung Squamous Cell Carcinoma AJCC v71
Not AvailableRecruitingSupportive CareStage IV Breast Cancer AJCC v6 and v71
Not AvailableRecruitingTreatmentAdvanced Pancreatic Ductal Adenocarcinoma / Malignant Neoplasm of Pancreas1
Not AvailableRecruitingTreatmentAtypical Teratoid/Rhabdoid Tumor (AT/RT) / Ewing's Family Tumors / Germ Cell Tumors / Hepatoblastomas / Medulloblastomas / Primary Malignant Brain Neoplasms / Renal Tumors / Retinoblastoma / Rhabdomyosarcomas / Soft Tissue Sarcoma (STS) / Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET) / Tumors of the Central Nervous System1
Not AvailableRecruitingTreatmentBreast Cancer / Chemotherapeutic Toxicity1
Not AvailableRecruitingTreatmentBreast Neoplasm Female1
Not AvailableRecruitingTreatmentCervical Cancers2
Not AvailableRecruitingTreatmentGastric Carcinoma1
Not AvailableRecruitingTreatmentLocally Advanced Pancreatic Cancer1
Not AvailableRecruitingTreatmentOrganoid1
Not AvailableRecruitingTreatmentPancreatic Cancer Stage IV1
Not AvailableRecruitingTreatmentTriple Negative Breast Cancer (TNBC)1
Not AvailableTerminatedNot AvailableBreast Cancer1
Not AvailableTerminatedTreatmentFallopian Tube Cancer / Ovarian Cancer / Primary Peritoneal Cancer1
Not AvailableTerminatedTreatmentStage IA Uterine Sarcoma / Stage IB Uterine Sarcoma / Stage IC Uterine Sarcoma / Stage IIA Uterine Sarcoma / Stage IIB Uterine Sarcoma / Stage IIIA Uterine Sarcoma / Stage IIIB Uterine Sarcoma / Stage IIIC Uterine Sarcoma / Stage IVA Uterine Sarcoma / Stage IVB Uterine Sarcoma / Uterine Carcinosarcoma1
Not AvailableUnknown StatusNot AvailableNon-Small Cell Lung Carcinoma (NSCLC)1
Not AvailableUnknown StatusTreatmentBreast Cancer3
Not AvailableUnknown StatusTreatmentPeripheral Arterial Disease (PAD) / Restenosis1
Not AvailableWithdrawnNot AvailableOvarian Cancer1
Not AvailableWithdrawnTreatmentBreast Cancer2
Not AvailableWithdrawnTreatmentBreast Cancer / Elderly Patients Diagnosed With Breast Cancer / HER2 Positive Breast Cancers1
Not AvailableWithdrawnTreatmentMalignancies1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
  • Abraxis BioScience Inc.
  • Accord Healthcare
  • APP Pharmaceuticals
  • Barr Pharmaceuticals
  • Bedford Labs
  • Ben Venue Laboratories Inc.
  • Bristol-Myers Squibb Co.
  • Ebewe Pharma
  • Ethex Corp.
  • Fresenius Kabi AB
  • Hospira Inc.
  • Intas Pharmaceuticals Ltd.
  • Ivax Pharmaceuticals
  • Mead Johnson and Co.
  • Pharmachemie BV
  • Pliva Inc.
  • Teva Pharmaceutical Industries Ltd.
  • UDL Laboratories
Dosage forms
FormRouteStrength
Injection, powder, for suspensionIntravenous5 mg/ml
Injection, powder, lyophilized, for suspensionIntravenous100 mg/20mL
Powder, for suspensionIntravenous
Injection, solution, concentrateIntravenous6 mg/1mL
InjectionIntravenous100 mg/16.7mL
InjectionIntravenous30 mg/5mL
InjectionIntravenous300 mg/50mL
InjectionIntravenous6 mg/1mL
Injection, solutionIntravenous100 mg/16.7mL
Injection, solutionIntravenous30 mg/5mL
Injection, solutionIntravenous300 mg/50mL
LiquidIntravenous6 mg
LiquidIntravenous
SolutionIntravenous
PowderNot applicable1 g/1g
Injection, solution, concentrateIntravenous6 mg/ml
Injection, solutionIntravenous6 mg/1mL
SolutionIntravenous6 mg
Prices
Unit descriptionCostUnit
Abraxane 100 mg vial1119.6USD vial
Taxol 30 mg/5 ml vial35.06USD ml
Onxol 30 mg/5 ml vial34.54USD ml
Onxol 300 mg/50 ml vial34.54USD ml
Paclitaxel 300 mg/50 ml vial5.31USD ml
Paclitaxel 100 mg/16.7 ml vial4.45USD ml
Paclitaxel 30 mg/5 ml vial3.54USD ml
Paclitaxel 150 mg/25 ml vial3.36USD ml
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)
US5498421No1996-03-122013-03-12Us
US5439686No1995-08-082013-02-22Us
CA2155947No2007-08-212014-02-22Canada
CA2086874No1998-09-012013-01-07Canada
US7923536Yes2011-04-122024-06-09Us
US8034375Yes2011-10-112027-02-13Us
US8138229Yes2012-03-202024-06-09Us
US8268348Yes2012-09-182026-08-21Us
US8314156Yes2012-11-202024-06-09Us
USRE41884No2010-10-262016-08-14Us
US7758891Yes2010-07-202026-08-21Us
US9101543Yes2015-08-112026-08-21Us
US7820788Yes2010-10-262025-04-27Us
US8853260Yes2014-10-072021-04-10Us
US9597409Yes2017-03-212032-09-04Us
US9393318Yes2016-07-192032-09-04Us
US9511046Yes2016-12-062034-07-12Us
Additional Data Available
  • Filed On
    Filed On

    The date on which a patent was filed with the relevant government.

    Learn more

Properties

State
Solid
Experimental Properties
PropertyValueSource
melting point (°C)216-217 °CFDA label
water solubilityInsolubleFDA label
logP3Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00556 mg/mLALOGPS
logP3.2ALOGPS
logP3.54ChemAxon
logS-5.2ALOGPS
pKa (Strongest Acidic)10.36ChemAxon
pKa (Strongest Basic)-1ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count10ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area221.29 Å2ChemAxon
Rotatable Bond Count14ChemAxon
Refractivity218.29 m3·mol-1ChemAxon
Polarizability87.17 Å3ChemAxon
Number of Rings7ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.914
Blood Brain Barrier-0.9748
Caco-2 permeable-0.8957
P-glycoprotein substrateSubstrate0.8345
P-glycoprotein inhibitor IInhibitor0.5509
P-glycoprotein inhibitor IINon-inhibitor0.7309
Renal organic cation transporterNon-inhibitor0.9349
CYP450 2C9 substrateNon-substrate0.837
CYP450 2D6 substrateNon-substrate0.9116
CYP450 3A4 substrateSubstrate0.7278
CYP450 1A2 substrateNon-inhibitor0.9045
CYP450 2C9 inhibitorNon-inhibitor0.9071
CYP450 2D6 inhibitorNon-inhibitor0.9231
CYP450 2C19 inhibitorNon-inhibitor0.9025
CYP450 3A4 inhibitorNon-inhibitor0.8309
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8937
Ames testNon AMES toxic0.9132
CarcinogenicityNon-carcinogens0.9158
BiodegradationNot ready biodegradable0.9491
Rat acute toxicity2.4391 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9978
hERG inhibition (predictor II)Non-inhibitor0.7982
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0a4i-3971000000-2a76bfe38de6d5790a39

Taxonomy

Description
This compound belongs to the class of organic compounds known as taxanes and derivatives. These are diterpenoids with a structure based either on the taxane skeleton, or a derivative thereof. In term of phytochemistry, several derivatives of the taxane skeleton exist: 2(3->20)-abeotaxane, 3,11-cyclotaxane, 11(15->1),11(10->9)-abeotaxane, 3,8-seco-taxane, and 11(15->1)-abeotaxane, among others. More complex skeletons have been found recently, which include the taxane-derived [3.3.3] propellane ring system.
Kingdom
Organic compounds
Super Class
Lipids and lipid-like molecules
Class
Prenol lipids
Sub Class
Diterpenoids
Direct Parent
Taxanes and derivatives
Alternative Parents
Tetracarboxylic acids and derivatives / Benzoic acid esters / Benzoyl derivatives / Alpha-acyloxy ketones / Fatty acid esters / Tertiary alcohols / Secondary alcohols / Oxetanes / Carboxylic acid esters / Cyclic alcohols and derivatives
show 9 more
Substituents
Taxane diterpenoid / Tetracarboxylic acid or derivatives / Benzoate ester / Benzoic acid or derivatives / Benzoyl / Fatty acid ester / Alpha-acyloxy ketone / Monocyclic benzene moiety / Fatty acyl / Benzenoid
show 25 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
taxane diterpenoid, tetracyclic diterpenoid (CHEBI:45863)

Targets

Kind
Protein
Organism
Humans
Pharmacological action
Yes
Actions
Inhibitor
General Function
Structural constituent of cytoskeleton
Specific Function
Tubulin is the major constituent of microtubul